Sommaire

• • ·Scientific Programme Committee

    Page :A1

    
• • ·Aim and Scope

    Page :A2

    
• • ·Editorial Board

    Page :A3

    
• • ·Table of Contents

    Page :A4

    Plan Plan

• Podium Sessions

  • ·POD-01.01: Image guided I¹²⁵ prostate brachytherapy in the community setting: six year results

    Page :1

    D.A. Roszhart, T.G. Shanahan, W. Severino, D. Lieber, P.W. Mueller, S. Markwell, R.B. Maxey

    Plan Plan
  • ·POD-01.02: Hybrid interactive prostate brachytherapy: increasing the role of the urologist in the or

    Page :1

    D.A. Roszhart, T.G. Shanahan

    Plan Plan
  • ·POD-01.03: The impact of first repeated biopsy in predicting progression in a cohort of prostate cancer patients managed with active surveillance

    Page :1-2

    M.F. Al Otaibi, N. Fahmy, P. Ross, W. Kassouf, S. Jeyaganth, J. Steinberg, L.R. Begin, K. Sircar, A. Aprikian, S. Tanguay

    Plan Plan
  • ·Abstract Withdrawn

    Page :2

    
  • ·POD-01.04: High-intensity focused ultrasound for the treatment in 503 patients with localized prostate cancer

    Page :2

    T. Uchida, M. Nitta, S. Hongo, S. Shoji, Y. Nagata, Y. Usui, T. Terachi

    Plan Plan
  • ·POD-01.05: The advanced learning curve in robotic-assisted laparoscopic radical prostatectomy: a multi-institutional survey

    Page :2

    H.J. Lavery, T. Ahlering, A. Tewari, J.A. Smith, A. Shalhav, D. Albala, P. Wiklund, A.J. Costello, K.J. Palmer, K. Shah, R. Thaly, V. Patel

    Plan Plan
  • ·POD-01.06: Phase II trial of weekly docetaxel and complete androgen blockade prior to radical prostatectomy in high-risk localized prostate cancer patients

    Page :2-3

    F.J. Gómez Veiga, A. Sousa, A. Alcaraz, J. Areal, N. Hannaoui, L.A. Aparicio, B. Mellado, E. Gallardo, P. Gascón, A. Font

    Plan Plan
  • ·POD-01.07: Laparoscopic radical prostatectomy: minimum 5 year follow-up of the first 100 UK cases

    Page :3

    D. Merilees, C. Chabert, C. Eden

    Plan Plan
  • ·POD-01.08: Curtain dissection of the lateral prostatic fascia and potency following laparoscopic radical prostatectomy – a veil of mystery

    Page :3

    D. Merilees, C. Chabert, C. Eden

    Plan Plan
  • ·POD-01.09: A validation/evaluation of 5 postoperative prostate cancer prognostic tools

    Page :3-4

    B.A. Inman, S. Siddiqui, B.C. Leibovich, I. Frank

    Plan Plan
  • ·POD-01.10: Oncological and functional outcomes with sutureless vesicourethral alignment in open and laparoscopic radical prostatectomy: 6 years experience

    Page :4

    N. Simforoosh, A. Tabibi, A. Javaherforooshzadeh

    Plan Plan
  • ·POD-01.11: Increased incidence of urosepsis following transrectal prostate biopsies: a possible solution

    Page :4

    D. Pode, I. Golan, G. Lorber

    Plan Plan
  • ·POD-01.12: High intensity focused ultrasound therapy for clinically localized prostate cancer: efficacy and morbidity of the minimally invasive procedure

    Page :4-5

    S. Mallick, L. Taksin, S. Le Toquin, A. Dufour, Y. Fouques, H. Bensadoun

    Plan Plan
  • ·POD-01.13: Minimally invasive therapy using high intensity focused ultrasound for localized recurrence of prostate cancer after radiation failure

    Page :5

    S. Mallick, L. Taksin, S. Le Toquin, A. Dufour, Y. Fouques, H. Bensadoun

    Plan Plan
  • ·POD-02.01: Holmium: YAG incompatibility between lasers and fibers

    Page :5

    A. Marks, A.C. Mues, B.E. Knudsen, J.M.H. Teichman

    Plan Plan
  • ·POD-02.02: The assessment of clinical efficacy of intranasal desmopressin spray and suppository diclofenac in the treatment of renal colic in comparison with suppository diclofenac alone

    Page :5-6

    A. Roshani, Z. Atrkar Roshan, T. Zarkami, M. Palizkar

    Plan Plan
  • ·POD-02.03: Risk factors for urinary stone formation in the morbidly obese

    Page :6

    M. Monga, B. Duffey, R. Pedro, D. Weiland, J. Melquist, C. Kriedberg, S. Ikramuddin, T. Kellogg, B. Slusarek, M. Stessman

    Plan Plan
  • ·POD-02.04: CT visible internal stone structure—but not Hounsfield unit value—of calcium oxalate monohydrate (COM) calculi predicts lithotripsy fragility in vitro

    Page :6-7

    J.C. Williams, C.A. Zarse, T.A. Hameed, M.E. Jackson, Y.A. Pishchalnikov, J.E. Lingeman, J.A. McAteer

    Plan Plan
  • ·POD-02.05: Percutaneous nephrolithotomy versus extracorporeal shockwave lithotripsy for the treatment of lower calyceal stones

    Page :7

    G.A. Al-Atrach, A.M. El-Nashar, M.E. Sherief, E.A. El-Gawad, M. Hassan Ali

    Plan Plan
  • ·POD-02.06: Coherent-scatter computed tomography of urinary calculi: a novel technique to identify mineral composition at stone core

    Page :7

    G. Wignall, J. Denstedt, I. Cunningham

    Plan Plan  
  • ·POD-02.07: Management of proximal ureteric calculi: pre and post holmium laser era

    Page :7-8

    A. Bhandarkar

    Plan Plan
  • ·POD-02.08: Aid to percutaneous renal access by virtual projection of the ultrasound puncture tract onto fluoroscopic images

    Page :8

    P. Conort, P. Mozer, A. Leroy, M. Baumann, G. Chevreau, J. Troccaz, E. Chartier-Kastler, F. Richard

    Plan Plan
  • ·POD-03.01: Development and application of mixed vaccines in renal cell carcinoma: combining autologous tumor cells with dendritic cells derived from autologous or allogeneic origin

    Page :8

    D.S. Park, H.J. Cho, M.Y. Han, S.J. Lee, D.Y. Oh, S.K. Hwang

    Plan Plan
  • ·POD-03.02: Minimally invasive management of upper tract transitional cell carcinoma at a tertiary care center

    Page :8-9

    M. Nomikos, D.A. Tolley, S. Sowter

    Plan Plan
  • ·POD-03.03: Surgical management and outcome of renal cell carcinoma with level III IVC thrombus: a single center experience

    Page :9

    M. Manoharan, R. Ayyathurai, R. De Los Santos, M.S. Soloway, G. Ciancio

    Plan Plan
  • ·POD-03.04: Percutaneous radiofrequency ablation (PRFA) of small renal tumors under ultrasound (US) in high risk patients: three year follow-up

    Page :9

    M. Brausi, M. Gavioli, G. Peracchia, G. De Luca, G. Verrini, M. Viola, G. Simonini, G.L. Giliberto, F. Ferrari

    Plan Plan
  • ·POD-03.05: The role of thrombospondin-1 in angiogenesis and patients survival after radical nephrectomy for clear cell renal cell carcinoma

    Page :9-10

    D.P. Zubac, L. Bostad, C. Gestblom, T. Seidal, T. Wentzel-Larsen, S. Haukaas

    Plan Plan
  • ·POD-03.06: Renal insufficiency is not a contraindication for renal cryoablation

    Page :10

    J.C. Vestal, B.F. Schwartz, T.B. Manny, J.C. Rewcastle

    Plan Plan
  • ·POD-03.07: High tumor expression of KI-67 is an independent predictor of poor outcome among patients treated surgicaly for clear cell renal cell carcinoma

    Page :10-11

    M.K. Tollefson, Y.M. Sheinin, J.C. Cheville, B.C. Leibovich, M.L. Blute, C.M. Lohse, E.D. Kwon

    Plan Plan
  • ·Abstract Withdrawn

    Page :11

    
  • ·POD-04.01: Postoperative nomogram for clinical unilateral T3a prostate cancer

    Page :11

    C.Y. Hsu, S. Joniau, R. Oyen, T. Roskams, H. van Poppel

    Plan Plan  
  • ·POD-04.02: The percentage of positive biopsies is an independent predictor of survival at the onset of hormonal treatment for advanced prostate cancer

    Page :11

    G. Normand, O. Celhay, B. Merlet, F. Ouaki, C. Pirès, B. Doré, J. Irani

    Plan Plan
  • ·POD-04.03: NeuroD1 expression in human prostate cancer

    Page :12

    L. Cindolo, R. Franco, M. Cantile, P. Chiodini, L. Salzano, M. Falsaperla, C. Cillo

    Plan Plan
  • ·POD-04.04: Serum selenium level and prostate cancer: case-control study

    Page :12

    G. Pourmand, A. Emamzadeh, K. Moradi, M. Taherimahmoudi, A. Mehrsai, M. Nikoobakht

    Plan Plan
  • ·POD-04.05: Semaphorin4D and plexinB1 expression in clinically localised prostate cancer

    Page :12

    J. Nariculam, A. Freeman, M. Feneley, M. Williamson, J.R. Masters

    Plan Plan
  • ·POD-04.06: Hedgehog signalling in advanced prostate cancer

    Page :12-13

    G. Shaw, P. Purkis, T. Oliver, D. Prowse

    Plan Plan
  • ·POD-04.07: A gene expression profile predictive of outcome in men at high-risk of systemic progression and death from prostate cancer following radical prostatectomy

    Page :13

    R.J. Karnes, J. Cheville, G. Vasmatzis

    Plan Plan
  • ·POD-04.08: Treatment outcome of immediate versus delayed hormone therapy in patients with lymph node metastases following radical prostatectomy

    Page :13

    Y. Fradet, R. Tiguert, D. Chautard, L. Lacombe, F. Harel

    Plan Plan
  • ·POD-05.01: Effect of gas flow on postoperative analgesic use in laparoscopic varicocelectomy

    Page :13-14

    R. Maghsoudi, A. Elahian, H. Aliasgharpour

    Plan Plan
  • ·POD-05.02: A novel form of the “Whitaker” test for ejaculatory duct obstruction

    Page :14

    M.L. Eisenberg, K. Shinohara, M. Garcia, P.J. Turek

    Plan Plan
  • ·POD-05.03: Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double blind placebo-controlled, fixed dose, randomized study

    Page :14

    M.R. Safarinejad

    Plan Plan
  • ·POD-05.04: A congenital factor in the development of erectile dysfunction: pelvic artery variations

    Page :14-15

    Y. Kawanishi, H. Muguruma, H. Sugiyama, J. Kagawa, M. Yamanaka, K. Kojima, A. Numata

    Plan Plan
  • ·Abstract Withdrawn

    Page :15

    
  • ·POD-05.05: Efficacy and safety of dapoxetine for premature ejaculation (PE): Results from a placebo-controlled, double-blind, randomized, parallel-group study in 22 countries

    Page :15

    Jacques Buvat, Francois Giuliano, Fisseha Tesfaye, Margaret Rothman, David Rivas

    Plan Plan
  • ·POD-05.06: The peripheral role of serotonin reuptake inhibitors on the human seminal vesicle: in vitro study

    Page :15

    P. Birowo, S. Ückert, G. Kedia, C. Keil, M. Meyer, H.J. Mägert, S. Machtens, W.F. Thon, F. Scheller, U. Jonas, A. Taher, D. Rahardjo

    Plan Plan
  • ·POD-05.07: Efficacy and tolerability of sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction

    Page :15-16

    J. Buvat, D. Hatzichristou, M. Maggi, I. Farmer, J.M. Martinez-Jabaloyas, P.J. Miller, G. Schnetzler

    Plan Plan
  • ·POD-05.08: Efficacy and patient satisfaction associated with first time and revision penile prosthesis surgery

    Page :16

    P.G. Barboglio, C.T. Soloway, Y.Y. Yang, B.R. Kava

    Plan Plan  
  • ·POD-05.09: A 6 month interim analysis of the effect of nightly intraurethral alprostadil vs sildenafil on penile morphometrics after nerve sparing radical prostatectomy (NSRRP)

    Page :16-17

    D. Fenig, D. Robbins, D. Brassil, B. Goodwin, A. McCullough

    Plan Plan
  • ·Abstract Withdrawn

    Page :17

    
  • ·POD-05.10: Efficacy of sildenafil citrate in treatment of erectile dysfunction: impact of associated co-morbidities

    Page :17

    A.I. El-Sakka

    Plan Plan
  • ·POD-05.11: The soluble guanylyl cyclase stimulator BAY 41-2272 reverses endothelial and nerve dysfunction in corpus cavernosum from spontaneously diabetic (db/db -/-) mice

    Page :17

    C.E. Teixeira, F.B.M. Priviero, R.C. Webb

    Plan Plan
  • ·POD-06.01: Profile and management of patients treated for the first time for LUTS/BPH in four European countries

    Page :17-19

    R.O. Fourcade, N. Théret, C. Taïeb

    Plan Plan
  • ·POD-06.02: The effects of dutasteride, tamsulosin, and combination therapy on lower urinary tract symptoms and Qmax in men with BPH and prostatic enlargement: Two-year results from the Combination of Avodart^® and Tamsulosin (CombAT) study

    Page :19

    C. Roehrborn, P. Paul Siami, J. Jack Barkin, R. Ronaldo Damião, F. Montorsi, CombAT Study Group

    Plan Plan  
  • ·Abstract Withdrawn

    Page :19

    
  • ·POD-06.03: Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over a wide range of baseline prostate size: data from MTOPS and PLESS

    Page :19-20

    S.A. Kaplan, A.G. Meehan, S. Suryawanshi, J.W. Kusek, L.M. Nyberg

    Plan Plan  
  • ·POD-06.04: Efficacy and duration of symptom improvement after prostate botulinum toxin injection for BPH

    Page :20

    Y.C. Chuang, P.H. Chiang, N. Yoshimura, M. Chancellor

    Plan Plan
  • ·Abstract Withdrawn

    Page :20

    
  • ·POD-06.05: BPH: gyrus loop TURP versus conventional TURP: prospective trial - 3 years follow up

    Page :20

    A. Tan, R. Chean, S. Murray

    Plan Plan
  • ·POD-06.06: Holmium laser prostatectomy: Indian experience

    Page :21

    A. Varshney, A. Agarwal, B.S. Bansal, P. Joshi, S. Yadu

    Plan Plan
  • ·POD-06.07: TUNA therapy: improvement in technical device - better clinical outcome

    Page :21

    D.P. Zubac, T. Wentzel-Larsen, T. Østrem

    Plan Plan
  • ·POD-06.08: Benign prostate specific antigen: distribution and clinical correlates in a community-based sample of men

    Page :21-22

    T. Rhodes, S.J. Jacobsen, D.J. Jacobson, M.E. McGree, K. Demissie, G.G. Rhoads, C.J. Girman, M.M. Lieber, J.L. Sauver, G.G. Klee

    Plan Plan
  • ·POD-06.09: PVP update 3 years of data on photo selective vapourisation of the prostate

    Page :22

    S.W. Alkhayal, T.R.G. Larner

    Plan Plan
  • ·POD-06.10: Alfuzosin 10 mg once daily shows no deleterious effect on ejaculation components in real life practice

    Page :22-23

    J.M. Fitzpatrick, R. Rosen

    Plan Plan
  • ·POD-06.11: Prevalence of ejaculatory dysfunction in men with lower urinary tract symptoms (LUTS) suggestive of BPH receiving medical or surgical treatment

    Page :23

    J.M. Fitzpatrick, R. Rosen

    Plan Plan
  • ·Abstract Withdrawn

    Page :23

    
  • ·POD-07.01: Do public schools teach voiding dysfunction? The results of an elementary school teachers survey in Urmia City, Iran

    Page :23

    M. Moosavi, D. Mehraban, S. Samadzadeh, M. Salehi

    Plan Plan
  • ·POD-07.02: Augmentation ureterocystoplasty: an outcome review in 21 cases

    Page :23-24

    R. Mahdavi, A. Taghizadeh, S. Mirsadraee, H. Shakibi, H. Patel

    Plan Plan
  • ·Abstract Withdrawn

    Page :24

    
  • ·POD-07.03: The Mitrofanoff continent external urinary diversion in children: indications and results

    Page :24

    M. Hadj Slimen, W. Guedrib, M. Bouacida, I. Ben Abdellah, H. Jallouli, K. Chabchoub, A. Bahloul, M.N. Mhiri

    Plan Plan
  • ·POD-07.04: Change of renal parenchymal thickness according to the age of pyeloplasty in children with unilateral ureteropelvic junction obstruction

    Page :24

    M. Baek, D.S. Park, S.H. Paick, S.J. Jeong, S.K. Hong, H. Choi

    Plan Plan
  • ·POD-07.05: One-day hospitalization after open pyeloplasty can be performed safely

    Page :24-25

    J.S. Palmer

    Plan Plan
  • ·POD-08.01: Is it appropriate to apply age-specific PSA reference to clinical practice based on PSA cutoff 3.0 ng/ml in Korean men?

    Page :25

    S.J. Jeong, J.H. Han, I.H. Chang, J.H. Yu, B.K. Han, K.H. Moon, S.K. Hong, S.S. Byun, S.E. Lee

    Plan Plan
  • ·POD-08.02: Prostate biopsy indications: practice patterns and the potential role of PCA3

    Page :25

    B. Tombal, H. van Poppel, C. Schulman, J. Irani, A. de la Taille, R. Berges, A. Haese, P. Mulders, T. de Reijke, M. Emberton, D. Gillatt

    Plan Plan
  • ·POD-08.03: Antibiotic prophylaxis in transrectal prostate biopsy in the Netherlands

    Page :25-26

    C.H.I. Pelser, M.T.W.T. Lock

    Plan Plan
  • ·POD-08.04: PCA3 molecular urine assay predicts tumor volume in prostatectomy

    Page :26

    H. Nakanishi, J. Groskopf, H.A. Fritsche, V. Bhadkamkar, A. Blasé, S. Vikas Kumar, J.W. Davis, P. Troncoso, H. Rittenhouse, R.J. Babaian

    Plan Plan
  • ·POD-08.05: The PCA3 assay is useful in guiding prostate biopsy (PB) decision in men with a prior negative biopsy

    Page :26-27

    A. Haese, H. van Poppel, M. Marberger, P. Mulders, C. Abbou, L. Boccon-Gibod, A. Stenzl, H. Huland, A. de la Taille, J. Schalken

    Plan Plan
  • ·POD-08.06: Does inflammation on prostate needle biopsy increase the likelihood of cancer on subsequent biopsy?

    Page :27

    W.W.B. Bassett, D.M.R. Bettendorf, J.M. Lewis, K.R. Loughlin

    Plan Plan
  • ·POD-08.07: A comparison of predictive nomograms for the presence of high grade prostate cancer: the PCPT risk calculator, the Spurgeon CART and the Windsor model

    Page :27

    S. Robinson, O. Karim, H. Motiwala, M. Laniado

    Plan Plan
  • ·POD-09.01: The value of adjuvant instillational treatments in prognosis of Ta, T1 bladder cancers

    Page :27-28

    G. Glück, O. Drăgoescu

    Plan Plan
  • ·POD-09.02: Staging muscle invasive bladder cancer with dynamic gadolinium enhanced magnetic resonance imaging

    Page :28

    M. Wagner, J. Prather, N. Dobos, L. Chow, D. Siamak

    Plan Plan
  • ·POD-09.03: Endovesical epirubicin and interferon ⍺ 2b is comparable to BCG as adjuvant treatment for T1 tumours with or without CIS

    Page :28

    M. Duchek, F. Wiklund, S. Jahnson, O. Mestad, P. Hellström, S. Hellsten, P.U. Malmström

    Plan Plan
  • ·POD-09.04: A comparison of specificity of urine cytology, urinary nuclear matrix protein 22 [NMP22] and multi-target fluorescent in situ hybridization [FISH] assay in bladder cancer patients with no recurrence at surveillance

    Page :28-29

    E.O. Kehinde, F. Al-Mulla, S. Jacob, K. Kapila, J.T. Anim, V. Jerin

    Plan Plan
  • ·POD-09.05: Is neo-adjuvant chemotherapy better tolerated than adjuvant chemotherapy in patients undergoing cystectomy?

    Page :29

    R. Ayyathurai, M.A. Reyes, R. Singal, M. Manoharan, M.S. Soloway

    Plan Plan
  • ·POD-09.06: Radical cystectomy in nonmuscle invasive bladder cancer

    Page :29-30

    S.A. El Abd, A.R. Ramadan, M.D. El-Sharaby, M.A. El-Gharbawy

    Plan Plan
  • ·POD-09.07: Number of lymph nodes retrieved in lymphadenectomy specimen during radical cystectomy and local disease control

    Page :30

    S.A. El Abd, A.R. Ramadan, M.D. El-Sharaby, M.A. El-Gharbawy

    Plan Plan
  • ·POD-09.08: The predictive role of the re-TURB in the evaluation of high-grade disease progression rate of T1G3 bladder neoplasm

    Page :30-31

    R. Giulianelli, S. Brunori, B.C. Gentile, G. Vincenti, F. Pisanti, L. Mavilla, L. Albanesi, T. Shestani

    Plan Plan
  • ·POD-09.09: Outcomes and prognostic significance of second look TURB of high risk non invasive bladder cancer

    Page :31

    R. Sanseverino, A. Campitelli, G. Napodano, A. Baio, G. Miracolo, G. Contaldo

    Plan Plan
  • ·POD-09.10: Prognotic factors in patients with urothelial bladder cancer submitted to radical cystectomy

    Page :31

    F.P. da Fonseca, A.L. de Godoy, G.C. Guimaraes, I.N. Nishimoto, S.C. Zequi, F.A. Soares, A. Lopes

    Plan Plan
  • ·POD-09.11: Fully-automated FISH-based testing using robotic microscopy: application in bladder cancer identification and recurrence monitoring

    Page :31-32

    N. Romas, M.W. Kilpatrick, T. Tafas, R. Gasparini, P. Tsipouras

    Plan Plan
  • ·POD-10.01: Radiofrequency ablation of renal tumors: an alternative for patients with imperative indication for nephron-sparing surgery or those with significant co-morbidities

    Page :32

    K.J. Palmer, R. Thaly, K. Shah, V. Patel

    Plan Plan
  • ·POD-10.02: The long-term results of laparoscopic pyeloplasty

    Page :32

    D. Merilees, C. Chabert, C. Eden

    Plan Plan
  • ·POD-10.03: Laparoscopic adrenalectomy for functioning and non functioning adrenal tumors: experience with 50 cases

    Page :32-33

    A.E. Abdel Maksoud, M.R. El Halaby, M.E. Ibrahim, G. Janetschek

    Plan Plan
  • ·POD-10.04: Autologous fibrin glue using the vivostat system for hemostasis in laparoscopic partial nephrectomy

    Page :33

    L. Cindolo, S. Gidaro, K. Lipsky, O. Dalpiaz, R. Zigeuner, L. Schips

    Plan Plan
  • ·POD-10.05: The prognostic impact of comorbidities in patients with renal cancer, 1985-2004: a Danish population-based study

    Page :33

    L. Lund, A. Riis, M. Nørgård, J. McLaughlin, B. Blot, H. Sørensen

    Plan Plan
  • ·POD-10.06: Predictors of laparoscopic adrenalectomy morbidity

    Page :33-34

    O. Castillo, F. Secin, M. Kerkebe, G. Vitagliano, R. Sanchez-Salas, M. Díaz, A. Foneron

    Plan Plan
  • ·POD-10.07: Analysis of the causes of nephrectomy in 1980-2005

    Page :34

    K. Kim, C. Cho

    Plan Plan
  • ·POD-10.08: Complications in laparoscopic transperitoneal partial nephrectomy

    Page :34

    O. Castillo, M. Diaz, G. Vitagliano, A. Foneron, R. Sanchez-Salas

    Plan Plan
  • ·POD-11.01: Percutaneous pudendal nerve stimulation for the treatment of urge incontinence

    Page :35

    G.H. Grier

    Plan Plan
  • ·POD-11.02: Improvements in incontinence and urgency are associated with reduced symptom bother and improved health-related quality of life

    Page :35-36

    S.A. Kaplan, S. Herschorn, N. Zinner, I. Hissain

    Plan Plan
  • ·POD-11.03: Prevalence, severity and impact on quality of life of urinary incontinence in the young and middle age adult (20-60 years old) in Greece

    Page :36

    E. Spyropoulos, C. Theodorou

    Plan Plan
  • ·POD-11.04: Our experience using the periurethral constrictor, a simplified silicon made device, in the male urinary incontinence treatment

    Page :36

    J.L. Schiavini, E.A. Da Silva, J.S. Toledo, R. Damiao, M.C. Dornas, J.A.D. Resende

    Plan Plan
  • ·POD-11.05: The effect of endogenous testosterone on urodynamic parameters in men with bladder outlet obstruction

    Page :36-37

    G. Koritsiadis, K. Stravodimos, D. Mitropoylos, C. Constantinides, I. Fokitis, G.R. Doymanis, S. Koritsiadis

    Plan Plan
  • ·POD-11.06: Use of the adjustable continence therapy for post prostatatectomy urodynamic stress urinary incontinence

    Page :37

    E. Kocjancic, S. Crivellaro, S. Ranzoni, B. Frea

    Plan Plan
  • ·POD-11.07: Evaluation of bladder sensation during cystometry: a reliable tool?

    Page :34-35

    T. Realfonso, U. Di Mauro, G. Napodano, A. Campitelli, O. Intilla, R. Sanseverino

    Plan Plan

• Moderated Poster Sessions

  • ·MP-01.01: CD38 expression and function in human detrusor muscle: augmentation by interleukin-8

    Page :38

    K. Bouchelouche, J. Nordling, P. Bouchelouche

    Plan Plan
  • ·MP-01.02: Prevalence and significance of abdomino-pelvic tenderness in men with chronic prostatitis/chronic pelvic pain syndrome

    Page :38

    D. Shoskes, R. Berger, K. Propert, A. Elmi, S. Zeitlin, The CPCRN Study Group

    Plan Plan
  • ·MP-01.03: Proteomic characterization of interstitial cystitis/painful bladder syndrome

    Page :38-39

    F. de Miguel, M. Chancellor, N. Yoshimura, P. Tyagi

    Plan Plan
  • ·MP-01.04: Intraprostatic botulinum toxin injection inhibits COX-2 expression and suppresses prostatic pain in rat prostatitis model

    Page :39

    Y.C. Chuang, C.C. Huang, P.H. Chiang, N. Yoshimura, M. Chancellor

    Plan Plan
  • ·MP-01.05: Bilirubin attenuates cyclophosphamide-induced cystitis in rats

    Page :39

    Y. Matsuoka, H. Masuda, M. Yokoyama, S. Yoshida, K. Kihara

    Plan Plan
  • ·MP-01.06: Corynebacterium urealyticum urinary tract infection (UTI): early diagnosis in radiated and immunosuppressed patients is mandatory

    Page :39-40

    C. González Enguita, F. Soriano, R. Vela Navarrete, M.C. Ponte

    Plan Plan
  • ·MP-01.07: Present aspects and trend of acute simple cystitis in japanese females

    Page :40

    K. Suzuki, K. Igarashi, H. Sekine, E. Nozawa, N. Yoshida, N. Ishii

    Plan Plan
  • ·Abstract Withdrawn

    Page :40

    
  • ·MP-01.09: Emphysematous pyelonephritis in non diabetic patients differs from diabetic patients

    Page :40

    A.R. Pontin, R.D. Barnes

    Plan Plan
  • ·MP-01.10: Antibacterial treatment of asymptomatic prostatitis can not exclude prostate cancer and should not delay prostate biopsies

    Page :40-41

    D. Pode, R. Katz, O. Gofrit, A. Shapiro

    Plan Plan
  • ·MP-01.11: Efficacy of cefdinir against acute uncomplicated cystitis

    Page :41

    T. Yamane, H. Hayami, S. Era, Y. Uchida, K. Nishiyama, M. Nakagawa

    Plan Plan
  • ·MP-01.12: Intermittent pelvic floor stimulation for treatment of interstitial cystitis

    Page :41

    P. De Jong, P. Radziszewski, A. Rosamilia, H. O’Connell, B. Farnsworth, J. Nordling, M. Parsons, J. Groen, M. Cervingi, I. Nissenkorn

    Plan Plan
  • ·MP-01.13: Laser doppler flowmetry in patient with chronic cystitis treated by alfuzosin

    Page :42

    A. Zaitcev, P. Rasner, A. Matsaev

    Plan Plan
  • ·MP-01.14: Use of hyperbaric oxygenation in the treatment of patients with BPS/IC

    Page :42

    A. Zaitcev, A. Mazaev, A. Davidyanz, R. Farmanov

    Plan Plan
  • ·MP-01.15: Practical significance of endovesical electromotive drug administration in the multimodality treatment BPS/IC

    Page :42-43

    D. Pushkar, A. Zaitcev, I. Korsunskaya, P. Rasner

    Plan Plan
  • ·MP-01.16: The etiology of acute epididymitis

    Page :43

    K. Kim, H. Jung, J. Cho, S. Cho, Y. Lee

    Plan Plan
  • ·MP-01.17: New approach in treatment of pelvic chronic pain syndrome (CPPS)

    Page :43

    J. Tornero, P. López, P. López-Cubillana, G. Gómez, M. Pérez

    Plan Plan
  • ·MP-01.18: Extracellular beta-nad⁺ increases intracellular free calcium in human detrusor muscle cells and induces relaxation of human detrusor detrusor muscle

    Page :43-44

    K. Bouchelouche, J. Nordling, P. Bouchelouche

    Plan Plan
  • ·Abstract Withdrawn

    Page :44

    
  • ·MP-01.20: Comparison of effect of alpha-blocker and terpene mixure on CPPS

    Page :44

    K. Mo, K.S. Lee, K.H. Kim, H.C. Jung, J.H. Seo, Y.J. Seo

    Plan Plan
  • ·MP-01.21: Dyspareunia in interstitial patients improves after therapeutic solution instillations

    Page :44

    B.J. Welk, J.M.H. Teichman

    Plan Plan
  • ·MP-01.22: Clinical features of confirmed versus suspected urogenital tuberculosis in a region with an extremely high prevalence of pulmonary tuberculosis

    Page :44-45

    A.D. Zarrabi, S.M. van Deventer, C.F. Heyns

    Plan Plan
  • ·MP-01.23: Chronic nonbacterian prostatitis associated with ED

    Page :45

    P. Geavlete, D. Georgescu, Gh. Nita, B. Geavlete

    Plan Plan
  • ·MP-01.24 (podium): Hyperbaric oxygen therapy (HOT), surgery and advanced dressings (AD), in the treatment of Fournier’s Gangrene (FG)

    Page :45

    G. Passavanti, V. Pizzuti, A. Bragaglia, F.M. Costantini, M. Brauzzi, P. Tanasi, M.R. Pagni, E. Norgini, R. Paolini

    Plan Plan
  • ·MP-01.25 (podium): ‘Circumcision Sunday’: a Swazi study model for mass circumcision against HIV transmission

    Page :45-46

    A.E. Groeneveld

    Plan Plan
  • ·MP-01.26 (podium): Use of pulsed KTP laser coagulation of submucosal telangiectatic vessels in patients with radiation cystitis

    Page :46

    B. Chapin, B. Eisner, S. Tabatabaei

    Plan Plan
  • ·MP-02.01: Initial results of a novel procedure for the repair of ureteropelvic junction obstruction in children

    Page :46

    H.-G. Mesrobian

    Plan Plan
  • ·Abstract Withdrawn

    Page :46

    
  • ·MP-02.02: Reliability and validity assessment of society for fetal urology ultrasound grading system for hydronephrosis

    Page :46-47

    M. Keays, L. Guerra, J. Mihill, G. Raju, N. Al-Asheeri, P. Geier, I. Gaboury, M.A. Matzinger, J. Pike, M. Leonard

    Plan Plan
  • ·MP-02.03: Correlation between HLA system and primary vesicoureteral reflux

    Page :47

    S. Tavasoli Yousefabad, S. Falahatkar

    Plan Plan
  • ·MP-02.04: Can a slit-like meatus be achieved with the V incision sutured meatoplasty for onlay island flap hypospadias repair?

    Page :47

    Y. Hayashi, A. Nakane, H. Kamisawa, K. Kohri

    Plan Plan
  • ·MP-02.05: Ventral based dartos flap for the prevention of the urethrocutaneous fistula on hypospadias urethroplasty

    Page :47

    Y. Hayashi, A. Nakane, H. Kamisawa, K. Kohri

    Plan Plan
  • ·MP-02.06: Combined use of Mathieu procedure with TIP-principle as a novel technique for hypospadiasis repair: RCT preliminary results

    Page :47-48

    A.R. Aminsharifi, A.R. Taddayun, A. Assadolahpoor

    Plan Plan
  • ·MP-02.07: Dorsal dartos flap in Snodgrass hypospadias repair: how to use it

    Page :48

    M. Mustafa, B.S. Wadie, H.A. Abol-Enein

    Plan Plan
  • ·MP-02.08: Evaluation of the long-term function outcome with uroflowmetry: the meatal-based flip-flap repair for distal hypospadias

    Page :48

    M. Imura, Y. Hayash, Y. Kojima, S. Kurokawa, A. Nakane, K. Mizuno, T. Maruyama, Y. Iwase, K. Kohri

    Plan Plan
  • ·MP-02.09: A clinical spectrum of posterior urethral valves with long-term follow-up

    Page :48-49

    T. Mitsui, K. Moriya, H. Tanaka, T. Kitta, M. Nakamura, K. Nonomura

    Plan Plan
  • ·MP-02.10: Ectopic ureterocele: long-term results of open surgical therapy in 54 patients

    Page :49

    A. Beganović, A.J. Klijn, P. Dik, T.P.V.M. De Jong

    Plan Plan
  • ·MP-02.11: Analysis of urodynamic study in children with primary monosymptomatic nocturnal enuresis

    Page :49

    K.H. Huang

    Plan Plan
  • ·MP-02.12: Xanthogranulomatous pyelonephritis in children: a series of 20 cases

    Page :49

    W. Chaaben, A. Sahnoun, A. Bahloul, M.N. Mhiri

    Plan Plan
  • ·MP-02.13: Female phallic urethra with native urethral hypospadias: a rare entity

    Page :50

    U. Sathaye

    Plan Plan
  • ·MP-02.14: Pediatric ESWL: 15 years single centre experience (219 cases)

    Page :50

    I. Sinescu, R. Manu, M.A. Manu, M. Brânzan, G. Chiriac-Babei, C. Arion

    Plan Plan
  • ·MP-02.15: The investigation of calcium oxalate urolithiasis formation mechanism-the relation with the calcium oxalate urolithiasis low rate of incidence of children

    Page :50

    I. Yoshioka, A. Momohara, M. Tsujihata, A. Okuyama

    Plan Plan
  • ·MP-02.16: Passive dilation by ureteral stenting prior to ureteroscopy eliminates the need for active dilation

    Page :50-51

    J.S. Palmer

    Plan Plan
  • ·MP-02.17: Two regimens for the treatment of phimosis with topical betamethasone

    Page :51

    J.S. Palmer, L.S. Palmer

    Plan Plan
  • ·MP-02.18: Ungated ESWL is safe and effective in children

    Page :51

    J.S. Palmer

    Plan Plan
  • ·MP-02.19: Use of the adjustable continence therapy (ACT®) in pediatrics with neurogenic disorders: pilot study

    Page :51-52

    E. Kocjancic, S. Crivellaro, E. Merlini, M. Mihelic, B. Frea

    Plan Plan
  • ·MP-02.20: Midline scroto-perineal approach for innervation preserving sphincteroplasty and penile lengthening: a technique to improvise functional outcome of single stage reconstruction of exstrophy-epispadias

    Page :52

    S.N. Kureel, D. Dalela, V. Singh

    Plan Plan
  • ·MP-02.21: Botulinum-toxin injections in children after failure of conservative treatment: case report from 10 children

    Page :52

    S. Laschke, S. Carl

    Plan Plan
  • ·MP-03.01: Wire-based ureteral stents: Impact on tensile strength and compression

    Page :52

    M. Monga, R.N. Pedro, C. Kriedberg, K. Hendlin

    Plan Plan
  • ·MP-03.02: A double-blind, placebo-controlled comparison of voltaren and tramadol for acute renal colic

    Page :53

    H. Ahmadnia, M. Darabi, S. Ghanbarizadeh, M. Molaee, M. Shokohian

    Plan Plan
  • ·MP-03.03: In situ de novo ESWL of ureteral stones: evolution in treatment results 1990-2007

    Page :53

    G.G. Tailly

    Plan Plan
  • ·MP-03.04: Retrograde proximal rigid ureteroscopy and pyeloscopy: its safety and efficacy

    Page :53

    A. Hidoussi, M. Jaidane, A. Slama, A. Youssef, Y. Kalel, N. Ben Sorba, A.F. Mosbah

    Plan Plan
  • ·MP-03.05: Tubeless percutaneous nephrolithotomy: five years of experience, review of 201 patients

    Page :53

    H. Karami, M. Jabbari

    Plan Plan
  • ·MP-03.06: Oxalate-induced nadph oxidase mediated free radical generation is protein kinase C-dependent in renal epithelial cells

    Page :53-54

    V. Thamilselvan, M. Menon, S. Thamilselvan

    Plan Plan
  • ·MP-03.07: Retrograde ureteroscopy for large ureteral stones: an effective first-line therapy

    Page :54

    A. Hidoussi, M. Jaidane, A. Slama, A. Youssef, K. Yosri, N. Ben Sorba, A.F. Mosbah

    Plan Plan
  • ·MP-03.08: Predictors of blood transfusion in percutaneous nephrolithotomy (PCNL)

    Page :54

    S.R. Biyabani, A.A. Zehri, K. Siddiqui, A. Memon

    Plan Plan
  • ·MP-03.09: ESWL with wide focal spot – one year experience with Siemens Lithoskop^®

    Page :54-55

    T. Bergsdorf, C. Chaussy, S. Thueroff

    Plan Plan
  • ·MP-03.10: Higher efficacy of ESWL with abdominal compression belt

    Page :55

    T. Bergsdorf, C. Chaussy, S. Thueroff

    Plan Plan
  • ·MP-03.11: How much shockwave energy is mandatory for stone fragmentation with ESWL?

    Page :55

    C. Chaussy, T. Bergsdorf, S. Thueroff

    Plan Plan
  • ·MP-03.12: Tamsulosin effect on the peristalsis of completely and partially obstructed ureter in the anesthetized dog

    Page :55-56

    R. Seyam, W. Al-Taweel, A. Mokhtar, R. El-Sayed, K. Hanash

    Plan Plan
  • ·MP-03.13: Percutaneous nephrolithotomy using a novel 4-mm ballistic lithotripsy probe: a randomized trial

    Page :56

    K. Nouri-Mahdavi, M.H. Khorrami, A. Ghalamkari

    Plan Plan
  • ·MP-03.14: Comparative study on the efficacy of different alpha adrenergic blockers for distal ureteral stones with or without shock wave lithotripsy

    Page :56

    M. Hassan Ali, G. Elatrash, H. Hafez, M. Hegazy, O. Abd Elkader, W. Aboud, S. Shabaan

    Plan Plan
  • ·MP-03.15: Laparoscopic ureterocalicostomy: the reliable last resource

    Page :56-57

    O. Castillo, G. Vitagliano, M. Díaz, R. Sánchez-Salas, A. Foneron

    Plan Plan
  • ·MP-03.16: Difficulties in focusing during ESWL calculus treatment

    Page :57

    I. Sinescu, R. Manu, G. Glück, M.A. Manu, G. Chiriac-Babei

    Plan Plan
  • ·Abstract Withdrawn

    Page :57

    
  • ·Abstract Withdrawn

    Page :57

    
  • ·MP-03.17: Comparison of the efficacy of intranasal Desmopressin and Pethidine alone and in combination for treatment of renal colic

    Page :57

    H. Tajari, M. Rabie, F. Eftekhari

    Plan Plan
  • ·MP-03.18 (podium): Evidence based selection of pneumatic lithotriptor probe diameter

    Page :57

    P. Shadpour, M. Masoud Etemadian, A. Abdolhossein Saidi, M.J. M. Javad Solemani

    Plan Plan
  • ·MP-04.01: Molecular mechanisms of the urinary bladder carcinogenesis (the intercellular proteolysis alteration) influenced by persistent, long-term, low-dose ionizing radiation in humans

    Page :58

    A.M. Romanenko, A.F. Vozianov, S. Fukushima

    Plan Plan
  • ·MP-04.02: Enzymatic immuno-assay quantification of C-erbB-2 oncogene expression in urinary bladder cancer

    Page :58

    A.A. Mehena, M. Wishahi, S. Hassan, N. El-Sayed

    Plan Plan
  • ·MP-04.03: The value of tissue polypeptide antigen (TPA) in the after care patients with bladder cancer: relationship with conventional urine cytology

    Page :58-59

    A. Bantis, A. Zissimopoulos, C. Kalaitzis, P. Sountoulides, S. Giannakopoulos, E. Patris, E. Aggelonidou, C. Voudalikakis, S. Touloupidis

    Plan Plan
  • ·MP-04.04: Glutathione S-transferase (GST) M1, T1 and N-acetyltransferase 2 (NAT2) polymorphisms and urothelial cancer risk with tobacco smoking

    Page :59

    H. Tsukino, T. Katoht, R. Hamasuna, K. Nose, K. Inoue, M. Nagano, H. Wakeda, T. Kamimura, Y. Hasui, Y. Osada

    Plan Plan
  • ·MP-04.05: Development and DNA microarray analysis of cisplatin, gemcitabine and docetaxel-resistant bladder cancer cell lines

    Page :59

    E. Lee, W. Yeo, I.G. Jeong, S.H. Kim, S.S. Byun, S.J. Jin Yoon

    Plan Plan
  • ·Abstract Withdrawn

    Page :59

    
  • ·Abstract Withdrawn

    Page :59

    
  • ·MP-04.06: Gene expression profile of urine sediment for the non-invasive diagnosis of bladder cancer

    Page :59-60

    D. MacDonald, S. Henderson, D. Boumpoulia, D.C. Hanbury, T.A. McNicholas, G.B. Boustead, C. Boshoff

    Plan Plan
  • ·MP-04.07: CD-4⁺ CD-25⁺ regulatory T-cells in the tumor draining lymph nodes of patients with urothelial carcinoma

    Page :60

    M.K. Tollefson, B.C. Leibovich, J.C. Cheville, H. Dong, E.D. Kwon

    Plan Plan
  • ·MP-04.08: Clinical evaluation of NMP22 in the diagnosis of urothelial cancer

    Page :60

    H. Ikeda, Y. Ishida, S. Seko, M. Mizutani

    Plan Plan
  • ·MP-04.09: Usefulness of virtual cystoscopy using 64-channel multidetector-row computed tomography scanner for detecting bladder tumors

    Page :60

    S.B. Ryu, K. Park, D.D. Kwon, S.S. Shin, I.S. Hwang, T.W. Kang

    Plan Plan
  • ·MP-04.10: DNA repair gene polymorphisms and toxicity in chemoradiotherapy for bladder cancer

    Page :60-61

    S. Sakano, H. Matsumoto, S. Eguchi, T. Misumi, Y. Kawai, T. Hara, K. Nagao, C. Ohmi, H. Matsuyama, K. Naito

    Plan Plan
  • ·Abstract Withdrawn

    Page :61

    
  • ·MP-04.11: Non-invasive detection of bladder cancer by measurement of tumor-related transcript markers in urine

    Page :61

    C. Rippel, J. Schmidt, W.-Y. Siow, S. Fuessel, A. Meye, A. Lohse, M.-O. Grimm, O.W. Hakenberg, M.P. Wirth

    Plan Plan
  • ·MP-04.12: Anti angiogenic VEGF₁₆₅b is an inhibitory splice variant of VEGF in transitional cell carcinoma of the bladder

    Page :61

    S.S. Gopi, M.H. Zadeh, S.J. Harper, D.O. Bates, D.A. Gillatt

    Plan Plan
  • ·Abstract Withdrawn

    Page :62

    
  • ·MP-04.13: Epirubicin and ciprofloxacin synergistically induce apoptosis in human urothelial cancer cell lines

    Page :62

    D.S. Engeler, E. Scandella, H.P. Schmid, B. Ludewig

    Plan Plan
  • ·MP-05.01: Retrocaval ureter: a study of 13 cases

    Page :62

    A. Yarmohamadi

    Plan Plan
  • ·MP-05.02: Flexible percutaneous approach in uretero-enteric stenosis

    Page :62

    P. Geavlete, R. Multescu, V. Mirciulescu, D. Georgescu, B. Geavlete

    Plan Plan
  • ·MP-05.03: HLA and ureteropelvic junction obstruction

    Page :62-63

    R. Farajidarkhaneh, S. Falahatkar, S. Aghazadeh, S. Tavasoli Yousefabad

    Plan Plan
  • ·Abstract Withdrawn

    Page :63

    
  • ·MP-05.04: Valvular heart disorders in end stage renal disease patients

    Page :63

    F. Ataei, K. Pishehvar Esfahani, H. Shamsolkottabi, M. Shirazinejad, S. Yavari

    Plan Plan
  • ·Abstract Withdrawn

    Page :63

    
  • ·MP-05.05: Possible cytoprotective roles of glyoxalase I and heat shock proteins in acute renal cell injury

    Page :63

    P. Pyo, M. Hoffman, R. Simon, H. Tazaki, M. Choudhury, S. Konno

    Plan Plan
  • ·MP-05.06: Results from an anatomic study of variations of renal vessels (240 cases)

    Page :63-64

    D.A. Lappas, A. Lekas, I. Gisakis, A. Karamanou, S. Vrakas, M. Chrisofos, C. Deliveliotis, P. Scandalakis

    Plan Plan
  • ·Abstract Withdrawn

    Page :64

    
  • ·MP-05.08: Laparoscopic adrenalectomy for suspected metastasis of the adrenal glands: our experience

    Page :64

    O. Castillo, G. Vitagliano, M. Kerkebe, M. Díaz, R. Sánchez-Salas, A. Foneron

    Plan Plan
  • ·MP-05.09: Prevalence of incidental prostate cancer in radical cystectomy specimens

    Page :64

    C. Sweeney, D.S. Hendry

    Plan Plan
  • ·Abstract Withdrawn

    Page :64

    
  • ·MP-05.10: Antegrade versus retrograde stenting in laparoscopic pyeloplasty: a two centre analysis

    Page :64-65

    N. Arumainayagam, A. Minervini, K. Davenport, V. Kumar, L. Masieri, S. Serni, M. Carini, A.G. Timoney, F. Keeley

    Plan Plan
  • ·MP-05.11: Percutaneous biopsy of indeterminate renal masses in patients with tuberous sclerosis complex (TSC)

    Page :65

    S.K. Misra, J.A. Cox, J.C. Kingswood, T. Doyle

    Plan Plan
  • ·Abstract Withdrawn

    Page :65

    
  • ·MP-05.12: Determination of success by laparoscopic pyeloplasties based on strict renal scintigraphic criteria: no difference between primary and non-primary pyeloplasty success rates

    Page :65-66

    F. Pouliot, M.H. LeBel, J.F. Audet, T. Dujardin

    Plan Plan
  • ·MP-05.13: Urological aspects in retroperitoneal sarcomas

    Page :66

    M.C. Persoon, A. Hennipman, M.T.W.T. Lock

    Plan Plan
  • ·MP-05.14: Laparoscopic partial nephrectomy: what we have learned after 200 cases?

    Page :66

    T. Dujardin, W. Massoud, N. Rebai, N. Saheb, O. Dumonceau, V. V. Molinié, H. Baumert

    Plan Plan
  • ·MP-06.01: Erectile nerve preservation during daVinci prostatectomy: a novel method using nerve action potential monitoring

    Page :66-67

    R. Fagin

    Plan Plan
  • ·MP-06.02: Robotic equipment malfunction during robotic prostatectomy: a multi-institutional study

    Page :67

    H.J. Lavery, T. Ahlering, A. Tewari, J.A. Smith, A. Shalhav, D. Albala, P. Wiklund, A.J. Costello, K.J. Palmer, K. Shah, R. Thaly, V. Patel

    Plan Plan
  • ·Abstract Withdrawn

    Page :67

    
  • ·MP-06.04: Hem-o-lok polymer ligating clip for vascular control of the renal pedicle: points of controversy

    Page :67

    H. Izaki, M.G. El-Moula, T. Fukumori, M. Takahashi, R. Taue, T. Kishimoto, S. Kagawa, H. Kanayama

    Plan Plan
  • ·MP-06.05: Laparoscopic partial cystectomy for malignant and benign bladder conditions

    Page :67-68

    H. Kinoshita, G. Kawa, K. Yasuda, S. Kawakita, Y. Hiura, K. Muguruma, K. Yoshida, T. Masuda, T. Murota, T. Matsuda

    Plan Plan
  • ·MP-06.06: Ten years of experience with simple renal cyst sclerotherapy using acetic acid

    Page :68

    K. Yoo, J. Kim, S. Lee

    Plan Plan
  • ·MP-06.07: Nephron damages after partial nephrectomy with microwave tissue coagulator: three-year follow up study after surgery

    Page :68

    M. Kawasaki, Y. Satoh, C. Fujiyama, J. Uozumi

    Plan Plan
  • ·MP-06.08: Retroperitoneal laparoscopic nephrectomy for inflammatory renal diseases

    Page :68

    Y.S. Jeon, T.H. Oh, D.S. Kim, C.H. Lee, N.K. Lee

    Plan Plan
  • ·MP-06.09: Assessment of the durability of robotic-assisted laparoscopic sacrocolpopexy for the treatment of vaginal vault prolapse

    Page :68-69

    D.S. Elliott, I. Frank, G. Chow

    Plan Plan
  • ·Abstract Withdrawn

    Page :69

    
  • ·Abstract Withdrawn

    Page :69

    
  • ·MP-06.10: Comparison between endoscopic minilaparotomy radical prostatectomy and conventional radical prostatectomy for prostate cancer

    Page :69

    Y. Kamiryo, Y. Urabe, N. Yamamoto, T. Moriwaka

    Plan Plan
  • ·MP-06.11: Preoperative erectile function and nerve-sparing are useful predictors for early recovery of urinary continence after laparoscopic radical prostatectomy

    Page :69-70

    A. Takenaka, H. Soga, T. Terakawa, A. Kumano, J. Furukawa, M. Muramaki, T. Kurahashi, H. Miyake, K. Tanaka, M. Fujisawa

    Plan Plan
  • ·MP-06.12: Laparoscopic simple prostatectomy with precise vascular control: going back to basics

    Page :70

    O. Castillo, D. Degiovanni, R. Saánchez-Salas, G. Vitagliano, A. Foneron, M. Diaz

    Plan Plan
  • ·MP-06.13: The impact of posterior sphincteropexy on early continence rates following laparoscopic radical prostatectomy

    Page :70

    C. Chabert, D. Merilees, C. Eden

    Plan Plan
  • ·MP-06.14: Usefulness of preoperative multidetector-row computed tomography with three-dimensional pelvic angiography in patients who undergo pelvic lymphadenectomy in robot-assisted radical prostatectomy: preliminary analysis of outcomes

    Page :70-71

    S.Y. Park, S.J. Park, Y.H. Lee, H.J. Kim, S.W. Lee, W.K. Han, J.H. Kim, Y.D. Choi, K.H. Rha, S.C. Yang

    Plan Plan
  • ·MP-06.15: Robot-assisted laparoscopic radical prostatectomy in Korea: initial 160 cases

    Page :71

    S.Y. Park, S.J. Park, Y.H. Lee, H.J. Kim, S.W. Lee, W.K. Han, J.H. Kim, Y.D. Choi, K.H. Rha, S.C. Yang

    Plan Plan
  • ·MP-06.16: Trans vesico-prostatic approach of laparoscopic simple prostatectomy (LSP): novel technique avoiding post operative bladder irrigation

    Page :71

    W. Massoud, N. Rebai, A. Ballaro, N. Saheb, J. Schlosser, O. Dumonceau, H. Baumert

    Plan Plan
  • ·Abstract Withdrawn

    Page :71

    
  • ·MP-07.01: The natural history of hydronephrosis after hysterectomy: a prospective study

    Page :71-72

    M. Mansourghanai, S.A. Asgari

    Plan Plan
  • ·MP-07.02: Risk of gestational hypertension and pre-eclampsia in patients with polycystic ovarian syndrome (PCOS) in Iran

    Page :72

    M.R. Razaghi, S. Zadeh Modares, M. Karbalaeizadeh

    Plan Plan
  • ·MP-07.03: Intense inflammatory reaction with small intestine submucosa tensionless pubovaginal sling or tape for stress urinary incontinence

    Page :72

    T.T. John, N. Aggarwal, A.K. Singla, R.A. Santucci

    Plan Plan
  • ·Abstract Withdrawn

    Page :72

    
  • ·MP-07.05: The usefulness of transurethral resection for the treatment of intravesical tape erosion with bladder stone following tension-free vaginal tape (TVT) procedure

    Page :72

    J.H. Kim, J.O. Kwon, D.S. Ryu, T.H. Oh

    Plan Plan
  • ·MP-07.06: Factors influencing the outcome after mid-urethral sling procedures in female urinary incontinence

    Page :72

    S. Park, J. Ku, H. Son, S.J. Oh, S. Kim, J.S. Paick

    Plan Plan
  • ·MP-07.07: A novel visual analogue self-compiled sketch questionnaire as diagnostic tool for the prediction of disturbed urination in working women

    Page :73

    A. Lekas, I. Fokitis, V. Politis, G. Koritsiadis, S. Koritsiadis

    Plan Plan
  • ·MP-07.08: Endometriosis of the urogenital tract

    Page :73

    D. Papadopoulos, A. Lekas, A. Balangas, A. Schneider, S.O. Schattka, R. Homberg, A. Kollias

    Plan Plan
  • ·MP-07.09: Efficacy of tamsulosin in female patients with lower urinary tract symptoms

    Page :73

    H.S. Chang, C.H. Park, C.I. Kim, H.C. Jung, T.C. Park, H.S. Shin, T.G. Kwon, D.Y. Kim, T.H. Oh, D.S. Ryu

    Plan Plan
  • ·Abstract Withdrawn

    Page :74

    
  • ·MP-07.11: Characteristics of voiding dysfunction in women with lower urinary tract disorders

    Page :74

    N. Seki, M. Takei, A. Yamaguchi, S. Naito

    Plan Plan
  • ·MP-07.12: Sexual dysfunction in women with newly diagnosed multiple sclerosis

    Page :74

    K. Skriapas, C. Konstantinidis, V. Tzortzis, G. Hadjigeorgiou, M. Samarinas, K. Aggelakis, V. Poulakis, M. Melekos

    Plan Plan
  • ·MP-07.13: Transobturator suburethral tape ARIS in the treatment of stress urinary incontinence: one year evaluation

    Page :74-75

    V. Delmas, P. Ballanger, P. Grise, C. Ortuno

    Plan Plan
  • ·MP-07.14: Anatomical basis of total vaginal mesh for rectocele and vaginal vault prolapse

    Page :75

    S. Ben Rhouma, A. Anghelus, V. Boublil, S. Dominique, V. Ravery, J.F. Hermieu, L. Boccon Gibod, V. Delmas

    Plan Plan
  • ·MP-07.15: Anatomical basis of total vaginal mesh for cystocele

    Page :75

    A. Anghelus, S. Ben Rhouma, V. Boublil, S. Dominique, V. Ravery, J.F. Hermieu, L. Boccon Gibod, V. Delmas

    Plan Plan
  • ·MP-07.16: Seven year follow-up of the tendinous vaginal support: a minimally invasive approach for stress urinary incontinence

    Page :75-76

    P. Palma, C. Riccetto, M. Martins, M. Dambros, R. Fraga, N. Netto

    Plan Plan  
  • ·MP-07.17 (podium): Female bladder outlet obstruction in community urology practice: is AUA symptom score helpful in prediction?

    Page :76

    P. Pandey, L. Hegde, C.D. Marsh, L.D. Monahan

    Plan Plan
  • ·MP-07.18 (podium): Reliability, validity and responsiveness of international prostate symptom score in females with lower urinary tract symptoms

    Page :76

    B.Y. Low, M.L. Liong, K.H. Yuen, C. Chee, W.S. Leong, W.L. Chong, N.K. Khan, P.Y. Cheah

    Plan Plan
  • ·MP-07.19 (podium): Women with type 2 diabetes: understanding bladder dysfunction

    Page :77

    J.L. Mehdizadeh, D.Y. Deng, W.C. Sweeting, P. Mallipeddi, J.M. Creasman, J.S. Brown

    Plan Plan
  • ·MP-08.01: Salvage therapy with bicalutamide 150 mg in patients with PSA failure under LHRH therapy or surgical castration for advanced prostate cancer

    Page :77

    Y. Fradet

    Plan Plan
  • ·MP-08.02: Metronomic chemotherapy for hormone refractory prostate cancer (HRPC)

    Page :77-78

    S. Hoshi, K. Hoshi, K. Ono, T. Kobayashi, M. Sasaki, K. Suzuki, M. Tukigi, K. Numahata, S. Ishidoya, S. Saito, Y. Arai

    Plan Plan
  • ·MP-08.03: Changes in the characteristics of patients and results of radical prostatectomy in the years 1990-2005

    Page :78

    G. Hidas, O.N. Gofrit, R. Katz, E.H. Landau, A. Shapiro, D. Pode

    Plan Plan
  • ·Abstract Withdrawn

    Page :78

    
  • ·MP-08.05: Usefulness of prostate-specific antigen change as predictor of survival of patients with advanced prostate cancer after hormonal therapy

    Page :78

    H. Ehara, T. Katoh, K. Mizutani, K. Nakane, K. Seike, T. Sugawara, S. Katoh, T. Masue, T. Gotoh, T. Deguchi

    Plan Plan
  • ·MP-08.06: Amifostine administration during radiotherapy for prostate cancer: a prospective study

    Page :78-79

    E. Patris, C. Kalaitzis, S. Gianacopoulos, A. Bantis, N. Sofikitis, M. Koukourakis, S. Touloupidis

    Plan Plan
  • ·MP-08.07: Pathological correlation between prostatic needle biopsy and radical prostatectomy specimen in patients with localized prostate cancer

    Page :79

    M.A. Bulbul, Y. El-Hout, A. Tawil, R.B. Khauli, K. Hemady, W. Wazzan, A. Hujeij, N. Bou Diab, M.C. Haddad

    Plan Plan
  • ·MP-08.08: Docetaxel-prednisolone combination therapy for japanese patients with hormone-refractory prostate cancer: a phase 2 study

    Page :79

    N. Miura, K. Numata, A. Shirato, K. Hashine, Y. Sumiyoshi

    Plan Plan
  • ·MP-08.09: Docetaxel, etoposide, and estramustine phosphate in the treatment of hormone-refractory prostate cancer

    Page :79-80

    K. Nagao, T. Misumi, M. Sasaki, Y. Kawai, S. Eguchi, T. Hara, C. Ohmi, S. Sakano, H. Matsuyama, K. Naito

    Plan Plan
  • ·MP-08.10: The relationship between Charlson score and clinical unilateral T3a prostate cancer

    Page :80

    C.Y. Hsu, S. Joniau, R. Oyen, T. Roskams, H. van Poppel

    Plan Plan
  • ·MP-08.11: Lymph node collection in radical prostatectomy

    Page :80

    N. Arumainayagam, S. McPhail, B. Ayres, J. MacGrath, S. Fowler, B. Cottier, J. Verne, D.A. Gillatt

    Plan Plan
  • ·MP-08.12: One single dose of zoledronic acid (Zometa) annually can prevent bone mineral density (BMD) in patients with prostate cancer treated with LHRH: early results of a randomized trial

    Page :80-81

    A. Lekas, M. Chrisofos, I. Fokitis, A. Balangas, A. Kollias, C. Deliveliotis

    Plan Plan
  • ·MP-08.13: Does saturation biopsy reliably predict unilateral prostate cancer in patients with low-risk tumours?

    Page :81

    D. Pushkar, A. Govorov, J. Kosko, M. Kovylina, M. Kurjiev, A. Bormotin

    Plan Plan
  • ·MP-08.14: Eradication of osteoblastic and osteolytic skeletal metastases of hormone refractory prostate cancer (mHRPC) after treatment with pegylated trispecific disulfide linked Fv (sdFv) targeting epitopes of EGFR, PTHrP and RANKL conjugated covalently with SATA to vinorelbine tartrate

    Page :81

    J. Giannios, N. Alexandropulos, E. Michailakis

    Plan Plan
  • ·MP-08.15: Low dose-rate brachytherapy with I125 in patients with local prostate cancer relapse after radical prostatectomy

    Page :81-82

    F.G. Veiga, J. Ponce, L.A. Castelo, E. Romero, A. Marinño, A. Candal, C. Veiras, J. Janeiro, D. Loópez, M. Gonzaález Martín

    Plan Plan
  • ·MP-08.16: Docetaxel and oral estramustine phosphate in patients with hormone refractory prostate cancer

    Page :82

    T. Segawa, N. Masuda, Y. Shiraishi, H. Negoro, H. Oka, H. Iwamura, S. Moroi, K. Okubo, T. Okada, M. Kawakita

    Plan Plan
  • ·MP-08.17: Correlation of clinical and pathological staging in patients undergoing radical prostatectomy

    Page :82

    N. Arumainayagam, S. McPhail, B. Ayres, J. MacGrath, S. Fowler, B. Cottier, J. Verne, D.A. Gillatt

    Plan Plan
  • ·MP-08.18: Robot-assisted laparoscopic radical prostatectomy in locally advanced prostate cancer: results of a single surgeon experience in Korea

    Page :82-83

    S.Y. Park, S.J. Park, Y.H. Lee, H.J. Kim, S.W. Lee, W.K. Han, J.H. Kim, Y.D. Choi, K.H. Rha, S.C. Yang

    Plan Plan
  • ·MP-08.19: Salvage HIFU effectively reduces PSA in patients with biochemical recurrence after attempted curative treatment for prostate cancer

    Page :83

    E. Zacharakis, H.U. Ahmed, A. Ishaq, R. Scott, R. Illing, G. Shaw, J. Calleary, C. Allen, M. Emberton

    Plan Plan
  • ·MP-08.20: Ablative salvage therapy following combination low dose rate brachytherapy and external beam radiation therapy is associated with higher levels of rectal toxicity

    Page :83

    E. Zacharakis, H.U. Ahmed, A. Ishaq, R. Scott, G. Shaw, R. Illing, J. Calleary, C. Allen, M. Emberton

    Plan Plan
  • ·MP-08.21: A multicentre, randomised one year dose-finding study of degarelix, a gonadotrophin-releasing hormone (GnRH) receptor blocker, in prostate cancer patients

    Page :83-84

    M. Gittelman, P.J. Pommerville, B.E. Persson, T. Kold Olesen

    Plan Plan
  • ·Abstract Withdrawn

    Page :84

    
  • ·MP-08.23: Zoledronic acid produces benefits in patients with early malignant bone disease from hormone-refractory prostate cancer

    Page :84

    F. Saad, Y.M. Chen

    Plan Plan
  • ·MP-08.24: Zoledronic acid-mediated normalization of NTX levels correlates with increased clinical benefits in patients with bone metastases secondary to prostate cancer

    Page :84-85

    F. Saad, A. Lipton, R. Coleman

    Plan Plan
  • ·MP-08.25: Prevalence of symptoms and effectiveness of symptom relief for patients with advanced prostate cancer

    Page :85

    S. Wozniak, R. Zdrojowy, A. Kolodziej

    Plan Plan
  • ·MP-08.26: Staging saturation biopsy in patients with prostate cancer on an active surveillance protocol

    Page :85

    R. Abouassaly, J.S. Jones

    Plan Plan
  • ·MP-10.01: Treatment of post-operative male urinary incontinence by invance prosthesis: results and complications

    Page :85-86

    T.H. Arvanitakis, A. Rempelakos, A. Marketakis, S. Mpisias, A. Georgalis

    Plan Plan
  • ·MP-10.02: Activity of different phospholipids in hyperactivity in bladder irritation

    Page :86

    P. Tyagi, M.B. Chancellor, N. Yoshimura, J. Kaufmann

    Plan Plan
  • ·MP-10.03: Renal function and urodynamic evaluations in spina bifida patients managed with clean intermittent catheterization

    Page :86

    K. Inoue, H. Tsukino, H. Wakeda, M. Nagano, K. Nose, Y. Osada

    Plan Plan
  • ·MP-10.04: New male sling procedure in men with stress urinary incontinence

    Page :86-87

    A. Hidoussi, M. Jaidane, A. Slama, A. Youssef, Y. Kalel, N. Ben Sorba, A.F. Mosbah

    Plan Plan
  • ·MP-10.05: Heart rates and cardiovascular co-morbidities in overactive bladder (OAB) patients

    Page :87

    K.E. Andersson, K. Kahler, U. Ebinger

    Plan Plan
  • ·Abstract Withdrawn

    Page :87

    
  • ·MP-10.07: A cost-utility analysis of solifenacin 5 mg versus tolterodine ER 4 mg

    Page :87

    A. Thorpe, T. Terry, M. Fynes, M. Sidhu, J. Warner

    Plan Plan
  • ·MP-10.08: Effect of an antiepileptic - Levetiracetam (Keppra^™) - on neurogenic overactive bladder in chronic paraplegic rats

    Page :87-88

    E.A. Elzayat, L. Campeau, G. Karsenty, B. Blok, A.L. Padjen, J. Corcos

    Plan Plan
  • ·MP-10.09: The effect of darifenacin on health-related quality of life in patients with overactive bladder: results from the ABLE study

    Page :88

    M. Chancellor, W.S. Aronstein, M. Egermark, R. Ariely, U. Ebinger, F. Kianifard

    Plan Plan
  • ·MP-10.10: Experimental studies of influence of laser neuromodulation on detrusor function

    Page :88

    I.A. Makedonsky

    Plan Plan
  • ·MP-10.11: Collagen injection for incontinence after prior urethral or peri-urethral surgery

    Page :88-89

    P.E. Zimmern, G. Isom-Batz

    Plan Plan
  • ·MP-10.12: How does functional capacity and first sensation during cystometrogram relate to nocturia?

    Page :89

    S.S. Steele, J.B. Gajewski

    Plan Plan
  • ·MP-10.13: Use of the adjustable continence therapy for the treatment of recurrent female urodynamic stress urinary incontinence

    Page :89

    E. Kocjancic, S. Crivellaro, M. Favro, B. Frea

    Plan Plan
  • ·MP-10.14: Efficacy and tolerability of the OROS-based oxybutynin extended-release formulation (Lyrinel) in patients with neurogenic detrusor overactivity

    Page :89-90

    G. Riedasch, A. Reitz

    Plan Plan
  • ·MP-10.15: Responses to solifenacin in male and female patients with overactive bladder syndrome: post-hoc results from the randomised, double-blind STAR study

    Page :90

    C.R. Chapple, T. Drogendijk, D.M. Wright, J. Bolodeoku

    Plan Plan
  • ·MP-10.16: Responses to solifenacin in overactive bladder patients with or without incontinence (‘OAB wet’ and ‘OAB dry’): post-hoc results from the randomised, double-blind STAR study

    Page :90-91

    C.R. Chapple, T. Drogendijk, D.M. Wright, J. Bolodeoku

    Plan Plan
  • ·MP-10.17: Transrectal ultrasound-guided implantation of the ProACT system in patients with post-radical prostatectomy stress urinary incontinence: preliminary outcome data of a prospective study

    Page :91

    A. Gregori, S. Galli, S. Zaramella, M. Favro, S. Ranzoni, I.K. Goumas, F. Scieri, S. Stener, C. Terrone, F. Gaboardi

    Plan Plan
  • ·Abstract Withdrawn

    Page :91

    
  • ·MP-10.18: Adjustable male sling: combined pre and retropubic approaches

    Page :91-92

    P. Palma, C. Riccetto, R. Oliveira, C. D’Ancona, N. Netto

    Plan Plan
  • ·Abstract Withdrawn

    Page :92

    
  • ·MP-10.19: Urodynamic evaluation after transobturator sling in patients with stress urinary incontinence

    Page :92

    P. Palma, C. Riccetto, R. Oliveira

    Plan Plan
  • ·MP-10.20: Receiver operator curves describing near infrared spectroscopy (NIRS) changes during pressure flow studies in men with obstruction

    Page :92

    A. McNab, L. Stothers

    Plan Plan
  • ·MP-10.21: The treatment of male urinary incontinence with AdVance^™: first European results

    Page :92-93

    P. Rehder, O. Dalpiaz, A. Kerschbaumer, C. Gozzi

    Plan Plan
  • ·MP-10.22: Intravesical instillation of human urine after oral administration of solifenacin, but not tolterodine or darifenacin, blocks carbachol-induced detrusor overactivity in a rat model

    Page :93

    M. Chancellor, C. Thomas, S. Tyagi, N. Yoshimura, P. Tyagi

    Plan Plan
  • ·MP-11.01: Clavien classification system-based report of short and long term complications of open retropubic radical prostatectomy

    Page :93

    C. Constantinides, S. Tyritzis, L. Evangelos, A. Skolarikos, C. Deliveliotis

    Plan Plan
  • ·MP-11.02: Motivating influences for patients seeking consultation for robotic prostatectomy

    Page :94

    K.J. Palmer, V. Patel, R. Thaly, K. Shah

    Plan Plan
  • ·MP-11.03: Prostate specific antigen adjusted for transition zone volume is useful for pre-biopsy prediction of clinically significant prostate cancer

    Page :94

    T. Ohigashi, R. Mizuno, K. Kanao, E. Kikuchi, A. Miyajima, K. Nakagawa, J. Nakashima, M. Murai

    Plan Plan
  • ·MP-11.04: Saturation biopsy does not improve concordance of Gleason grading between prostate needle biopsy and radical prostatectomy

    Page :94-95

    S. Hoshi, K. Suzuki, M. Tukigi, O. Sugano, K. Ono, G. Tamura, S. Saso, N. Yanagawa, T. Yamamoto

    Plan Plan
  • ·MP-11.05: Management of recurrent bladder neck contracture following radical prostatectomy using Ho:YAG laser and steroid injection

    Page :95

    E.A. Eltahawy, R. Virasoro, S. Schlossberg, G.H. Jordan

    Plan Plan
  • ·MP-11.06: Real-time balloon inflation elastography (RBIE) for prostate cancer detection: Clinicopathological analysis

    Page :95

    M. Tsutsumi, T. Matsumura, T. Miyagawa, S. Ishikawa, T. Shiina

    Plan Plan
  • ·MP-11.07: Results in patients who underwent prostate biopsy with PSA values 2,5 - 4 ng/ml

    Page :95-96

    E. Romero Selas, G. Veiga, D.R. Ponce, S. Pertega, A. Castelo, J. Janeiro, P. Casas, G. Martín

    Plan Plan
  • ·MP-11.08: Reduced infiltration of macrophage scavenger receptor is associated with poor prognosis of prostate cancer

    Page :96

    H. Takayama, N. Nonomura, A. Nagahara, D. Oka, Y. Nakai, M. Shiba, M. Nakayama, K. Nishimura, A. Okuyama

    Plan Plan
  • ·MP-11.09: Is there a role for digital rectal examination in the diagnosis of prostate cancer in symptomatic men with prostate specific antigen less than 3ng/ml?

    Page :96

    M. Nomikos, P. Mariappan, A. McNeil, P.R. Bollina

    Plan Plan
  • ·MP-11.10: DD3/PCA3 (differential display code 3) in prostate cancer diagnosis – first data from Czech Republic

    Page :96-97

    J. Klecka, M. Hora, M. Pesta, L. Holubec, O. Topolcan, V. Eret

    Plan Plan
  • ·MP-11.11: Can prostate biopsies be avoided in men above 75 years with a raised PSA?

    Page :97

    M. Nomikos, P. Mariappan, P.R. Bollina

    Plan Plan
  • ·MP-11.12: Japanese prospective cohort study of screening for prostate cancer (JPSPC): the study concept and the first analyses on compliance and contamination for the PSA test (gunma section)

    Page :97

    M. Kobayashi, Y. Takezawa, H. Takechi, K. Ito, T. Yamamoto, K. Suzuki, Y. Tomaru

    Plan Plan
  • ·MP-11.13: Examining the financial costs of robotic-assisted laparoscopic radical prostatectomy

    Page :97-98

    V. Patel, A. Gandevivala, R. Balkrishnan, K. Shah, K.J. Palmer

    Plan Plan
  • ·MP-11.14: Diagnosis of anterior prostate cancer by dynamic contrast-enhanced combined with T2W MR imaging

    Page :98

    A. Villers, L. Lemaitre, P. Puech, E. Poncelet, X. Leroy, J. Biserte

    Plan Plan
  • ·MP-11.15: Comparison study between ten core extended and saturation prostate biopsy in a repeat prostate biopsy population

    Page :98

    J. Ponce, F. Veiga, E. Romero, S. Pértega, J. Janeiro, P. Casas, S. Martínez, D. Lopez, I. Rodríguez, E. Fernández, M. González Martín

    Plan Plan
  • ·MP-11.16: Prostate cancer predictive model for patients candidates to first extended prostate biopsy with PSA 2.5 - 10 ng/ml

    Page :98-99

    J. Ponce, F.G. Veiga, E. Romero, S. Pértega, P. Casas, J. Janeiro, D. Loópez, S. Martínez, E.F. Rosado, I.R. Goómez, M. González Martín

    Plan Plan
  • ·MP-11.17: Pathological review of radical prostatectomy specimens identifies patients who benefit most from immediate post-operative irradiation (EORTC 22911)

    Page :99

    T. Van Der Kwast, M. Bolla, H. Van Poppel, K. Vekemans, P. Van Cangh, K.H. Kurth, F. Schroder, L. Dapozzo, J.F. Bosset, L. Collette

    Plan Plan
  • ·MP-11.18: Is there evidence of a continued stage migration in the PSA screening era in an Australian population?

    Page :99-100

    D. Golovsky, R. Thanigasalam, K. Rasiah, A.M. Haynes, S. Sutherland, P. Stricker, S. Henshall, L. Horvath

    Plan Plan
  • ·MP-11.19: Can dynamic contrast enhanced magnetic resonance imaging of the prostate reliably detect prostate cancer prior to TRUS biopsy?

    Page :100

    P. Rouse, G. Shaw, J.G. Calleary, H.U. Ahmed, E. Zacharakis, R. Illing, A. Kirkham, A. Freeman, C. Allen, M. Emberton

    Plan Plan
  • ·MP-11.20: The best decision-making nomogram for TRUS Bx

    Page :100

    L. Safarik, K. Novak, J. Stolz, M. Pesl, J. Dvoracek

    Plan Plan  
  • ·MP-11.21: Diagnostic accuracy of standard 6-core and extended 12-core transrectal prostate biopsy

    Page :100-101

    B.H. Eisner, B.C. Chapin, S.P. Psutkah, W.S. McDougal, S.T. Tabatabaei

    Plan Plan
  • ·MP-11.22 (podium): Laparoscopic radical prostatectomy: the impact of training on service provision

    Page :101

    C. Chabert, D. Merilees, C. Eden

    Plan Plan
  • ·MP-12.01: Analysis of spermatogenesis in nonobstructive azoospermia associated with unilateral testis pathology: does side matter?

    Page :101

    S. Shefi, P.J. Turek

    Plan Plan
  • ·MP-12.02: Male hypogonadism: clinical or lab reality?

    Page :102

    M. Grasso, F. Torelli, S. Blanco, S. Confalonieri, A. Grasso

    Plan Plan
  • ·MP-12.03: Conceiving a child after vasectomy

    Page :102

    R.P.J. Schroeder, M.L. Bots, V.F. de Kemp, P.M.M. Kastrop, M.T.W.T. Lock

    Plan Plan
  • ·MP-12.04: Validity of Spermcheck Vasectomy^® to predict post-vasectomy sperm concentrations

    Page :102-103

    M. Labrecque, M.A. Coppola, K. Ramsey, V.M. Brugh, K.L. Klotz, J.C. Herr

    Plan Plan
  • ·MP-12.05: Mechanisms of action of human growth hormone on isolated human penile erectile tissue

    Page :103

    S. Ückert, A.J. Becker, F. Scheller, U. Jonas, C.G. Stief

    Plan Plan
  • ·MP-12.06: Effect of hyperforin enriched extract on pro-ejaculatory effect of 8-OH-DPAT in anesthetized rats

    Page :103

    C.A. Thomas, S. Tyagi, N. Yoshimura, M.B. Chancellor, P. Tyagi

    Plan Plan
  • ·MP-12.07: Soluble guanylate cyclase b₁-subunit and pde-5 levels in peripheric mononuclear cells of E.D. patients treated with continuous or on demand treatment with sildenafil

    Page :103-104

    J.V. Garcia Cardoso, R. Vela Navarrete, A. Lopez Farre, P. Mateos Caceres, L. Lapuente, S. Zamorano

    Plan Plan
  • ·Abstract Withdrawn

    Page :104

    
  • ·Abstract Withdrawn

    Page :104

    
  • ·Abstract Withdrawn

    Page :104

    
  • ·MP-12.08: Combination of alfuzosin and tadalafil exerts an additive relaxing effect on precontracted human corpus cavernosum

    Page :104

    S. Oger, D. Behr-Roussel, D. Gorny, J.C. Tremeaux, M. Combes, J. Bernabé, L. Alexandre, F. Giuliano

    Plan Plan
  • ·MP-12.09: Enhancement of the glans penis with partial disassembly technique

    Page :104

    J.S. Byun, J.M. Joo, S.C. Kang, Y.H. Jung, J.H. Jang, I.C. Park

    Plan Plan
  • ·MP-12.10: 6-month interim analysis of the longitudinal effects on penile oxygen saturation from a randomized study of the nightly use of intraurethral alprostadil vs sildenafil following nerve sparing radical prostatectomy (NSRRP)

    Page :104-105

    A. McCullough, D. Robbins, D. Fenig, D. Brassil, B. Goodwin

    Plan Plan  
  • ·MP-12.11: Pharmacological characterization of the novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum

    Page :105

    G. De Nucci, R. Lorenzetti, C.E. Okuyama, J.S. Baracat, J.L. Donato, E. Antunes, C.E. Teixeira

    Plan Plan
  • ·MP-13.01: Development and validation of the pelvic floor inventories leiden (PelFIs)

    Page :105-106

    P.J. Voorham–van der Zalm, A. Stiggelbout, I. Aardoom, S. Deckers, I. Greve, G.A.B. Lycklama à Nijeholt, R.C.M. Pelger

    Plan Plan
  • ·MP-13.02: Determination of the upper time limits of prolonged warm and cold ischemia in a solitary kidney rabbit model undergoing partial nephrectomy

    Page :106

    S. Tyritzis, A. Kyroudi, K. Pavlakis, T. Manousakas, M. Zachariades, A. Zervas, C. Constantinides

    Plan Plan
  • ·Abstract Withdrawn

    Page :106

    
  • ·MP-13.03: Effect of cannabinoids on evoked CGRP release from bladder

    Page :106

    M. Hayn, B. Philips, C.A. Thomas, M.B. Chancellor, N. Yoshimura, P. Tyagi

    Plan Plan
  • ·Abstract Withdrawn

    Page :106

    
  • ·MP-13.04: Cardiovascular risk factors in chronic renal disease

    Page :106-107

    J. Wagner, V. Šerić, B. Babić-Ivančić, J. Milas-Ahić, H. Kuveždić

    Plan Plan
  • ·MP-13.05: Inhibitory effects of β-adrenoceptor agonists involve the urothelium and the β₃-adrenoceptor subtype in pig bladder dome

    Page :107

    K. Masunaga, C.R. Chapple, S. Murakami, M. Yoshida, D.J. Sellers

    Plan Plan
  • ·MP-13.06: Are age-related changes in the pelvic connective tissue related to function?

    Page :107

    C. Wallner, J. Bouma, N.F. Dabhoiwala, M.C. DeRuiter, W.H. Lamers

    Plan Plan
  • ·MP-13.07: The levator ani nerve and its clinical implications

    Page :107-108

    C. Wallner, C.P. Maas, N.F. Dabhoiwala, W.H. Lamers, M.C. DeRuiter

    Plan Plan
  • ·MP-13.08: Functional aspects of the pelvic floor in urinary continence

    Page :108

    C. Wallner, N.F. Dabhoiwala, M.C. DeRuiter, W.H. Lamers

    Plan Plan
  • ·MP-13.09: Proliferation and differentiation of renal urothelial transitional cells (RUTEC) after unilateral ureteral obstruction

    Page :108-109

    A. Girshovich, C. Vinsonneau, O. Traxer, S. Vandermersch, E. Letavernier, J. Perez, L. Baud, J.P. Haymann

    Plan Plan
  • ·MP-13.10: Combination of alfuzosin and tadalafil exerts additive relaxant effect on human prostate

    Page :109

    S. Oger, D. Behr-Roussel, O. Lecoz, T. Lebret, Y. Denoux, P. Denys, F. Giuliano

    Plan Plan
  • ·MP-13.11: The role of the cholinergic and purinergic interaction in the contraction of the cultured human and rat urinary bladder smooth muscle cells

    Page :109

    L. Lörincz, A. Varga, G.P. Szigeti, Á. Jenes, F. Ruzsnavszky, E.A. Széll, G.T. Somogyi, L. Csernoch

    Plan Plan
  • ·MP-13.12: Myths on polypropylene mesh structure: in vivo stereological study

    Page :109-110

    P. Palma, R. Siniscalchi, C. Riccetto, N. Netto, R. Miyaoka, L. Maciel

    Plan Plan
  • ·MP-13.13: Impact of helper orifices in monofilament meshes on the tensile strength at the interface: in vivo study

    Page :110

    P. Palma, C. Riccetto, R. Siniscalchi, R. Fraga, M. Suarez, N. Netto

    Plan Plan  
  • ·Abstract Withdrawn

    Page :110

    
  • ·MP-13.14: Stereological comparison of collagen and inflammatory reaction induced by four different synthetic slings

    Page :110

    P. Palma, M. Thiel, C. Riccetto, M. Dambros, N. Netto

    Plan Plan
  • ·MP-14.01: Dynamic functional MRI and multiple combined conventional modalities in different renal diseases

    Page :110-111

    N. Fouda, M. El-Rakhawy, A. Ashamalla, W. Abd-El-Baky

    Plan Plan
  • ·MP-14.02: Initial experience of functional imaging of upper urinary tract urotherial carcinoma by diffusion-weighted MRI

    Page :111

    S. Yoshida, H. Masuda, C. Ishii, Y. Matsuoka, N. Numao, K. Saito, F. Koga, T. Kobayashi, S. Kawakami, K. Kihara

    Plan Plan
  • ·MP-14.03: Comparison of conventional vs. current imaging modalities in the evaluation of hemato-chyluria

    Page :111

    P. Wadhwa, C.J. Das, V. Jain, R. Sharma, A.K. Hemal

    Plan Plan
  • ·MP-14.04: Evaluation of prostate cancer with real-time tissue elastography based on step-section pathologic analysis after radical prostatectomy

    Page :111-112

    M. Sumura, K. Shigeno, T. Hyuga, T. Yoneda, S. Shiina, M. Igawa

    Plan Plan
  • ·MP-14.05: A retrospective review of solid epididymal masses evaluated by scrotal sonography with pathologic and clinical correlation

    Page :112

    W. Alleman, B.F. King, D.L. Larson, J.C. Cheville, A. Nehra

    Plan Plan
  • ·MP-14.06: Evaluation of pelvic floor reconstructive surgery using tridimensional helical CT

    Page :112

    P. Palma, C. Riccetto, R. Fraga, R. Maia, N. Netto

    Plan Plan  
  • ·MP-14.07: The value of Doppler ureteral jets in patients with upper urinary tract pathology

    Page :113

    P. Geavlete, V. Cauni, C. Persu, S. Bancu, B. Geavlete

    Plan Plan
  • ·Abstract Withdrawn

    Page :113

    
  • ·Abstract Withdrawn

    Page :113

    
  • ·MP-14.08: Diagnostic ureteroscopy for upper urinary tract tumours

    Page :113

    T. Oikawa, M. Endo, N. Sekido, S. Hinotsu, N. Miyanaga, K. Kawai, T. Shimazui, H. Akaza

    Plan Plan
  • ·MP-14.09: The development of urology in Zambia

    Page :113-114

    M. Labib

    
  • ·MP-14.10: Application of the Yang-Monti channel in adult continent cutaneous urinary diversion

    Page :114

    M. Wagner, D. Siamak

    Plan Plan
  • ·MP-14.11: Long term evaluation of the outlet after orthotopic urinary diversion: 15 years experience

    Page :114

    K. Fawaz, T. Osman, M. Shoeib, K. Taema, A. Abdelmaksoud, M.R. El-Halaby

    Plan Plan
  • ·MP-14.12: Long-term functional results of the implementation of the serous-lined extramural tunnel technique of ureterointestinal reimplantation in ileal neobladders and rectosigmoid urinary reservoirs

    Page :114-115

    A. Hinev, S. Paunov, D. Anakievski, P. Chankov, R. Raikov, S. Dyakov

    Plan Plan
  • ·MP-14.13: How to achieve urinary continence in neuropathic sphincters failure?

    Page :115

    L. Skobejko-Wlodarska, K. Felberg, P. Gastol, M. Baka-Ostrowska

    Plan Plan
  • ·MP-14.14: Surgical treatment for urethral recurrence of bladder cancer after ileal neobladder reconstruction

    Page :115

    K. Yoshida, H. Kinoshita, T. Matsuda

    Plan Plan
  • ·Abstract Withdrawn

    Page :115

    
  • ·MP-14.15: Tuberculous bladder contracture treated by augmentation ileocystoplasty

    Page :115

    J. Hadzi-Djokic, T. Pejcic, M. Acimovic, Z. Dzamic

    Plan Plan
  • ·MP-14.16: Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection

    Page :116

    M. Rouprêt, O. Traxer, M. Tligui, P. Conort, S. Beley, V. Misraï, E. Chartier-Kastler, F. Haab, F. Richard, O. Cussenot

    Plan Plan
  • ·MP-14.17: Patient safety in the operating room

    Page :116

    B. Cilento, C. Estrada, M. Dierks

    Plan Plan
  • ·MP-14.18 (podium): Increasing urologic wait times in a universal health care system

    Page :116

    J. Kawakami, W.M. Hopman, R. Smith-Tryon, J.S. Lott, D.R. Siemens

    Plan Plan
  • ·MP-15.01: Tuberculosis in Iranian kidney transplant recipients: a single center experience

    Page :116-117

    A. Taghizade Afshari, A. Ghafari

    Plan Plan
  • ·Abstract Withdrawn

    Page :117

    
  • ·MP-15.02: The bioflavonoids curcumin and quercetin improve early and late kidney transplant function: long term follow up of a randomized, placebo controlled study

    Page :117

    D.A. Shoskes, C. Lee, A. Wee

    Plan Plan
  • ·MP-15.03: Last resort for renal transplant recipients, diseased kidney from living donor/patients

    Page :117

    S. Fujita, R. Mannami, N. Mitsuhata, M. Nishi, K. Nanba, M. Mannami

    Plan Plan
  • ·MP-15.04: Nationality related living kidney donation as an extension of Iran model

    Page :117-118

    S.M. Kazemeyni, G. Naderi, D. Mehraban, A. Razi, M.A. Sedighi Gilani

    Plan Plan
  • ·MP-15.05: Comparison of outcome in renal transplant recipients with respect to arterial anastomosis: the internal versus the external iliac artery - a prospective randomized study

    Page :118

    A. Bahlooli, M. Amjadi, A. Zomorrodi, H. Barhaghi

    Plan Plan
  • ·MP-15.06: 10 years experience in renal transplantation challenged by renal graft vascular anomalies

    Page :118-119

    I. Sinescu, M. Hârza, B. Serbanescu, M. Manu, D. Tacu, E. Kerezsy, L. Domnisor, D. Daia

    Plan Plan
  • ·MP-15.07: Management of ureteral urologic complications: experience after 700 kidney transplantations

    Page :119

    A. Emamzadeh, A.R. Mehrsai, M.R. Nikoobakht, M. Maherimahmodi, G. Pourmand

    Plan Plan
  • ·MP-15.08: Early postoperative vascular complications following implantation of renal allografts with multiple renal arteries

    Page :119

    D. Basic, D. Milutinovic, J.H. Djokic, M. Djokic, Z. Boric, R. Blagojevic, D. Radivojevic, S. Micic

    Plan Plan
  • ·MP-15.10: A retrospective comparison in living-related renal transplantation in hand-assisted and full laparoscopic donor nephrectomy in Singapore general hospital

    Page :119-120

    C. Teo, S.K.H. Yip, W. Lau, Y.H. Tan, W.S. Cheng, A. Vathsala

    Plan Plan
  • ·MP-15.11: Retroperitoneoscopic hand-assisted surgery is ideal for live donor nephrectomy: Acceptable technical and functional outcomes in Jichi medical university hospital

    Page :120

    M. Yashi, T. Yagisawa, N. Ishikawa, A. Nukui, T. Fujiwara, Y. Sakuma, N. Miyamoto, F. Endo, O. Muraishi

    Plan Plan
  • ·MP-15.12: De novo malignancies after renal transplantation: a single center experience

    Page :120

    Z. Popov, O. Ivanovski, P. Kolevski, O. Stankov, D. Petrovski, N. Vanovski

    Plan Plan
  • ·MP-15.13: Power Doppler versus resistive index measurements for functional evaluation of early renal allograft complications

    Page :120-121

    M. Setten, T. El-Diasty, N. Fouda, H. Abd-El-Azez, H. Arif

    Plan Plan
  • ·MP-15.14 (Podium): Outcome after renal transplantation in pediatric patients: results of 15 years experience in a single center

    Page :121

    R. Taghavi, R. Mahdavi, M.R. Darabi, N. Naghibi, F. Nazemian, A. Zerati, S. Hashemi, M. Zolfaghari, G. Baghestani, M. Hossein Zadeh

    Plan Plan
  • ·MP-15.15 (Podium): Kidney transplantation before or after augmentation cystoplasty in children with high-pressure neurogenic bladder

    Page :121

    A. Basiri, H. Otookesh, R. Hoseini, N. Simforoosh, F. Farrokhi

    Plan Plan
  • ·MP-15.16 (Podium): Hand-assisted retro-peritoneoscopic live donor nephrectomy

    Page :121-122

    S. Kumar, S. Malek, S.G. Tullius

    Plan Plan
  • ·MP-16.01: Reduction of the cytosolic Cdk11 protein expression in clear cell renal cell carcinoma

    Page :122

    A. Kapoor, L. He, C. Fan, A. Rybak, J. Cutz, D. Tang

    Plan Plan
  • ·MP-16.02: The prognostic value of cyclooxygenase-2 expression and microvessel density in transitional cell carcinoma of the upper urinary tract

    Page :122

    S.J. Kim, H.S. Ahn, M.H. Cha, D.S. Cho, S. Kim, H. Yim, S.J. Hong, K.S. Cho, N.H. Cho

    Plan Plan
  • ·MP-16.03: Pathophysiological and clinical characterization of novel tumor suppressor kank gene in renal cell carcinoma

    Page :122-123

    T. Aoyagi, S. Kitsukawa, T. Samejima, B.C. Roy, R. Kiyama

    Plan Plan
  • ·MP-16.04: Prognostic factors for bladder recurrence after nephroureterectomy for upper tract urothelial carcinoma

    Page :123

    S. Chung, S. Chueh, H. Yu

    Plan Plan
  • ·MP-16.05: Chemotherapy of urothelial carcinomas of the upper urinary tract with Gemcitabine and Cis-/Carboplatin

    Page :123

    X. Krah, E. Hauschild, G. Atanassov, C. Güttner, H.M. Weber, G. Eschholz

    Plan Plan
  • ·MP-16.06: Promoter hypermethylation of the potential tumour suppressor genes in renal cell carcinoma and its clinical significance

    Page :123-124

    T. Kishida, T. Murakami, N. Nakaigawa, M. Baba, Y. Kubota, M. Yao, F. Latif

    Plan Plan
  • ·MP-16.07: Lymphovascular invasion is a useful prognostic factor for recurrence free survival in patients with upper urinary tract urothelial carcinoma

    Page :124

    R. Takazawa, Y. Kubo, T. Tujii

    Plan Plan
  • ·MP-16.09: Galectin-3 is overexpressed in renal cell carcinoma and it regulates immune suppression through the induction of apoptosis of cytotoxic T cells

    Page :124

    T. Fukumori, N. Oka, M.G. El-Moula, R. Nakanishi, R. Taue, T. Kishimoto, H. Izaki, M. Takahashi, S. Kagawa, H.O. Kanayama

    Plan Plan
  • ·MP-16.10: Nitrogen-containing bisphosphonates inhibit the growth of renal cell carcinoma cells

    Page :124-125

    N. Fujimoto, M. Nomura, H. Nishi, T. Matsumoto

    Plan Plan
  • ·MP-16.11: A comprehensive prognostic stratification for patients with metastatic renal clear cell carcinoma treated with nephrectomy and immunotherapy

    Page :125

    S.J. Hong, S.J. Kim, B.H. Chung, Y.D. Choi, I.R. Cho, Y.S. Kim, K.S. Cho, W.S. Ham, H.S. Kim, J.S. Lee, C.I. Kim, D.H. Sung, D.H. Lee, J.S. Cho, Y.S. Song, W.J. Yang, S.I. Kim, S.H. Cheon, S.Y. Cho, D.J. Kim

    Plan Plan
  • ·MP-16.12: Surgical treatment of T3c Renal Cell Carcinoma with atrial tumor thrombus

    Page :125

    Z. Dobrowolski, W. Lipczynski, P. Trybek, J. J. Sadowski, B. Dobrowolska, J. Wojcik

    Plan Plan
  • ·MP-16.13: Acquisition of susceptibility in interferon-alpha (IFN) -resistant cell line by IFN response related gene in renal cell carcinoma cell line

    Page :126

    T. Shimazui, K. Yoshikawa, Y. Ami, T. Kojima, K. Uchida, Hinotsu Shiro, Saga Shinsuke, Akaza Hideyuki

    Plan Plan
  • ·MP-16.14: Rhabdoid phenotype renal cell carcinomas: clinicopathologic, immunohistochemical, and flow cytometry study

    Page :126

    J.P. Rioja, A. Panizo, J.E. Robles, J.J. Sola, A. Saiz, M.A. Idoate, D. Rosell, J.J. Zudaire, F.J. Pardo, J.M. Berian

    Plan Plan
  • ·MP-16.15: Endothelial fenestration of tumor microvasculature as a predictive factor of anti-VEGF therapy in clear cell renal cell carcinoma

    Page :126-127

    T. Kamba, T. Yamasaki, E. Nakamura, T. Kamoto, O. Ogawa

    Plan Plan
  • ·MP-16.16: Imbalance of PTEN, pAkt and p27 expression in acquired cystic disease of the kidney associated with renal cell carcinoma

    Page :127

    J. Sugimura, R. Konda, F. Soma, W. Obara, T. Fujioka

    Plan Plan
  • ·MP-16.17: A study of microsatellite instability of upper urinary tract transitional cell carcinoma

    Page :127

    S.B. Ryu, K. Park, D.D. Kwon, C. Choi, I.S. Hwang, T.W. Kang

    Plan Plan
  • ·MP-16.18: Expression of the apoptosis inhibitors survivin and XIAP in pulmonary metastases of renal cell carcinoma (RCC)

    Page :127-128

    P. Schneider, B. Baier, O. Holotiuk, M. Meinhardt, J. Stade, A. Meye, A. Rolle, M.P. Wirth

    Plan Plan
  • ·MP-16.19: FISH analysis of PTEN/mmca1 gene in patients with renal cell carcinoma treated exclusivelly with surgery

    Page :128

    S. Zequi, E. Campos, G. Guimarães, F. Fonseca, W. Bachega, I. Werneck, F. Soares, A. Lopes

    Plan Plan
  • ·MP-16.20: Thalidomide in combination with interleukin-2 for patients with metastatic renal cell carcinoma refractory to prior IL-2 and alpha-interferon treatment

    Page :128

    R. Shiroki, S. Mori, S. Miyakawa, M. Ichino, M. Hirano, M. Kusaka, K. Hayakawa, K. Ishikawa, K. Hoshinaga

    Plan Plan
  • ·MP-16.21: Aggressive variants of chromophobe renal cell carcinoma: a clinico-pathological study of prognostic factors

    Page :128-129

    L. Zini, X. Leroy, S. Aubert, L. Lemaitre, C. Fantoni, J. Biserte, A. Villers

    Plan Plan
  • ·MP-16.22: Contemporary open nephron sparing surgery offers excellent tumor control with significantly diminished perioperative morbidity

    Page :129

    B.R. Kava, R. De Los Santos, R. Ayyathurai, M. Manoharan, M.S. Soloway

    Plan Plan
  • ·MP-16.23: Efficacy of nephron sparing surgery for renal cell carcinoma > 4 cm

    Page :129

    E.G. Nemr, G. Azar, S. Merhej, E. Chalouhy, M. Moukarzel, P. Sarkis, R. Khoury, N. Ayoub

    Plan Plan
  • ·MP-16.24: Co-expression of CAIX and VEGF in clear cell renal cell carcinoma: implication for prognosis and immunotherapy

    Page :129-130

    N.B. Phuoc, H. Ehara, T. Gotoh, M. Nakano, S. Yokoi, T. Deguchi, Y. Hirose

    Plan Plan
  • ·MP-17.01: Identification of biomarker for androgen independence in prostate cancer

    Page :130

    Y. Ohno, M. Ohori, M. Tachibana, S. Akimoto, K. Yoshioka, T. Hatano, N. Sakamoto, T. Gondo, Y. Nakagami, Y. Horiguchi

    Plan Plan
  • ·MP-07.02: Bcl-2, bax expression in prostate carcinogenesis

    Page :130

    G. Mitropoulou, A. Georgalis, K. Tsakanika, A. Rempelakos, N. Apostolikas, A. Thanos, E. Panotopoulou

    Plan Plan
  • ·Abstract Withdrawn

    Page :130

    
  • ·MP-17.04: Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer

    Page :130-131

    T. Akashi, K. Koizumi, K. Tsuneyama, I. Saiki, Y. Takano, H. Fuse

    Plan Plan
  • ·MP-17.05: A potent target for prevention: Increased cysteinylLT1 receptor expression and induction of apoptosis by its agonist in human prostate cancer

    Page :131

    M. Matsuyama, T. Hayama, K. Funao, T. Hase, K. Kuratsukuri, T. Tanaka, Y. Takemoto, T. Nakatani, R. Yoshimura

    Plan Plan
  • ·MP-17.06: Validation study for the diagnostic accuracy of complexed and total prostate specific antigen in Japanese men using discordance analysis characteristics (DAC)

    Page :131

    K. Okihara, O. Ukimura, T. Nakamura, S. Ushijima, Y. Mizutani, A. Kawauchi, Y. Naya, M. Kojima, Miki Tsuneharu

    Plan Plan
  • ·MP-17.07: Endogenously expressed sex hormone-binding globulin (SHBG) mediates the steroid response of prostate cancer cells

    Page :131-132

    S.M. Kahn, Y.H. Li, D.J. Hryb, A.M. Nahkla, W. Rosner, N.A. Romas

    Plan Plan
  • ·MP-17.08: Roles of vinexinβ in growth and paclitaxel resistance in androgen-independent human prostate cancer PC-3 cells

    Page :132

    K. Mizutani, K.I. Nagata, H. Ehara, Y. Nozawa, T. Deguchi

    Plan Plan  
  • ·MP-17.09: Serum chromogranin A in bone metastatic prostate cancer: comparison with prostatic specific antigen

    Page :132

    A. Bantis, A. Zissimopoulos, C. Kalaitzis, P. Sountoulides, S. Giannakopoulos, E. Patris, E. Aggelonidou, C. Voudalikakis, S. Touloupidis

    Plan Plan
  • ·MP-17.10: Peroxisome proliferator-activated receptor-gamma ligands inhibit cell growth of human prostate cancer

    Page :132-133

    Y. Hashimoto, Y. Naruyama, K. Tozawa, K. Kohri

    Plan Plan
  • ·MP-17.11: Detection of TMPRSS2: ERG fusion gene in the urine of men with prostate cancer

    Page :133

    E. Dimitriadis, T. Arvanitakis, A. Thanos, T. Kalogeropoulos, A. Pallantzas, A. Apostolaki, N. Pandis

    Plan Plan
  • ·MP-17.12: Bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient

    Page :133

    Y. Shimizu, T. Yoshida, T. Segawa, T. Inoue, T. Kobayashi, N. Terada, E. Nakamura, H. Kinoshita, T. Kamoto, O. Ogawa

    Plan Plan
  • ·Abstract Withdrawn

    Page :133

    
  • ·Abstract Withdrawn

    Page :133

    
  • ·MP-17.13: Silencing of clusterin gene with siRNA accelerates doxazosin induced apoptosis in PC-3 human prostate cancer cell lines

    Page :133-134

    G.S. Cha, T.K. Yoo, Y.H. Youm, M.K. Jo, C. Lee

    Plan Plan
  • ·MP-17.14: Survivin shRNA constructed in adenovirus vector and apoptosis induction of prostate cancer PC-3 cells

    Page :134

    Y.X. Shan, P. Gao, D.R. Yang

    Plan Plan
  • ·MP-17.15: Expression of DD3PCA3 is androgen dependent

    Page :134

    G. Shaw, P. Purkis, T. Oliver, D. Prowse

    Plan Plan
  • ·MP-17.16: Distinct role of DNA methyltransferases and methyl-CpG binding proteins on apoptosis, invasion, proliferation and migration of prostate cancer cell – an in-vitro study

    Page :134-135

    A. Yaqinuddin, F. Abbas, S. Qureshi

    Plan Plan
  • ·MP-17.17: FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome

    Page :135

    M. Yoshimoto, I.W. Cunha, R.A. Coudry, F.P. Fonseca, C.H. Torres, F.A. Soares, J.A. Squire

    Plan Plan
  • ·MP-18.01: PSA kinetics and PSA bounce following permanent seed prostate brachytherapy

    Page :135

    J. Crook, C. Gillan, I. Yeung, M. McLean, G. Lockwood

    Plan Plan
  • ·MP-18.02: Evaluation of the continuous vesicourethral anastomosis after robotic-assisted laparoscopic radical prostatectomy

    Page :135

    A. Mues, K.J. Palmer, K. Shah, R. Thaly, V. Patel

    Plan Plan
  • ·MP-18.03: High resolution imaging of the radical prostatectomy specimen: feasibility to predict positive margin status

    Page :136

    K. Shah, K.J. Palmer, R. Thaly, V.R. Patel

    Plan Plan
  • ·MP-18.04: Robotic-assisted laparoscopic radical prostatectomy: perioperative outcomes of 1500 consecutive cases

    Page :136

    K.J. Palmer, K. Shah, R. Thaly, V. Patel

    Plan Plan
  • ·Abstract Withdrawn

    Page :136

    
  • ·MP-18.06: Immediate adjuvant radiation and hormonal therapy for positive surgical margins following radical prostatectomy: selection criteria and outcome

    Page :136

    M.A. Bulbul, N. Bou Diab, Y. Hout, A. Hujeij, O. Darwish, A. Tawil, F. Geara

    Plan Plan
  • ·MP-18.07: The association of prostatitis and prostate cancer in patient undergoing radical prostatectomy for localized disease and its effect on tumor parameters

    Page :136-137

    M.A. Bulbul, A. Hujeij, Y. El-Hout, S. Saab, A. Tawil

    Plan Plan
  • ·MP-18.08: Incidental prostatic neoplasia in patients undergoing radical cystoprostatectomy: does it affect the overall prognosis?

    Page :137

    R. Ayyathurai, S. Vyas, M. Manoharan, T. Luongo, M.S. Soloway

    Plan Plan
  • ·MP-18.09: Treatment results of patients with seminal vesicle invasion (pT3b) undergoing radical prostatectomy with wide resection

    Page :137

    I. Fukui, J. Yonese, S. Kawakami, Y. Fujii, S. Yamamoto, Y. Ohkubo

    Plan Plan
  • ·MP-18.10: The effect of risedronate for prostate cancer patients under androgen deprivation therapy

    Page :137-138

    K. Ishizaka, T. Machida, M. Tanaka, N. Kawamura, K. Nakamura, Y. Mizuno, K. Maekawa, T. Kamai, M. Honda, K.I. Yoshida

    Plan Plan
  • ·MP-18.11: Venous thromboembolism in radical prostatectomy: Is postoperative heparinoid prophylaxis recommended?

    Page :138

    M. Grasso, F. Torelli, S. Blanco, S. Confalonieri, A. Grasso

    Plan Plan
  • ·MP-18.12: Urologic factors associated with post-permanent prostate brachytherapy urinary retention

    Page :138

    T. Wilson, D. Hillman, L. Mynderse, B. Davis

    Plan Plan
  • ·MP-18.13: Quality of life after radical prostatectomy: a comparison of operative methods

    Page :138-139

    A. Kaipia, E. Johansson, M. Häggman, H. Ageheim, S. Brändstedt

    Plan Plan
  • ·MP-18.14: Seed migration rate to the chest following permanent prostate brachytherapy is markedly reduced with the use of seeds in vicryl suture material

    Page :139

    B. Davis, C. Goulet, K. Furutani, L. Mynderse, T. Wilson

    Plan Plan
  • ·MP-18.15: Visually-directed primary HIFU for treating localised prostate cancer: determinants of PSA kinetics

    Page :139-140

    E. Zacharakis, H.U. Ahmed, A. Ishaq, R. Scott, R. Illing, G. Shaw, J. Calleary, C. Allen, M. Emberton

    Plan Plan
  • ·MP-18.16: Modified transverse Pfannenstiel and vertical minilaparotomy incisions provide excellent exposure, minimal perioperative pain, and excellent cosmesis in patients undergoing radical retropubic prostatectomy

    Page :140

    B.R. Kava, C. Soloway, M. Manoharan, M.S. Soloway

    Plan Plan
  • ·MP-18.17: Retrospective analysis of the distance between neurovascular bundle and prostate cancer foci in radical prostatectomy specimen - clinical implication of nerve-sparing surgery

    Page :140-141

    H. Shiina, S. Urakami, S. Inoue, T. Hiraoka, M. Sumura, M. Igawa

    Plan Plan
  • ·MP-18.18: Thermoablation of localized prostate cancer: clinical results and complications

    Page :141

    R. Sanseverino, O. Intilla, A. Campitelli, G. Napodano, A. Barela, U. Di Mauro

    Plan Plan
  • ·MP-18.19: First surgical series of 100 radical retropubic prostatectomies from Pakistan

    Page :141

    F. Abbas, N. Faruqui, A. Razzak Nasir

    Plan Plan
  • ·MP-18.20: Comparison of prospective and longitudinal assessment of health- and disease-related QOL between radical perineal and retropubic prostatectomy in men with localized prostate carcinoma

    Page :141-142

    R. Shiroki, S. Mori, S. Miyakawa, M. Kusaka, K. Hayakawa, K. Ishikawa, K. Hoshinaga

    Plan Plan
  • ·MP-18.21: Comparative study of health-related quality of life in patients underwent brachytherapy, external beam radiation therapy combined with brachytherapy and radical prostatectomy for localized prostate cancer

    Page :142

    M. Kosugi, Y. Hanawa, T. Takeda, Y. Kono, H. Nagata, T. Momma, T. Ohashi, K. Toya, A. Yorozu, S. Saito

    Plan Plan
  • ·MP-18.22: Urinary continence evatuation in patients submitted to radical prostatectomy

    Page :142

    F.P. Fonseca, S. Carlos, S.C. Zequi, G.C. Guimarães, J. Francisco, I.N. Nishimoto, A. Lopes

    Plan Plan
  • ·MP-18.23: Primary cryoablation for Gleason 8, 9 or 10 localized prostate cancer: results from the COLD registry

    Page :142-143

    J.S. Jones

    Plan Plan
  • ·Abstract Withdrawn

    Page :143

    
  • ·MP-18.24: Primary prostate cryoablation: 5-year outcomes from a single center

    Page :143

    J. Vestal, J. Rewcastle, T. Manny, D. Ellis

    Plan Plan
  • ·MP-18.25: Repeat vascular targeted phototherapy with Tookad after EBRT failure

    Page :143

    J. Trachtenberg, M. Elhilali

    Plan Plan
  • ·MP-18.26: Focal and nerve sparing cryoablation: results from the COLD registry

    Page :143-144

    J.C. Rewcastle, A.E. Katz, B.J. Donnelly, L.L. Pisters, F.M. Lugnani, J.S. Jones

    Plan Plan
  • ·Abstract Withdrawn

    Page :144

    
  • ·MP-19.01: The use of KTP laser tumor ablation for treatment of bladder transitional cell carcinoma (initial results)

    Page :144

    B.F. Chapin, B.H. Eisner, S. Lahey, S. Tabatabaei

    Plan Plan
  • ·MP-19.02: The correlation of urine and serum P53 protein and protein overexpression in tumor of patient with transitional cell carcinoma of urinary bladder

    Page :144

    M.R. Darabi, N.T. Meibodi, R. Mahdavi, D. Arab, M. Zolfaghari, Z. Maleki

    Plan Plan
  • ·MP-19.03: Prognosis of primary and non-primary T1G3 bladder cancer: is there any difference?

    Page :145

    F. Ouaki, O. Celhay, B. Merlet, R. Briffaux, C. Pirès, B. Doré, J. Irani

    Plan Plan
  • ·MP-19.04: High incidence of independent non-urothelial tumours in the follow up of superficial bladder cancer

    Page :145

    D.S. Engeler, H. Zecha, H.P. Schmid

    Plan Plan
  • ·Abstract Withdrawn

    Page :145

    
  • ·MP-19.06: Metronomic-maintenance outpatient-based chemotherapy with daily oral 5 ′-DFUR and biweekly low-dose CDDP infusion in advanced urothelial cancer

    Page :145

    T. Hara, S. Yoshihiro, H. Ito, K. Nagao, C. Ohmi, S. Sakano, H. Matsuyama, K. Naito

    Plan Plan
  • ·MP-19.07: Low efficacy of intravesical BCG immunotherapy in elderly patients with intermediate-high risk Ta-T1 transitional cell carcinoma (TCC) of the bladder: long term experience of a single institution

    Page :145-146

    M.A. Brausi, G. Verrini, M. Gavioli, G. Peracchia, G. DeLuca, G.L. Simonini, M. Viola, G.D.L. Giliberto

    Plan Plan
  • ·MP-19.08: Reduced dose BCG is effective in carcinoma in situ (CIS) of the bladder: long term results of a phase ii study

    Page :146

    M. Brausi, G. Verrini, M. Gavioli, G.C. Peracchia, G. De Luca, G. Giliberto, M. Viola, G.L. Simonini

    Plan Plan
  • ·MP-19.09: Mast cell variations with histopathological grading in bladder transitional cell carcinoma

    Page :146

    D.S. Kim, J.H. Yun, S.W. Doo, J.E. Koh, C.H. Lee, Y.S. Jeon, N.K. Lee

    Plan Plan
  • ·MP-19.11: Does delay in radical cystectomy effect survival in invasive bladder cancer?

    Page :146-147

    B. Ayres, S. McPhail, N. Arumainayagam, J. McGrath, B. Khoubehi, B. Cottier, J. Verne, R. Persad, D. Gillatt

    Plan Plan
  • ·MP-19.10: Nomograms for prediction of disease recurrence and progression in patients with superficial bladder cancer

    Page :147

    S.J. Hong, K.S. Cho, W.S. Ham

    Plan Plan
  • ·MP-19.12: Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy

    Page :147

    A. Seth, S.B. Kolla, N.P. Gupta, A.K. Hemal, P.N. Dogra, R. Kumar

    Plan Plan
  • ·MP-19.13: CYP3A mediated dapsone recovery ratio may predict tumour progression in superficial bladder cancer

    Page :147-148

    B. Ayres, B. Buch, V. Kondragunta, D. Gillatt, M. Romkes, R. Branch, R. Persad

    Plan Plan
  • ·MP-19.14: Three year follow-up of a multicenter trial comparing mitomycin C (MMC) long term with short-term treatment with MMC or Bacillus Calmette-Guerin (BCG) in non muscle-invasive bladder cancer (NMIBC)

    Page :148

    M.G. Friedrich, U. Pichlmeier, H. Schwaibold, H. Huland, S. Conrad

    Plan Plan
  • ·Abstract Withdrawn

    Page :148

    
  • ·MP-19.15: Urinary fluorescence in situ hybridization predicts long-term disease status after bacillus Calmette-Guerin therapy

    Page :148

    J.R. Karnes, B.C. Leibovich, S. Boorjian, M.L. Blute

    Plan Plan
  • ·MP-19.16: Resection of small bladder tumors using a flexible cystoscopy on an out patient basis

    Page :148-149

    F. Endo, M. Ikeda, T. Oguchi, Y. Shiga, M. Yashi, O. Muraishi

    Plan Plan
  • ·MP-19.17: Prognostic factors for patients with lymph node metastases following radical cystectomy

    Page :149

    T. Osawa, T. Abe, N. Shinohara, T. Harabayashi, A. Sazawa, T. Shibata, S. Kamota, A. Kumagai, T. Mori, K. Nonomura

    Plan Plan
  • ·MP-20.01: Prediction of prostate volume in community dwelling men

    Page :149

    S.J. Jacobsen, D.J. Jacobson, J.L. St. Sauver, M.E. McGree, A.V. Sarma, C.J. Girman, M.M. Lieber

    Plan Plan
  • ·MP-20.02: The efficacy, duration of efficacy and safety of Ozarelix, a novel GnRH antagonist, in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH)

    Page :149-150

    B. Denes, A.V. Bantchev, S.S. Karanikolov, M. Nikolovski, P. Pantchev, L.D. Petkova, F. Debruyne

    Plan Plan
  • ·MP-20.03: Associations of obesity with lower urinary tract symptoms in Korean elderly men

    Page :150

    J.H. Kim, S. Lee, H.J. Lee, H.S. Jo

    Plan Plan
  • ·MP-20.04: Photoselective vaporization of the prostate (PVP) for treatment of large benign prostatic hyperplasia (BPH)

    Page :150-151

    J. Heo, G.W. Jung

    Plan Plan
  • ·MP-20.05: Alpha tocopherol inhibition of human prostatic stromal cell proliferation, correlates with inhibition of protein kinase C (PKC)-alpha activity

    Page :151

    B.B. Purnomo, D.M. Soebadi

    Plan Plan
  • ·MP-20.06: KTP laser vaporization of the prostate for the treatment of benign prostatic hyperplasia: preliminary results of a single surgeon experience

    Page :151

    R.O. Fourcade, A. Ammani, B. Faraj, B. Makhoul

    Plan Plan
  • ·MP-20.07: Endoscopic ablation of canine prostatic tissue using the diode laser

    Page :151-152

    P. Pyo, R. Simon, A. Chen, C. Dixon, M. Grasso

    Plan Plan
  • ·MP-20.08: The effect of the transition zone resection rate for transurethral resection of the prostate (TURP)

    Page :152

    H. Lee, H. Chung, J. Song

    Plan Plan
  • ·MP-20.09: Effects of preoperative methoxamine on blood loss and haemodynamic variables during transurethral prostatic resection under spinal anaesthesia

    Page :152

    S. Soleymani, R. Maghsoudi

    Plan Plan
  • ·MP-20.10: Hormonal characteristics of patients with benign prostate hyperplasia (BPH)

    Page :152-153

    S.Z. Bak, Z. Dobrowolski, W. Lipczynski, K. Sztefko, A. Malek, P. Trybek

    Plan Plan
  • ·MP-20.11: Holmium laser enucleation of prostate for post TURP symptomatic residual/recurrent prostatic adenomas

    Page :153

    A. Varshney, A. Agarwal, B.S. Bansal, P. Joshi, S. Yadu

    Plan Plan
  • ·MP-20.12: Alfuzosin, but not tamsulosin, relieves bladder hypertrophy in rats despite a persistent bladder outlet obstruction

    Page :153-154

    P. Lluel, M. Méen, A. Maurel, D. Heudes, P. Bruneval, S. Palea

    Plan Plan
  • ·MP-20.13: Prostate volume doubling time: long-term longitudinal study

    Page :154

    M.M. Lieber, T. Rhodes, D.J. Jacobson, M.E. McGree, C.J. Girman, S.J. Jacobsen, J.L. St. Sauver

    Plan Plan
  • ·MP-20.14: Combination of alfuzosin and tadalafil exerts an additive enhancing effect on norepinephrine-induced relaxation of pre-contracted human detrusor smooth muscle

    Page :154

    S. Oger, D. Behr-Roussel, D. Gorny, T. Lebret, P. Denys, J. Bernabé, F. Giuliano

    Plan Plan
  • ·MP-20.15: Transurethral resection of the prostate in the warfarinised patient

    Page :154-155

    D. MacDonald, K. Alo, A. Golash, S. Liu, C. Luscombe, M. Saxby

    Plan Plan
  • ·Abstract Withdrawn

    Page :155

    
  • ·MP-20.16: Safety and tolerability of dutasteride, tamsulosin and a combination of dutasteride and tamsulosin: Two-year results from the Combination of Avodart^® and Tamsulosin (CombAT) study

    Page :155

    R. Roehrborn, P. Siami, J. Barkin, R. Damião, F. Montorsi, CombAT Study Group

    Plan Plan
  • ·MP-20.17: Trends in LUTS BPH management: is real life a mirror of PLESS and MTOPS? Are older men disadvantaged?

    Page :155-156

    J. Graham, M. Hehir, K. Riddle, V. Crispin, M.A. Paterson

    Plan Plan
  • ·MP-20.18: Three-year review of 170 patients treated for BPH with RevoLix 2 micron continuous wave laser

    Page :156

    S. Mattioli

    Plan Plan
  • ·MP-20.19: Effects of dutasteride on the microvessel density of the prostate in BPH patients

    Page :156

    G.S. Cha, T.K. Yoo, M.K. Jo, H.S. Kim

    Plan Plan
  • ·MP-20.20: BPH surgical treatment trends in the U.S. – the dramatic increase in the application of minimally invasive technologies

    Page :156-157

    X. Yu, S.P. Elliott, T. Wilt, M. McBean

    Plan Plan  
  • ·MP-20.21: Rotoresection versus transurethral resection of the prostate: 2-years evaluation of a prospective randomized study

    Page :157

    S.A. Soliman, B.S. Wadie, E.H. Ibrahim, A. Shehab El-Dein

    Plan Plan
  • ·Abstract Withdrawn

    Page :157

    
  • ·MP-20.23: Tolterodine extended release (TER) and/or Tamsulosin (TAM) in men with lower urinary tract symptoms (LUTS) including overactive bladder (OAB): effects of serum prostate-specific antigen (PSA) level

    Page :157-158

    C.G. Roehrborn, S.A. Kaplan, S.R. Kraus, J.T. Wang, T. Bavendam, Z. Guan

    Plan Plan
  • ·MP-20.24: Tolterodine extended release (TER) and/or Tamsulosin (TAM) in men with lower urinary tract symptoms (LUTS) including overactive bladder (OAB): effects of prostate size

    Page :158-159

    C.G. Roehrborn, S.A. Kaplan, J.S. Jones, W. Steers, J.T. Wang, T. Bavendam, Z. Guan

    Plan Plan
  • ·MP-20.25: Lessons learnt from first 200 procedures of holmium laser enucleation of prostate (HoLEP)

    Page :159

    A. Bhandarkar

    Plan Plan
  • ·MP-20.26: A prospective study of long-term outcome following transurethral incision of the prostate (TUIP)

    Page :159

    D.J. Argirovic

    Plan Plan
  • ·MP-20.27: PV prostatectomy (KTP laser) as an office-based surgical procedure replacing the “gold standard” TURP

    Page :159-160

    A.C. Gellman, D. Dershewitz, M.A. Greenstein, S.C. Gillis

    Plan Plan
  • ·MP-20.28: Dutasteride provides greater improvement in symptoms and Qmax than tamsulosin in men with moderate-to-severe symptoms of BPH and prostate enlargement: Two-year results from the Combination of Avodart^® and Tamsulosin (CombAT) study

    Page :160

    C. Roehrborn, P. Siami, J. Barkin, R. Damião, F. Montorsi, CombAT Study Group

    Plan Plan
  • ·MP-21.01: Report on the early and late complications of 169 penile fractures

    Page :160-161

    S.A. Asgari, A. Roshani, S. Falahatkar, G. Mokhtari, F. Pourreza

    Plan Plan
  • ·MP-21.02: Comparative assessment of three different surgical modalities for urethroplasty in long strictures of the anterior urethra

    Page :161

    C.H. Slavov, E. Popov, M. Tzvetkov

    Plan Plan
  • ·MP-21.03: Penile brachytherapy: results for 60 patients

    Page :161

    J. Crook, L. Grimard, B. Esche, G. Pond

    Plan Plan
  • ·MP-21.04: Adult orchidopexy: is intraoperative testicular biopsy necessary?

    Page :161

    M. Moradi, A. Moradi, B. Karimian

    Plan Plan
  • ·MP-21.05: A pilot study to investigate the effect of pulsed radiofrequency in chronic testicular pain

    Page :161-162

    S.K. Misra, S. Ward, C. Coker

    Plan Plan
  • ·MP-21.06: Prognosis of advanced testicular cancer patients

    Page :162

    T. Miura, J. Oota, S. Sugiura

    Plan Plan
  • ·MP-21.07: Testicular cancer: its effect on fertility and changing practice?

    Page :162

    E. Mazaris, M. Chrisofos, I. Varkarakis, E. Chatzidarelis, A. Skolarikos, G. Alivizatos, C. Deliveliotis

    Plan Plan
  • ·MP-21.08: Salvage chemotherapy with paclitaxel, gemcitabine and nedaplatin (TGN) for cisplatin refractory germ cell tumors

    Page :162-163

    T. Nakamura, K. Mikami, N. Takaha, T. Shiraishi, A. Kawauchi, Y. Mizutani, T. Miki

    Plan Plan
  • ·MP-21.09: Laparoscopic resection of post-chemotherapy residual mass in nonseminomatous germ cell tumor: is it feasible?

    Page :163

    O. Castillo, J.M. Campero, R. Sanchez-Salas, F. Secin, G. Vitagliano, M. Diaz, J.C. Aranguibe, A. Foneron

    Plan Plan
  • ·MP-21.10: The value of repeat chest x-ray in the follow-up of stage one testicular germ cell tumours

    Page :163

    R. Richardson, A.E. Boeken Kruger, G. Stapper, M.T.W. Lock, J.L.H. Bosch

    Plan Plan
  • ·MP-21.11: Laparoscopic post chemotherapy retro peritoneal lymph node dissection for residual mass: initial results

    Page :163-164

    H. Baumert, W. Massoud, N. Rebai, N. Saheb, O. Dumonceau, V. Molinié, K. Fizazi

    Plan Plan
  • ·MP-21.12: Late relapses (LR) in 1503 patients (pts) with germ cell testicular tumors (GCTT)

    Page :164

    D.J. Argirovic, A. Argirovic

    Plan Plan
  • ·MP-21.13: High risk (HR) clinical stage A (CS-A) nonseminomatous testicular tumors (NSTT): patterns of recurrence and outcome of treatment

    Page :164

    D.J. Argirovic, A. Argirovic

    Plan Plan
  • ·MP-21.14: Dorsal onlay urethroplasty: our experience in 73 patients

    Page :164-165

    S. Bapat, P. Yadav, A. Padhye, P. Mahajan, A. Bhave

    Plan Plan
  • ·MP-21.15 (Podium): The protective effect of erythropoietin on seminiferous tubules damage in rat testicular torsion model

    Page :165

    B.B. Purnomo, A. Setiadi

    Plan Plan
  • ·MP-21.16 (Podium): Primary laparoscopic retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumor: long term results

    Page :165

    O. Castillo, J.M. Campero, R. Sanchez-Salas, F. Secin, G. Vitagliano, M. Diaz, J.C. Aranguibe, A. Foneron

    Plan Plan
  • ·MP-21.17 (Podium): Paratesticular masses: the Mayo Clinic experience

    Page :165-166

    A.K. Tsao, R.J. Karnes, T.J. Sebo, A. Nehra

    Plan Plan
  • ·MP-21.18 (Podium): Testosterone deficiency and bone metabolism damage in testicular cancer survivors

    Page :166

    D. Ondrus, B. Spanikova, M. Ondrusova, J. Mardiak

    Plan Plan
  • ·MP-22.01: Buccal mucosa graft combined with genital flaps for urethral lengthening in female transsexuals

    Page :166

    M. Djordjevic, S. Perovic, G. Korac, M. Bizic, M. Majstorovic

    Plan Plan
  • ·MP-22.02: Evaluation and management of blunt renal trauma in adults with solitary kidney or impaired renal function

    Page :166-167

    R. Santucci, E. Serafetinides, I. Mitsogiannis, K. Stravodimos, I. Anastasiou, M. Giannopoulou, A. Giannopoulos

    Plan Plan
  • ·Abstract Withdrawn

    Page :167

    
  • ·MP-22.03: First stage urethroplasty as a permanent solution in patients with complex anterior urethral stricture

    Page :167

    S.P. Elliott, J.W. McAninch

    Plan Plan
  • ·MP-22.04: Perineopenile degloving (PPD) in complex anterior urethral srictures

    Page :167

    A. Elkassaby, E. Eltahawy

    Plan Plan
  • ·MP-22.05: Perineal urethrostomy stenosis repair with buccal mucosa: Description of the technique and report of three cases

    Page :167

    N. Kamat

    Plan Plan
  • ·MP-22.06: Outcomes and special techniques for treatment of severe penile injuries

    Page :167-168

    S. Perovic, M. Djordjevic, R. Santucci, M. Bumbasirevic

    Plan Plan
  • ·MP-22.07: The main causes of surgical failure in the treatment of the posterior urethral stricture

    Page :168

    X. Hong, Y. Xu, Y. Qiao

    Plan Plan
  • ·MP-22.08: Is there any association among grade of renal injury and beta-2 microglobulin concentration in incidental urinary sample?

    Page :168

    A. Lekas, I. Fokitis, V. Politis, K. Filis, G. Lefakis, V. Maniotis, G. Koritsiadis, S. Koritsiadis

    Plan Plan
  • ·MP-22.09: Penetrating bladder injuries in abdominal trauma: Iraqi experience of Alyarmouk Teaching Hospital

    Page :168-169

    N.K.N. Alsaigh, F.G. Petros

    Plan Plan
  • ·MP-22.10: Management of urinary fistula: experience in a tertiary care hospital in Dhaka city

    Page :169

    Z.H. Bhuiyan, K.M.H. Tawhid, S.A. Khan, M. Fakhrul Islam

    Plan Plan
  • ·MP-22.11: Penile invagination technique in full length buccal mucosa urethroplasty

    Page :169

    S.B. Kulkarni, S. Lambe, A. Bapat, D. Kamat, A. Dhumavat, J. Kulkarni

    Plan Plan
  • ·MP-22.12: A new technique to repair urethro perineal fistula after abdominoperineal resection of rectum

    Page :169-170

    S.B. Kulkarni, S. Lambe, A. Bapat, D. Kamat, A. Dhumavat, J. Kulkarni

    Plan Plan
  • ·MP-22.13: Spectrum and challenges of elective reconstructive urologic operations in Sokoto, Nigeria

    Page :170

    I.A. Mungadi

    Plan Plan
  • ·Abstract Withdrawn

    Page :170

    
  • ·MP-22.14: Urethroplasty for bulbar urethral necrosis

    Page :170

    S.B. Kulkarni, S. Lambe, A. Bapat, D.T. Kama, A. Dhumavat, J. Kulkarni

    Plan Plan
  • ·Abstract Withdrawn

    Page :170

    

• Video Poster Sessions

  • ·VID-01.01: Beneficial effects of photoselective vaporization of the prostate-vaporization excision technique (PVP-VET)

    Page :171

    J.S. Byun, J.M. Joo, S.C. Kang, H.Y. Jung, J.H. Jang, I.C. Park

    Plan Plan
  • ·VID-01.02: Can holmium laser visual internal urethrotomy (VIU) replace cold knife VIU in the management of stricture urethra?

    Page :171

    A. Bhandarkar

    Plan Plan
  • ·VID-01.03: Thulium laser vapo-resection of the prostate

    Page :171

    W. Massoud, N. Rebai, N. Saheb, M. Fennouri, O. Dumonceau, H. Baumert

    Plan Plan
  • ·VID-01.04: Robotic-assisted laparoscopic radical prostatectomy in patients with previous inguinal meshplasty: technique and perioperative outcome

    Page :171-172

    K.J. Palmer, R. Thaly, K. Shah, V.R. Patel

    Plan Plan
  • ·VID-01.05: Transperitoneal laparoscopic prostatectomy: tips and tricks

    Page :172

    G. Fournier, A. Rammal, V. Joulin, C. Deruelle, B. Rousseau, A. Erauso, A. Valeri

    Plan Plan
  • ·VID-01.06: Early retrograde release of the neurovascular bundle during robotic-assisted laparoscopic radical prostatectomy

    Page :172

    K.J. Palmer, K. Shah, R. R. Thaly, V. Patel

    Plan Plan
  • ·VID-01.07: Transrectal pulsed focused ultrasound (3 MHz) as local prostate cancer treatment

    Page :172

    C. Chaussy, S. Thueroff

    Plan Plan
  • ·VID-01.08: Nerve sparing robotic prostatectomy – preserving the accessory obturator artery

    Page :172-173

    N.A. Bin Mohd Zam, K.O. Lau, K.H. Yip, W.S. Cheng

    Plan Plan
  • ·VID-01.09: Laparoscopic radical prostatectomy in a renal allograft recipient: surgical technique

    Page :173

    G. Fournier, A. Erauso, M. Moal, A. Rammal, V. Joulin, B. Rousseau, A. Valeri

    Plan Plan
  • ·VID-01.10: Different techniques for prostatic dissection according to individualised oncological and functional requirements

    Page :173

    N. Rebai, W. Massoud, N. Saheb, O. Dumonceau, H. Baumert

    Plan Plan
  • ·VID-01.11: Technique of laparoscopic extended lymphadenectomy for prostate cancer

    Page :173

    G. Fournier, C. Deruelle, J. Vincent, N. Kerfant, C. Fedorenko, R. El Atat, A. Valeri

    Plan Plan
  • ·VID-01.12: Tips and tricks of Ablatherm^® treatment

    Page :174

    S. Thueroff, C. Chaussy

    Plan Plan
  • ·VID-02.01: Video-urodynamic testing in the upper urinary tract

    Page :174

    R. Vela Navarrete, C. Gonzalez Enguita, L. Lopez Martin

    Plan Plan
  • ·VID-02.02: First stage incisionless placement of Implantable Pulse Generator (IPG) in children: video description of technique and results

    Page :174

    J.C. Routh, S.M. McGee, T.J. Roth, P. Hollatz, D.R. Vandersteen, Y. Reinberg

    Plan Plan
  • ·VID-02.03: Xenograft interposition in female urethral diverticulum surgery

    Page :175

    J.E. Robles, J.P. Rioja, A. Saiz, X. Brugarolas, A. Rincón, E. Tolosa, D. Rosell, J.J. Zudaire, J.M. Berian

    Plan Plan
  • ·VID-02.04: Uterus sparing procedure in total urogenital prolapse

    Page :175

    P. Palma, C. Riccetto, R. Fraga, V. Herrmann, N. Netto

    Plan Plan
  • ·VID-02.05: 46-XY complete gonadal dysgenesis

    Page :175

    D. Mehraban, M.A. Sedighi-Gilani

    Plan Plan
  • ·VID-02.06: Bolstering up the urethra in male urinary ıncontinence with folded polypropylene mesh

    Page :175-176

    M. Kilinc

    Plan Plan
  • ·VID-02.07: Miniperc sling for stress urinary incontinence: rationale & technique

    Page :176

    P. Palma, C. Riccetto, R. Fraga, R. Oliveira, L. Ikari, R. Miyaoka, A. Prudente, R. Aidar, N. Netto

    Plan Plan
  • ·VID-03.01: Laparoscopic dismembered pyeloplasty: an innovative technique for intracorporeal ureteral stenting

    Page :176

    A. El-Feel, H. Abouel-Fettouh, A. Abdel-Hakim

    Plan Plan
  • ·VID-03.02: Technique of robotic management of congenital primary obstructed megaureter with secondary stones in adults

    Page :176-177

    R. Rao, R. Nayyar, A.K. Hemal

    Plan Plan
  • ·VID-03.03: Laparoscopic pieloplasty in pelvic kidney

    Page :177

    M. Featherston, J. Rozanec, C. Vallote, J. Ares, A. Hernandez, R. Fabiano, M. Rumian, D. Hernandez, A. Nolazco

    Plan Plan
  • ·VID-03.04: Technique allowing the warm ischemia time to be reduced by half during laparoscopic partial nephrectomy

    Page :177

    N. Rebai, W. Massoud, N. Saheb, M. Fennouri, O. Dumonceau, H. Baumert

    Plan Plan
  • ·VID-03.05: Robotic extended pyelolithotomy – open surgery revisited

    Page :177-178

    R. Nayyar, A.K. Hemal

    Plan Plan
  • ·VID-03.06: Laparoscopic ureterolithotomy: a transition from transperitoneal to retroperitoneal approach

    Page :178

    B.K. Poh, S.H. Ho

    Plan Plan
  • ·VID-03.07: Laparoscopic assisted percutaneous nephrolithotomy in ectopic pelvic kidneys: what is best access point?

    Page :178

    S.H. Mousavi-Bahar, M.A. Amir-Zargar, H.R. Gholamrezaei, S. Amir-Hassani

    Plan Plan
  • ·VID-03.08: Indications and limits of diagnostic flexible ureteroscopy

    Page :178-179

    P. Geavlete, R. Multescu, D. Georgescu, B. Geavlete

    Plan Plan
  • ·VID-03.09: Mini-incisional nephrectomy in living donor kidney transplant (LDKT)

    Page :179

    R. Vela Navarrete, J.L. Rodriguez-Miñon, F. Calahorra Fernández, C. Gonzalez Enguita, J. Cabrera

    Plan Plan
  • ·VID-03.10: Novel technique for percutaneous nephrolithotomy in lateral decubitus flank position

    Page :179

    H. Karami, A.H.M.M. Arbab

    Plan Plan
  • ·VID-03.11: Particularities of flexible ureteroscopic approach in treatment of upper urinary tract lithiasis

    Page :179

    P. Geavlete, R. Multescu, V. Cauni, D. Georgescu, B. Geavlete

    Plan Plan
  • ·Abstract Withdrawn

    Page :179

    
  • ·VID-04.01: Reconstructive laparoscopy for ureteral lesions: a single institute experience

    Page :180

    A. El-Feel, H. Abouel-Fettouh, A. Abdel-Hakim

    Plan Plan
  • ·VID-04.02: The limits of nephron-sparing surgery in von hippel lindau disease

    Page :180

    R. Vela Navarrete, C. Gonzalez Enguita, J.V. Garcia Cardoso, F. Manzarbeitia, J. Gomez, C. Martin

    Plan Plan
  • ·VID-04.03: Laparoscopic adrenalectomy is feasible even for large tumors

    Page :180

    H.R. Gholamrezaie, A. Shadab, A. Akbarzadeh Pasha

    Plan Plan
  • ·VID-04.04: Supine position urethrectomy in conjunction with radical cystectomy for bladder cancer

    Page :180-181

    G. Glück, I. Sinescu

    Plan Plan
  • ·VID-04.05: Laparoscopic Boari bladder flap ureteroneocystostomy for distal uretral tumor: a case report

    Page :181

    A. Basiri, H. Karami, S. Mehrabi, A. Javaherforooshzadeh

    Plan Plan
  • ·Abstract Withdrawn

    Page :181

    
  • ·Abstract Withdrawn

    Page :181

    
  • ·VID-04.06: The Brazilian Urological Society’s “PTU Programa de Tele-Urologia”: an option for interactive telemedicine to a developing country

    Page :181

    S.C. Zequi, A.C. Nardi, C.A.R. Sacomani, C. Mendes Gomes, C.A.L. d’Ancona, E.R. Wroclawski, S. Glina

    Plan Plan
  • ·VID-04.07: Retroperitoneoscopic drainage of a psoas abscess

    Page :181

    R. Rabii, S. El Mhef, B. Querfani, A. Joual, F. Meziane

    Plan Plan
  • ·VID-05.01: Laparoscopic treatment for bilateral varicocel

    Page :181-182

    R. Rabii, S. Elmhef, B. Querfani, F. Meziane

    Plan Plan
  • ·VID-05.02: Three piece penile prosthesis implant (Titan^® with Resist^®) in complex cases

    Page :182

    S. Pecoraro, A. Fienga, B. Giammusso

    Plan Plan
  • ·VID-05.03: Original space maintainer device in penile lengthening: a new technique

    Page :182

    G. Alei, P. Letizia, F. Ricottilli

    Plan Plan
  • ·VID-05.04: “Double breasted” corporoplasty in congenital penile recurvatum: ten years’ experience

    Page :182-183

    G. Alei, P. Letizia, F. Ricottilli

    Plan Plan
  • ·VID-05.05: Laparoscopic cystectomy and neo-bladder formation in woman

    Page :183

    W. Massoud, N. Rebai, L. Peyrat, O. Dumonceau, H. Baumert

    Plan Plan
  • ·VID-05.06: Laparoscopic management of an ureteral injury during laparoscopic procedures

    Page :183

    N. Rebai, W. Massoud, N. Saheb, M. Fennouri, O. Dumonceau, H. Baumert

    Plan Plan
  • ·VID-05.07: Combined buccal mucosa graft and penile flap for urethral reconstruction in failed hypospadias repair

    Page :183

    M. Djordjevic, R. Santucci, S. Perovic

    Plan Plan
  • ·VID-05.08: Asopa’s technique for penile urethral reconstruction

    Page :183-184

    E. Palminteri, E. Berdondini

    Plan Plan
  • ·VID-05.09: Resurfacing of the glans penis

    Page :184

    E. Palminteri, E. Berdondini

    Plan Plan
  • ·VID-05.10: Management of iatrogenic urinary tract injuries

    Page :184

    M. Yazdani, K. Nouri-Mahdavi, M.R. Gheraati

    Plan Plan
  • ·VID-05.11: Radical cystectomy and orthotopic ileal neobladder with preservation of the prostate capsule and the seminal vesicles

    Page :184-185

    D. Delakas, I. Karyotis, C. Konstantinidis, G. Barbaras

    Plan Plan
  • ·VID-06.01: Glansectomy and circumcision for penile carcinoma with skin graft on the corporal heads

    Page :185

    C. Gingu, M. Harza, S. Patrascoiu, B. Serbanescu, B. Stefan, V. Zogas, R. Stoica, D. Tica, V. Cerempei, I. Sinescu

    Plan Plan
  • ·VID-06.02: Retroperitoneal lymph node dissection for testicular teratoma in a patient with horseshoe kidney

    Page :185

    C. Gîngu, M. Hârza, S. Pǎtrǎşcoiu, C. Chibelean, D. Tica, B. Ştefan, C. Bǎlşanu, C. Surcel, R. Stoica, C. Baston, I. Sinescu

    Plan Plan
  • ·VID-06.03: Multimodal salvage therapy for a patient with penile carcinoma and bulky inguinal lymph nodes metastases

    Page :185-186

    C. Gingu, S. Patrascoiu, M. Harza, C. Chibelean, B. Stefan, C. Balsanu, D. Tica, C. Surcel, I. Sinescu

    Plan Plan
  • ·VID-06.04: Ventral bulbar augmentation [VBA]: a technique to enhance support of buccal mucosal graft placed ventrally for proximal bulbar urethral strictures

    Page :186

    D. Dalela, R.J. Sinha, S. Sankhwar, V. Singh

    Plan Plan
  • ·VID-06.05: Substituiton urethroplasty for bulber-urethral stricture: modified Barbagli procedure: experience in 10 cases

    Page :186

    Z.H. Bhuiyan, K.M.H. Tawhid, S.A. Khan, M. Fakhrul Islam

    Plan Plan
  • ·VID-06.06: Induratio penis plastica: preliminary experience with extracorporeal shock-wave treatment (ESWT)

    Page :186-187

    R. Giulianelli, S. Brunori, G. Vincenti, F. Pisanti, L. Mavilla, L. Albanesi, Bc. Gentile, T. Shestani

    Plan Plan
  • ·VID-06.07: Introduction of the 2μM CW laser for several applications in urology

    Page :187

    T. De Boorder, M. Grimbergen, R. Bosch, J. Klaessens, R. Verdaasdonk, T. Lock

    Plan Plan
  • ·VID-06.08: Laparoscopic extra peritoneal post chemo retroperitoneal lymph node dissection (RPLND)

    Page :187

    W. Massoud, N. Rebai, N. Saheb, O. Dumonceau, H. Baumert

    Plan Plan
  • ·VID-06.09: Transperitoneal approach for laparoscopic retro peritoneal lymph node dissection (RPLND) for large residual mass

    Page :187-188

    H. Baumert, W. Massoud, N. Rebai, J. Schlosser, O. Dumonceau, K. Fizazi

    Plan Plan
  • ·VID-06.10: Bipolar endoscopic procedures in complicated urethral strictures

    Page :188

    P. Geavlete, D. Georgescu, V. Cauni, V. Mirciulescu, B. Geavlete

    Plan Plan

• Unmoderated Poster Sessions

  • ·POS-01.01: O’Connor technique and its effects on bladder function in previously failed vesicovaginal fistulas

    Page :189

    F. Sharifiaghdas, H. Akhavizadegan

    Plan Plan
  • ·POS-01.02: Efficacy analysis of trans-obturator tension-free vaginal tape (TVT-O) versus tension-free vaginal tape in the treatment of mixed urinary incontinence: a randomized study

    Page :189

    C. Moon, H.Y. Moon, D.H. Lim, C.S. Kim, J. Rho, H.S. Park, S.J. Chun

    Plan Plan
  • ·POS-01.03: Tension-free vaginal tape (TVT), suprapubic ARC (SPARC) sling and transobturator tape (TOT) in the treatment of mixed urinary incontinence in women

    Page :189

    S. Choi, J. Ku, H. Son, S.J. Oh, S. Kim, J.S. Paick

    Plan Plan
  • ·POS-01.04: Omentoplasty in the treatment of complex vesico-vaginal fistulas: A forgotten method?

    Page :189-190

    D.S. Popescu, V. Popescu, A. Irimie, S. Nicoara

    Plan Plan
  • ·POS-01.05: Anatomic and functional comparison of pelvic floor in women with voiding difficulty and normal women

    Page :190

    S. Hajebrahimi, Z. Miabi, A. Azaripour, A. Mahdkhah

    Plan Plan
  • ·POS-01.06: Novel technique for the treatment of stress urinary incontinence: early outcomes

    Page :190

    M. Mustafa, H. Abol-Enein

    Plan Plan
  • ·POS-01.07: Anatomical basis for effective placement of adjustable continence therapy (ACT®) balloons for treatment of female stress urinary incontinence

    Page :190-191

    E. Kocjancic, B. Frea, P. Robertson, H. O’Connell

    Plan Plan
  • ·POS-01.08: Periodic outcomes of tension-free vaginal tape procedure for women with stress urinary incontinence

    Page :191

    W.Y. Cho, T.H. Kim, K.S. Lee, Y.K. Seong, J.S. Hwang

    Plan Plan
  • ·POS-01.09: Female urethral tear resulting in urinary incontinence following spontaneous vaginal delivery

    Page :191

    A. Bolukbasi

    Plan Plan  
  • ·POS-01.10: Comparison of cystometric, uroflowmetric and voiding diary volumes to determine the correct maximum bladder capacity in women with urinary incontinence

    Page :191-192

    I. Sen, A. Çamtosun, M. Onaran, M. Kiraç, M.Ö. Tan, I. Bozkirli

    Plan Plan
  • ·POS-01.11: Comparison of uroflowmetry parameters in women with urge, stress and mixed type urinary incontinence

    Page :192

    I. Sen, A. Çamtosun, M. Onaran, M. Kiraç, M.Ö. Tan, I. Bozkirli

    Plan Plan
  • ·POS-01.12: The effects of estrogen on nNOS, eNOS expression and histologic composition in the rat bladder and urethra

    Page :192

    S.W. Park, C.Y. Lee, J.Z. Lee

    Plan Plan  
  • ·POS-01.13: Why do pre-pubic slings fail?

    Page :192-193

    P. Palma, A. Silveira, C. Riccetto, A. Prudente, M. Dambros, N. Netto

    Plan Plan
  • ·POS-01.14: Vaginal wall prolapse repair with and withot meshes: A global analysis of impact on symptons, quality of life and sexuality

    Page :193

    P. Palma, C. Riccetto, R. Thiel, L. Perchon, M. Dambros, V. Muller, N. Netto

    Plan Plan  
  • ·POS-01.15: Nazca: a monoprosthesis for the simultaneous correction of cystocele and urinary stress incontinence - a multicentric trial

    Page :193-194

    P. Palma, C. Riccetto, V. Muller, R. Fraga, O. Contreras, C. Sarsotti, M. Paladini, A. Cianci, P. Barthos

    Plan Plan
  • ·POS-01.16: Level specific correction of apical and posterior prolapses: why transcoccigeal fixation makes a difference

    Page :194

    P. Palma, C. Riccetto, R. Fraga, V. Pagotto, E. Castro, V. Herrmann, J. Tejerizo, S. Metrebien

    Plan Plan  
  • ·POS-01.17: The percutaneous sling for stress urinary incontinence: Towards the in-office procedure

    Page :194

    P. Palma, C. Riccetto, V. Herrmann, R. Miyaoka, R. Fraga

    Plan Plan  
  • ·POS-01.18: Can short-term administration of anticholinergics predict improvement of overactive bladder symptoms after sling surgery in patient with both stress urinary incontinence and overactive bladder?

    Page :194-195

    W.Y. Cho, T.H. Kim, D.W. Choi, D.W. Kim

    Plan Plan
  • ·POS-01.19: Managing vascular complications during transobturator sling

    Page :195

    P. Palma, R. Fraga, C. Riccetto, N. Netto

    Plan Plan
  • ·POS-01.20: Obstruction following sling procedures is more frequent in autologous than synthetics: urethrolysis effectiveness is similar

    Page :195-196

    P. Palma, C. Riccetto, R. Fraga, R. Oliveira, N. Netto

    Plan Plan
  • ·POS-01.21: Endoscopic treatment in vesicovaginal fistulas

    Page :196

    P. Geavlete, D. Georgescu, V. Mirciulescu, B. Geavlete

    Plan Plan
  • ·POS-01.22: Male infertility: sperm disorders and stytic dysfunction in Byzantine times (330-1453 AD)

    Page :196

    E. Poulakou-Rebelakou, C. Tsiamis, E. Koutsiaris, A. Rempelakos

    Plan Plan
  • ·POS-01.23: Consequences of the sexual behaviour of Byzantine emperors (330-1453 AD)

    Page :196-197

    A. Rempelakos, E. Koutsiaris, C. Tsiamis, E. Poulakou-Rebelakou

    Plan Plan
  • ·POS-01.24: The reasons of orchectomy from Hippocrates to the 20^th century

    Page :197

    E. Koutsiaris, A. Rempelakos

    Plan Plan
  • ·POS-01.25: French influence on the establishment and development of Greek urology

    Page :197

    E. Poulakou-Rebelakou, C. Tsiamis, E. Koutsiaris, A. Rempelakos

    Plan Plan
  • ·POS-01.26: The first urological department in Russia

    Page :197

    A. Novikov

    
  • ·POS-01.27: Prevalence of microorganisms colonizing in the bladder catheters in 204 patients

    Page :197-198

    T. Arvanitakis, A. Rempelakos, A. Palantzas, A. Marketakis, S. Mpisias, E. Chinou

    Plan Plan
  • ·POS-01.28: Changes in causative organisms and antimicrobial sensitivity of the urinary tract infection

    Page :198

    S.J. Oh, D.Y. Han, S.H. Baek, S.C. Park, J.S. Hwa, I.Y. Seo, H.J. Jeong, J.S. Rim

    Plan Plan
  • ·POS-01.29: Treatment of symptomatic simple renal cysts by percutaneous aspiration and ethanol sclerotherapy

    Page :198

    M. Labib

    Plan Plan
  • ·POS-01.30: Influence of E. coli genomic pathogenecity islands on the clinical course of urinary tract infections

    Page :198-199

    L.A. Khodyreva, A.E. Verschinin, V.M. Bondarenko, T.S. Perepanova, V.N. Sinyukhin

    Plan Plan  
  • ·POS-01.31: Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: analysis of 282 Japanese patients

    Page :199

    T. Ito

    Plan Plan
  • ·POS-01.32: Emphysematous pyelonephritis – our experience

    Page :199-200

    P.V.L.N. Murthy, J. Srikanth, C. Ramreddy, R. Devraj, B. Suresh, N. Prasad, H. Kumar

    Plan Plan
  • ·POS-01.33: Positive results of the URISCREEN^™ test for UTI may indicate bladder cancer

    Page :200

    D. Pode, I. Golan, A. Shapiro, R. Katz, O. Gofrit

    Plan Plan
  • ·POS-01.34: pCREB immunohistochemical staining of dorsal root ganglia after repeated UPEC infection into rat bladder

    Page :200

    W. Sung, H. Rho, S.J. Lee, S.G. Chang, J. Kim

    Plan Plan
  • ·Abstract Withdrawn

    Page :200

    
  • ·POS-01.36: Safety and pathological findings of prostate biopsy in male interstitial cystitis patients with an elevated PAS level: What dose an elevated PSA level mean?

    Page :200-201

    M. Kajiwara, K. Mutaguchi, M. Oki, H. Moriyama

    Plan Plan
  • ·POS-01.37: Novel quantification method using voided stain on paper technique for voiding analysis in the mouse

    Page :201

    Y. Sugino, A. Kanematsu, K. Yoshimura, Y. Hayashi, N. Yoshimura, O. Ogawa

    Plan Plan
  • ·POS-01.38: Isolated retrovesical cystic mass (hydatid cyst)

    Page :201

    D. Nourizadeh, M. Amjadi

    Plan Plan
  • ·POS-01.39: Septic shock after transrectal biopsy of prostate due to extended-spectrum beta-lactamase producing Escherichia coli

    Page :201-202

    K. Hikita, T. Watanabe, T. Isyama, M. Honda, N. Kobayashi, S. Morizane, S. Toji, M. Matsumoto, T. Masago, I. Miyagawa

    Plan Plan
  • ·POS-01.40: Filarial hydrocelectomy: the West African experience

    Page :202

    S. Mante, S. Anders

    Plan Plan
  • ·POS-01.41: Chlamydia trachomatis infection in male partners of infertile couples

    Page :202-203

    I. Ouzounova, V. Raykova, I. Mitov

    Plan Plan
  • ·POS-01.42: A comparative study of two methods of perineal and genital skin antiseptic preparation prior to urological procedures in adult male patients

    Page :203

    E.O. Kehinde, Y. Ali, F. Khodakhast, W. Jamal, M. Seshah, V.O. Rotimi

    Plan Plan
  • ·POS-01.43: Dorsal free buccal mucosal graft urethroplasty for recurrent anterior urethral strictures via ventral sagittal urethrotomy approach

    Page :203

    P. VLN Murthy, P. Sriman, C. Ramreddy, R. Devraj, V. Sagar, N. Prasad, J. Srikanth, B. Suresh

    Plan Plan
  • ·POS-01.44: Clinical study of male urethritis in Nagano Matsushiro General Hospital

    Page :203-204

    T. Nakagawa

    Plan Plan
  • ·POS-01.45: Alpha blockers versus phytotherapy for the treatment of chronic non-bacterial prostatitis

    Page :204

    M.H. Sherief, A. Elnashar, G. Alatrash, M. Motawe

    Plan Plan
  • ·POS-01.46: Levofloxacin for antibiotic prophylaxis in cases of prostate biopsy

    Page :204

    D. Pushkar, A. Zaitcev, A. Govorov, P. Rasner

    Plan Plan
  • ·POS-01.47: Male genital tuberculosis

    Page :204-205

    A. Bolukbasi, F. Þengül, C. Öztürk, O. Bayýr

    Plan Plan
  • ·POS-01.48: Sexual dysfunctions in infertile women

    Page :205

    S.M. Yassini Ardekani, M.R. Moein, N. Tayybi

    Plan Plan
  • ·POS-01.49: Bilateral but not unilateral testis hypotrophy predicts severe impairment of semen quality

    Page :205

    A. Wu, T.J. Walsh, P.J. Turek

    Plan Plan
  • ·Abstract Withdrawn

    Page :205

    
  • ·POS-01.51: Intratesticular blood flow in patients with azoospermia

    Page :205-206

    M.K. Alchinbaev, A.S.H. Ibraeva, T.E. Husainov, Y.S.H. Ismoldayev, A. Eralieva

    Plan Plan
  • ·POS-01.52: Semen profiles and body mass indices of African males seeking treatment for infertility in Ghana

    Page :206

    K.E.K. Aboah

    Plan Plan
  • ·POS-01.53: Interest of varicocele repair in azoospermic men

    Page :206

    H. Ketata, H. Jallouli, M. Bouacida, A. Sahnoun, S. Ben Amar, A. Kertiti, M.N. Mhiri

    Plan Plan
  • ·Abstract Withdrawn

    Page :206

    
  • ·POS-01.55: Investigation of tubular loop: New modified technique of microsurgical vasoepididymostomy

    Page :206-207

    R.K. Shimpi

    Plan Plan
  • ·POS-01.56: Does reactive oxygen species (ROS) production in seminal fluid correlate with the severity of varicocele in infertile men?

    Page :207

    M.R. Moein, M. Soleimani, N. Tabibnejad

    Plan Plan
  • ·POS-01.57: Sperm chromosomal abnormalities and DNA damage in infertile mustard gas casualties’ men detected by fluorescence in-situ hybridization, inverse restriction site mutation assay, sperm chromatin structure assay and the comet assay

    Page :207

    M.R. Safarinejad

    Plan Plan
  • ·POS-01.58: Participation of apoptosis in the mechanism of dysfunction of spermatogenesis after vasectomy

    Page :207-208

    Y. Umemoto, S. Sasaki, M. Hayase, Y. Kojima, Y. Kubota, K. Kohri

    Plan Plan
  • ·POS-01.59: Isolation and characterization of HANP1/H1T2, a novel histone H1-like protein involved in nuclear formation and sperm fertility

    Page :208

    Y. Matsuoka, A. Tsujimura, T. Takao, Y. Miyagawa, S. Takada, H. Tanaka, Y. Nishimune, A. Okuyama

    Plan Plan
  • ·POS-01.60: Comparision of semen profile and frequency of chromosome aneuploidy in sperm nuclei of patients with varicocele before and after surgical treatment

    Page :208

    H. Acar, M. Kilinc, T. Yurdakul, R. Celik, S. Guven

    Plan Plan
  • ·POS-01.61: Kartagener syndrome: An unusual presentation of the rare condition

    Page :208

    A. Jha, H. Yahiya, J. Flynn, A. Busutill

    Plan Plan
  • ·POS-01.62: Comparison of prevalence of varicocele in first-degree relatives of patients with varicocele and male kidney donors

    Page :208-209

    G.H. Mokhtari, A. Noshad, M. Jamali

    Plan Plan
  • ·POS-01.63: A prospective study comparing fluoxetine versus clomipramine in management of premature ejaculation

    Page :209

    R. Taghavi Razavizadeh, R. Mahdavi, M.R. Darabi, K. Tavakoli

    Plan Plan
  • ·POS-01.64: Surgical sperm retrieval: MESA continues to play a role for ICSI

    Page :209

    H. Hibi, T. Ohori, Y. Yamada, N. Honda, Y. Hashibi, Y. Asada

    Plan Plan
  • ·POS-01.65: Role of nitric oxide concentrations in the patients with oligozoospermia on spermatogenesis: using L-arginine loading test and supplementation therapy

    Page :209

    H. Terada, M. Harada, S. Ozono, M. Kanayama, T. Terao

    Plan Plan
  • ·POS-01.66: Varicocelectomy can improve natural and assisted procreation

    Page :209-210

    M.N. Mhiri, H. Jallouli, H. Ketata, M. Hadj Slimen, M. Bouacida, S. Ben Amar, H. Fakhfekh

    Plan Plan
  • ·POS-01.67: Results of vasoepididymostomy for non-vasectomy patients: comparative analysis of the side-to-side technique and the two-suture invagination technique

    Page :210

    T.N. Nguyen, D.T.B. Mai, V.L. Chuyen, Q.T. Duong, V.S. Tran

    Plan Plan
  • ·POS-01.68: Antegrade scrotal sclerotherapy for the treatment of varicocele: prospective study of 180 cases

    Page :210

    A. Hidoussi, M. Jaidane, A. Slama, A. Youssef, Y. Kalel, N. Ben Sorba, A.F. Mosbah

    Plan Plan
  • ·POS-01.69: Testicular sperm extraction in oncological patents: our results

    Page :210-211

    L. Rolle, C. Ceruti, A. Tamagnone, M. Timpano, C. Negro, D. Fontana

    Plan Plan
  • ·POS-01.70: Identification of the mineralocorticoid receptor (MR) in human corpus cavernosum penis

    Page :211

    T. Kishimoto, Y. Kawanishi, M. Sakaki, H. Muguruma, R. Taue, H. Izaki, T. Fukumori, M. Takahashi, S. Kagawa, H. Kanayama

    Plan Plan
  • ·POS-01.71: Effect of aldosterone on isolated human penile corpus cavernous tissue

    Page :211

    H. Muguruma, Y. Kawanishi, H. Sugiyama, S. Tanimoto, M. Yamanaka, K. Kojima, H. Anzai, A. Numata, T. Kishimoto, H. Kanayama

    Plan Plan
  • ·Abstract Withdrawn

    Page :211

    
  • ·POS-01.72: Relationship between lower urinary tract symptoms and erectile dysfunction in men above 50 years old

    Page :211-212

    F. Tadayyon, A. Pourreza, M. Yazdani

    Plan Plan
  • ·Abstract Withdrawn

    Page :212

    
  • ·POS-01.74: The real-life safety and efficacy of vardenafil (REALISE) study: results from the pooled European and overseas study

    Page :212

    H. van Ahlen, J. Zumbé, H. Landen, Vardenafil REALISE Study Group

    Plan Plan
  • ·POS-01.75: The real–life safety and efficacy of vardenafil (REALISE) study – six months’ follow-up data from Germany

    Page :212

    H. van Ahlen, J. Zumbé, K. Stauch, H. Landen

    Plan Plan
  • ·POS-01.76: A prevalence survey on sexual dissatisfaction in Rasht (North Iran-2006)

    Page :212-213

    S.A. Asgari, M. Mansour Ghanai

    Plan Plan
  • ·POS-01.77: Sexual dysfunction related to metabolic syndrome

    Page :213

    H. Lee, B.S. Shim, Y.Y. Park, Y.S. Hong

    Plan Plan
  • ·Abstract Withdrawn

    Page :213

    
  • ·POS-01.78: Study on correlation between metabolic syndrome and diabetes-related erectile dysfunction

    Page :213

    Y.J. Seo, K.S. Sim, J.M. Heo, J.O. Lee, J.Y. Park

    Plan Plan
  • ·POS-01.79: Sexual dysfunction in epileptic patients

    Page :213-214

    M.R. Nikoobakht, M. Motamedi, A.H. Orandi, S. Ebrahimi Nasrabady, A.A. Orandi, A. Afshin, F. Tale Khatibi

    Plan Plan
  • ·Abstract Withdrawn

    Page :214

    
  • ·POS-01.80: Relationship between polysomnographic indexes and erectile function in men who complain of sleep apnea

    Page :214

    D.Y. Yang, S.Y. Kim, H. Kim, S.W. Lee, J.H. Lee

    Plan Plan
  • ·POS-01.81: The effect of smoking on penile hemodynamics in erectile dysfunction

    Page :214

    H.J. Park, N.C. Park, S.K. Chung, W.H. Chon, C.Y. Lee

    Plan Plan
  • ·POS-01.82: A comparison of penile oximetry between low dose intraurethral alprostadil 125 and 250 Mcg and intracorporal prostaglandin E-1

    Page :214-215

    P. Padmanabhan, A. Kanofsky, D. Brassil, B. Goodwin, S. Telegrafi, A. McCullough

    Plan Plan
  • ·POS-01.83: Six-month interim analysis return of erectile function from a randomized study of nightly intraurethral alprostadil vs sildenafil as penile rehabilitation in post bilateral nerve sparing radical prostatectomy (BNSRRP)

    Page :215

    D. Fenig, D. Brassil, B. Goodwin, H. Lepor, S. Taneja, A. McCullough

    Plan Plan
  • ·POS-01.84: The differences of AMS score and testosterone level between rural and urban areas

    Page :215

    D. Rahardjo, A. Taher, C. A Mochtar, S. Hudaya, R. Hamid, A. Wahyudi, M. Palinrungi, G. Sutanto, E. Manuputty

    Plan Plan
  • ·POS-01.85: Penile strangulation: presentation of two unusual cases

    Page :215-216

    O. Ivanovski, O. Stankov, M. Kuzmanoski, S. Banev, L. Lekovski, Z. Popov

    Plan Plan  
  • ·Abstract Withdrawn

    Page :216

    
  • ·POS-01.86: Severity of erectile dysfunction at presentation: association of premature ejaculation and low desire

    Page :216

    A.I. El-Sakka

    Plan Plan
  • ·POS-01.87: Hypercium perforatum extract improves both intravaginal ejaculatory latency time and sexual satisfaction

    Page :216

    T.W. Cannon-Smith, J.H. Kaufman

    Plan Plan
  • ·Abstract Withdrawn

    Page :216

    
  • ·POS-01.88: Study of efficacy and safety of oral tramadol in the treatment of premature ejaculation

    Page :217

    A. Mohammadi-Jazi, K. Nori Mahdavi, S. Salehi

    Plan Plan
  • ·Abstract Withdrawn

    Page :217

    
  • ·Abstract Withdrawn

    Page :217

    
  • ·POS-01.89: Comparison of vitamin E and propionyl-l-carnitine, separately or in combination in patients with early chronic Peyronie’s disease: a double blind, placebo-controlled, randomized study

    Page :217

    M.R. Safarinejad

    Plan Plan
  • ·Abstract Withdrawn

    Page :217

    
  • ·Abstract Withdrawn

    Page :217

    
  • ·POS-01.90: The modified Nesbitt’s operation for penile curvature: our results in la Peyronie’s disease

    Page :217

    L. Rolle, C. Ceruti, A. Tamagnone, M. Timpano, C. Negro, D. Fontana

    Plan Plan
  • ·POS-01.91: Y-V preputioplasty for phimosis: an audit of 90 cases

    Page :217-218

    H. Khan, N.P. Munro, N.A. Shaikh, I. Appleyard, P. Koenig

    Plan Plan
  • ·POS-01.92: Penile augmentation in dysmorphopenophobic patients using a matrix collagen graft

    Page :218

    S. Pecoraro, A. Fienga, R. Giannella, G. Sepe

    Plan Plan
  • ·POS-01.93: The long term results of modified plication of the tunica albuginea in the congenital penile curvature

    Page :218

    J. Heo, G.W. Jung

    Plan Plan
  • ·POS-01.94: AMS 700 series inflatable penile prosthesis with the Momentary Squeeze pump: a review of the device modifications, intraoperative localization of the pump, and patient satisfaction results

    Page :218-219

    A. Nehra, D. Nienow

    Plan Plan
  • ·POS-01.95: Safety and efficacy of tubeless percutaneous nephrolithotomy

    Page :219

    S. Falahatkar, S. Tavasoli Yousefabad, I. Khosropanah, H. Niroumand, S. Nikpour

    Plan Plan
  • ·POS-01.96: Comparison of three less invasive procedures for large upper ureteral stones

    Page :219

    A. Basiri, N. Simforoosh, S.A.M. Ziaee, H. Shayaninasab, S. Hosseini, S.M.M. Moghaddam

    Plan Plan
  • ·POS-01.97: Comparison of balloon and Amplatz fascial dilation systems for percutaneous tract dilation in percutaneous nephrolithotomy

    Page :219-220

    Y.B. Jeong, S.B. Jeon, H.J. Kim, Y.G. Kim, Y.K. Park

    Plan Plan
  • ·POS-01.98: Efficiency of combined pneumatic and ultrasonic lithotripsy with transluminal suction in percutaneous nephrolithotripsy

    Page :220

    M. Etemadian, P. Shadpour, A. Saidi, M.J. Solemani

    Plan Plan
  • ·POS-01.99: Percutaneous nephrolithotomy (PCNL) in pediatric patients

    Page :220

    M. Hosseini, S. Shakeri, A. Khezri, A. Basiri, R. Inaloo, A. Yousefi, A. Hasanpour

    Plan Plan
  • ·POS-01.100: Management of 10-15 mm proximal ureteral stones: ureteroscopy or ESWL, a prospective patient preference trial

    Page :220

    S.A.M. Ziaee, M.R. Halimi, A. Aminsharifi, H. Shafi, A. Basiri

    Plan Plan
  • ·POS-01.101: One stage tract dilation for percutaneous nephrolithotomy: is it justified?

    Page :220

    S.A.M. Ziaee, H. Karami, A. Aminsharifi, S. Mehrabi, S. Zand, A. Javaherforooshzadeh

    Plan Plan
  • ·POS-01.102: Does sealing of the tract with absorbable gelatin (Spongostan^™) facilitate ‘tubeless percutaneous nephrolithotomy’? A pilot study

    Page :221

    I. Singh, G. Mehrotra, R. Saran, A. Singh, M. Jain

    Plan Plan
  • ·POS-01.103: The use of ureteroscopy (URS) in ureteral stone treatment

    Page :221

    D. Papadopoulos, A. Lekas, A. Balangas, A. Schneider, S.O. Schattka, R. Homberg, A. Kollias

    Plan Plan
  • ·POS-01.104: ESWL for treatment of large ureteral stones

    Page :221

    N. Rexha, I.A. Jusuj, A. Hoxha, A. Hazrolli, S. Rexha, R. Kasumaj

    Plan Plan
  • ·POS-01.105: Ureteroscopy without fluoroscopy for distal ureteral stones

    Page :221-222

    M. Wishahi, M. Roushdy, H. El-Ganzoury, S. Ghobashy, A. El-Baz, T. El-Leithy, I. Mahmoud, M. Ali, T. El.kalsh

    Plan Plan
  • ·POS-01.106: Treatment of intravesical ureterocele with transurethral resection in adults

    Page :222

    L. Lõrincz, A. Varga, A. Farkas, C. Berczi, C. Tóth, T. Flaskó

    Plan Plan
  • ·POS-01.107: Asymptomatic microscopic hematuria and urinary lithiasis

    Page :222

    S. Falahatkar, S. Tavasoli Yousefabad, H. Farhadabadi, S. Nikpour

    Plan Plan
  • ·POS-01.108: Survey of relative frequency of microbial agents in urine culture and their sensitivity to antibiotics in patients with renal stone

    Page :222-223

    S. Tavasoli Yousefabad, S. Falahatkar

    Plan Plan
  • ·POS-01.109: The local factor is more important than systemic factor in the formation of bladder uric acid stone

    Page :223

    C.C. Li, W.M. Li, Y.H. Chou, C.C. Liu, W.J. Wu, C.H. Huang

    Plan Plan
  • ·POS-01.110: Contralateral ureterolithotomy

    Page :223

    S.B. Kulkarni, S. Lambe, A. Bapat, D. Kamat, A. Dhumavat, J. Kulkarni, D. Kirpekar

    Plan Plan
  • ·POS-01.111: TUL or ESWL is the approach of choice for upper ureter stones management: a comparative study

    Page :223-224

    M. Nikoobakht, A. Emamzadeh, A. Abedi, A. Mehrsai, M. Taherimahmoudi, G. Pourmand

    Plan Plan
  • ·POS-01.112: Electrostimulation in the therapy of post-prostatectomy incontinence

    Page :224

    W. Hoffman, S. Hoffman, U. Otto

    Plan Plan
  • ·POS-01.113: Effects of clomipramine, imipramine, doxepine and duloxetine on acetic acid-induced bladder irritation in rabbits

    Page :224

    F.J. Perez Martínez, R. Vela Navarrete, C. Castilla Reparaz, C. González Enguita

    Plan Plan
  • ·POS-01.114: Treatment of post prostatectomy incontinence using the SAFYRE male sling

    Page :224-225

    M.R. El Halaby, A. Abdelmaksoud, T. Osman, K. Fawaz

    Plan Plan
  • ·POS-01.115: Correlation of self-assessment instruments with pad count in patients after laparoscopic radical prostatectomy

    Page :225

    J.M. Fialkov

    Plan Plan
  • ·POS-01.116: The 1-year outcome and prognostic factor of suprapubic arch sling (SPARC) operation in female stress urinary incontinence in multicenter study

    Page :225

    H.K. Park, H.W. Lee, K.S. Lee, B.C. Jung, H. Son, S.S. Byun, S.E. Lee

    Plan Plan
  • ·POS-01.117: Comparison of transobturator suburethral sling (MONARC) vs suprapubic arc (SPARC) sling procedures for female stress incontinence in multicenter study

    Page :225-226

    H.K. Park, H.W. Lee, K.S. Lee, B.C. Jung, H. Son, S.S. Byun, S.E. Lee

    Plan Plan
  • ·Abstract Withdrawn

    Page :226

    
  • ·POS-01.118: Transobturator IVS used in failed stress urinary incontinence cases

    Page :226

    C. Chibelean, C. Surcel, M. Harza, C. Gingu, V. Cerempei, D. Avram, S. Patrascoiu, C. Moldovan, I. Sinescu

    Plan Plan
  • ·POS-01.119: Risk factors for postprostatectomy incontinence in a country with low incidence of prostate cancer

    Page :226-227

    A.Y. Lai, Y. Kuo, S. Lu, M. Lai, S.F. Hung

    Plan Plan
  • ·POS-01.120: Transrectal linear array ultrasonography complements urodynamics and eliminates cine’ radiation exposure

    Page :227

    I. Perkash, V. Wolfe, G. Friedland

    Plan Plan
  • ·POS-01.121: Improving voiding efficiency in the diabetic rat by a 5-HT1A serotonin receptor agonist

    Page :227-228

    B. Gu, J. Si, F. Liu, Y. Xu, K.E. Andersson

    Plan Plan
  • ·POS-01.122: Variation between clinical and urodynamic responses in patients receiving intradetrusor botulinum A for refractory neurogenic detrusor overactivity

    Page :228

    K.L. Toh, A. Tow

    Plan Plan
  • ·POS-01.123: Treatment of voiding dysfunction in patients with multiple sclerosis by injection of botulinum-A toxin (BTX-A) in external sphincter

    Page :228

    M.A. Mohamadzadeh Rezaei, M. Foroghipoor

    Plan Plan
  • ·POS-01.124: The application of solifenacin in myelodysplasic and other patients with ineffective pharmacological and/or surgical treatment

    Page :228-229

    L. Skobejko-Wlodarska, K. Felberg, P. Gastol, M. Baka-Ostrowska

    Plan Plan
  • ·POS-01.125: Two cases of intraperitoneal bladder rupture following vaginal delivery

    Page :229

    K.S. Png, Y.L. Chong, C.K. Ng

    Plan Plan
  • ·POS-01.126: Initial experience of transurethral bulking agent (deflux injection) in patients presenting with incontinence after radical prostatectomy or in advanced ca prostate involving posterior urethra/sphincter and unresponsive to conservative measures

    Page :229

    R. Sood, S. Kathuria

    Plan Plan
  • ·POS-01.127: Urodynamic and erectile dysfunction outcomes of tamsulosin oral controlled absorption system in BPH

    Page :229-230

    C. Persu, S. Bancu, V. Cauni, P. Geavlete

    Plan Plan
  • ·POS-01.128: Why is a male transobturator sling retro-urethral and non-obstructive?

    Page :230

    P. Rehder, C. Gozzi

    Plan Plan
  • ·POS-01.129: X-linked recessive transmitted diabetes insipidus – an interdisciplinary urological challenge

    Page :230

    X. Krah, E. Hauschild, G. Atanassov, C. Güttner, G. Eschholz

    Plan Plan
  • ·POS-01.130: The effect of amitryptline in female overactive bladder patients with nocturia

    Page :230

    H.J. Jeong, D.Y. Han, S.H. Baek, S.C. Park, S.J. Oh, J.S. Rim, S.O. Kim, D.D. Kwon, J.H. Roh, J. Roh, Y.B. Jeong

    Plan Plan
  • ·POS-01.131: Besipirdine: a new and powerful drug for urinary incontinence

    Page :231

    F.C. Perez-Martinez, R. Vela-Navarrete, C. Castilla-Reparaz, F. Haab, J. Ferté, H. Bienaymé, P. Attali

    Plan Plan
  • ·POS-01.132: Diary and patient-reported outcomes with solifenacin in patients with overactive bladder reporting high symptom bother and residual urgency on tolterodine

    Page :231

    N. Zinner, M.B. Chancellor, S. Forero-Schwanhaeuser

    Plan Plan
  • ·POS-01.133: Clinical trial of tension-free transobturator suburethral tape (inside-out TVT-O) procedure for the treatment of stress urinary incontinence

    Page :231-232

    Y.J. Kim, J. Lee, J.S. Huh

    Plan Plan
  • ·POS-01.134: Responses to solifenacin in patients >65 years and ≤65 years with overactive bladder syndrome: post-hoc results from the randomised, double-blind STAR study

    Page :232

    C.R. Chapple, T. Drogendijk, D.M. Wright, J. Bolodeoku

    Plan Plan
  • ·POS-01.135: On integrative genito-urology and interdisciplinarity

    Page :232-233

    M.C.H. Michailov, E. Neu, J. Stiglmayr, G. Schulz, U. Welscher

    Plan Plan
  • ·Abstract Withdrawn

    Page :233

    
  • ·Abstract Withdrawn

    Page :233

    
  • ·POS-02.01: An experimental model of hydatidosis in rabbit testis

    Page :233

    H. Ahmadnia, M. Darabi, M. Movarekh, S. Ghanbarizadeh, M. Molaee, M. Shokohian

    Plan Plan
  • ·POS-02.03: Does Denonvilliers’ fascia consist of anterior and posterior layers? An anatomic study of cadaveric dissections and robotic prostatectomy findings

    Page :233

    A. Takenaka, H. Soga, A. Tewari, R. Leung, H. Miyake, K. Tanaka, M. Fujisawa

    Plan Plan
  • ·POS-02.04: Laparoscopic vesical autoaugmentation: An animal model in rabbits (Oryctolagus Cunilicus)

    Page :233-234

    R. Sanchez-Salas, K. Palmer-Román, H. Davila-Barrios, A. Sanchez-Ismayel, R. Miquilarena

    Plan Plan
  • ·POS-02.05: Prevention of renal fibrosis by angiotensin receptor blocker (ARB) in mice with pyelonephritis

    Page :234

    H. Miyakita, M. Tokunaga, T. Terachi

    Plan Plan
  • ·POS-02.06: Neoadjuvant chemotherapy with gemcitabine and carboplatin followed by concurrent chemoradiotherapy in locally advanced carcinoma of urinary bladder

    Page :234

    T.N. Ansari

    Plan Plan
  • ·POS-02.07: Alteration of the p53 expression in bladder transitional cell carcinoma

    Page :234-235

    M. Kalantari, H. Ahmadnia

    Plan Plan
  • ·Abstract Withdrawn

    Page :235

    
  • ·POS-02.09: Triptolide (PG490)-mediated sensitization of urothelial cancer cells to cisplatin via the interaction between glycogen synthase kinase-3β and p53

    Page :235

    H. Nishiyama, Y. Matsui, J. Watanabe, T. Kamoto, O. Ogawa

    Plan Plan
  • ·POS-02.10: Lymphatic vessel architecture in normal tissue and carcinoma of the urinary bladder

    Page :235

    K. Matsushita, K. Matsumoto, S. Soh, T. Fujita, T. Satoh, E. Satoh, M. Iwamura, T. Ishii, S. Baba

    Plan Plan
  • ·POS-02.11: Prognostic significance of Her2/neu overexpression in patients of muscle invasive urinary bladder carcinoma treated with radical cystectomy

    Page :235-236

    A. Seth, S.B. Kolla, M.K. Singh, N.P. Gupta, A.K. Hemal, P.N. Dogra, R. Kumar

    Plan Plan
  • ·POS-02.12: Analysis of genome-wide copy number changes in bladder cancers using array-based comparative genomic hybridization

    Page :236

    S. Eguchi, Y. Yamamoto, Y. Chochi, T. Furuya, A. Oga, S. Kawauchi, S. Sakano, H. Matsuyama, K. Sasaki, N. Naito

    Plan Plan
  • ·POS-02.13: siRNA-mediated multitarget inhibition of antiapoptotic BCL2, BCLX_L and XIAP in bladder cancer cells

    Page :236

    D. Kunze, D. Wuttig, J. Stade, S. Fuessel, O.W. Hakenberg, A. Meye

    Plan Plan
  • ·Abstract Withdrawn

    Page :236

    
  • ·POS-02.15: The expression of claudin-7 in transitional cell carcinoma of the urinary bladder: a quantitative reverse transcriptase-polymerase chain reaction analysis

    Page :236-237

    H. Kanayama, M. Gad El-Moula, T. Fukumori, E. Elsamman, R. Taue, T. Kishimoto, H. Izaki, N. Oka, M. Takahashi, S. Kagawa

    Plan Plan
  • ·Abstract Withdrawn

    Page :237

    
  • ·POS-02.17: Potent effects of two distinct mushroom extracts on growth of bladder cancer cells

    Page :237

    P. Pyo, M. Hoffman, P. Grewall, H. Tazaki, M. Choudhury, S. Konno

    Plan Plan
  • ·POS-02.18: BTA, UBC, TPS tumor markers, urinary cytology and cystoscopy in recurrent bladder tumors

    Page :237

    G. Glück, I. Sinescu, R. Stoica, O. Drăgoescu, Stanciu Adina, N. Stafidov, Bogdan Mariana, M. Stanciu

    Plan Plan
  • ·POS-02.19: C-reactive protein predicts prognosis of muscle-invasive bladder cancer patients treated with chemoradiotherapy

    Page :237-238

    S. Yoshida, K. Saito, F. Koga, Y. Kageyama, M. Yokoyama, Y. Matsuoka, H. Masuda, R. Kobayashi, S. Kawakami, K. Kihara

    Plan Plan
  • ·POS-02.20: FISH (Fluorescense hybridisation in situ) in the diagnosis of superficial bladder cancer

    Page :238

    B. Dobrowolska, W. Lipczynski, K. Juszczak, Z. Dobrowolski, R. Tomaszewska, A. Sinczak

    Plan Plan
  • ·POS-02.21: Upstaging in T1G3 urothelial urinary bladder cancer – an evaluation of data from Nordic cystectomy trial 1

    Page :238

    A. Sherif, E. Rintala, O. Mestad, S. Nilsson, P.U. Malmström, M. Duchek

    Plan Plan
  • ·POS-02.22: Neoadjuvant low-dose chemoradiotherapy against muscle-invasive bladder cancer: Possible improvement of survival and favorable local control for bladder-preserved patients

    Page :238-239

    F. Koga, S. Yoshida, Y. Kageyama, S. Kawakami, Y. Fujii, K. Saito, H. Masuda, T. Kobayashi, K. Kihara

    Plan Plan
  • ·POS-02.23: The association between prostatic involvement in transitional cell carcinoma of the bladder and pathologic characteristics of the bladder tumor

    Page :239

    A. Tabibi, N. Simforoosh, M. Parvin, H. Abdi, A. Javaherforooshzadeh, Z. Razzaghi

    Plan Plan
  • ·POS-02.24: Laparoscopic radical cystectomy in the treatment of invasive bladder cancer

    Page :239

    V.N. Dubrovin, A.V. Tabakov, G.A. Melnic, K.A. Kudriashov

    Plan Plan
  • ·POS-02.25: Combined intra-arterial chemotherapy and radiotherapy for treatment of invasive bladder cancer

    Page :239-240

    H. Mochizuki, K. Gotoh, K. Hieda, Y. Kobukata, N. Hiromoto, H. Kiriu

    Plan Plan
  • ·POS-02.26: Combined intra-arterial chemotherapy and radiotherapy for invasive bladder carcinoma

    Page :240

    H. Wakeda, Y. Hasui, H. Tshukino, K. Yakushiji, T. Kamimura, M. Nagano, K. Inoue, K. Nose, R. Hamasuna, Y. Osada

    Plan Plan
  • ·POS-02.27: Chemotherapy or radical cystectomy as first therapeutic option for young patients with locally invasive TCC (T2-3NxMo)

    Page :240

    J. Djozic, J. Bogdanovic, D. Donat, A. Zivanovic, M. Djozic, S. Djozic, N. Dejanovic, M. Dukic, I. Levakov, S. Vojnov, R. Herin

    Plan Plan
  • ·POS-02.28: Preoperative radiotherapy (rt) + cystectomy(c) vs cystectomy alone in pt3- t4 bladder cancer: long term results

    Page :240-241

    M. Brausi, M. Gavioli, G. Verrini, G. Simonini De Luca, M. Viola, G. Peracchia, G.L. Giliberto

    Plan Plan
  • ·POS-02.29: Gemcitabine plus cisplatin therapy, a safety regimen in advanced bladder tumor

    Page :241

    H. Lee, H. Chung, J. Song

    Plan Plan
  • ·POS-02.30: Review of latent prostatic adenocarcinoma in patients who underwent radical cystoprostatectomy for TCC of bladder

    Page :241

    A. Daneshdezfuli, S.Y. Hosseini, A. Nahabidian

    Plan Plan
  • ·POS-02.31: Squamous cell carcinoma of the bladder unrelated to schistosomiasis: A series of 51 cases

    Page :241-242

    W. Chaaben, A. Sahnoun, M. Bouacida, T. Bahcine, H. Fakhfekh, A. Bahloul, M.N. Mhiri

    Plan Plan
  • ·POS-02.32: Long term follow up of ileal neo bladder hautmann following radical cystectomy

    Page :242

    H. Elganzoury

    Plan Plan
  • ·POS-02.33: Primary lymphoepithelioma-like carcinoma of the urinary bladder (LELCB): report of a case and review of the literature

    Page :242

    N. Ferakis, K. Bouropoulos, T. Granitsas, C. Perivoliotis, D. Giannopoulos, A. Bamias, I. Poulias

    Plan Plan
  • ·POS-02.34: Clinical trial of metastatic bladder carcinoma treated by S-1/CDDP combination chemotherapy

    Page :242-243

    R. Ando, S. Okada, Y. Kojima, Y. Hashimoto, K. Tozawa, K. Hohri

    Plan Plan
  • ·Abstract Withdrawn

    Page :243

    
  • ·POS-02.36: Clinical experience with a novel transurethral resection protocol: TUR in saline (TURis)

    Page :243

    H. Hibi, T. Ohori, K. Naruse, Y. Yamada, N. Honda

    Plan Plan
  • ·POS-02.37: Value of three-dimensional echography in superficial bladder tumors diagnosis

    Page :243

    V. Cauni, D. Georgescu, P. Geavlete

    Plan Plan
  • ·POS-02.38: Impact of dose, follow-up period, age, and pretreatment episodes on bacillus calmette-guerin for eradication of superficial bladder cancers

    Page :243

    T. Okamura, M. Imura, T. Kaneko, Y. Yada, K. Mizuno, K. Tozawa, K. Kohri

    Plan Plan
  • ·POS-02.39: Chromocystoscopic assisted trans-urethral resection of superficial bladder tumors

    Page :243-244

    A.A. Mehena, M. Wishahi, H. Abdel Magid

    Plan Plan
  • ·POS-02.40: Local anesthesia (LA) with N-Do injector (PHYSION) for TUR of small bladder tumors (BT) and bladder mapping (BM): preliminary results and cost-effectiveness analysis

    Page :244

    M.A. Brausi, G. Verrini, M. Gavioli, G. Peracchia, G. DeLuca, G.L. Simonini, M. Viola, G.D.L. Giliberto

    Plan Plan
  • ·POS-02.41: Urinary tract infections are uncommon after instalation of intravesical mitomycin C

    Page :244

    S. Wozniak, N. Kuppurajan, C. Kouriefs, D. Ilo, N. Sarangi

    Plan Plan
  • ·POS-02.42: Superficial bladder tumors and metachronous upper urinary tract tumors

    Page :244-245

    P. Geavlete, D. Georgescu, S. Bancu, B. Geavlete

    Plan Plan
  • ·POS-02.43: Laser treatment of superficial bladder tumors

    Page :245

    P. Geavlete, G.H. Nita, S. Bancu, D. Soroiu, B. Geavlete

    Plan Plan
  • ·POS-02.44: Further evidence for a significance of the nitric oxide (NO) cyclic gmp signalling in the control of the human prostate

    Page :245

    S. Ückert, K. Richter, G. Bartsch, U. Jonas, G. Wolf

    Plan Plan
  • ·POS-02.45: Bag-1 and bax expression in benign prostatic hyperplasia and prostate cancer

    Page :245-246

    G. Mitropoulou, A. Georgalis, K. Tsakanika, A. Rempelakos, N. Apostolikas, A. Thanos, E. Panotopoulou

    Plan Plan
  • ·POS-02.46: Downregulation of nitric oxide synthase expression in lower urinary tracts from spontaneously diabetic goto-kakizaki rats: correlation with superoxide dismutase

    Page :246

    S.M. Yoon, T. Lee, Y.H. Kwon, C.S. Park, L.H. Jin, H.Y. Choi

    Plan Plan  
  • ·POS-02.47: Effect of 5 alpha reductase inhibitor in expression of cyclooxygenase-2 in benign prostatic hyperplasia

    Page :246

    H. Lee, H. Chung, J. Song

    Plan Plan
  • ·POS-02.48: Expression of nitric oxide synthase (NOS) in the rat bladder subjected to partial bladder outlet obstruction

    Page :246-247

    H. Lee, H. Chung, J. Song

    Plan Plan
  • ·POS-02.49: Immunohistochemical estimation of hypoxia in obstructed human bladders and correlations with clinical parameters

    Page :247

    G. Koritsiadis, K. Stravodimos, C. Constantinides, I. IAnastasiou, A. Lazaris, A. Lekas, S. Koritsiadis, A. Zervas

    Plan Plan
  • ·Abstract Withdrawn

    Page :247

    
  • ·Abstract Withdrawn

    Page :247

    
  • ·POS-02.52: Epidemiological study of patients having undergone surgery for benign prostatic hyperplasia

    Page :247

    S. Falahatkar, S. Tavasoli Yousefabad, G. Mokhtari

    Plan Plan
  • ·POS-02.53: Voiding dysfunction of men with metabolic syndrome

    Page :247-248

    B.S. Shim, H. Lee, Y.Y. Park, Y.S. Hong

    Plan Plan
  • ·Abstract Withdrawn

    Page :248

    
  • ·POS-02.55: BPH: a nosologic perspective, from F. Legueu (Paris 1921) to A. Randall (N.Y.1937)

    Page :248

    R. Vela Navarrete, R.O. Fourcade

    Plan Plan
  • ·POS-02.56: The risk factors of progression in patients with BPH in real practice

    Page :248

    S.C. Park, S.H. You, S.J. Oh, I.Y. Seo, H.J. Jeong, J.S. Rim

    Plan Plan
  • ·POS-02.57: Follow up survey of a prostate assessment clinic cohort

    Page :248

    K. Riddle, M. Hehir, J. Graham, V. Crispin, M.A. Paterson

    Plan Plan
  • ·POS-02.58: Etiology and management of urinary retention in men admitted to a tertiary level teaching hospital in South Africa

    Page :248-249

    S. Van Vuuren, S. Van Deventer, C. Heyns

    Plan Plan
  • ·POS-02.59: IPSS as a prognostic predictor of BPH development and treatment in men of different age

    Page :249

    D. Mladenov, I. Donkov, M. Tzvetkov

    Plan Plan
  • ·POS-02.60: Independent predictors of bladder outlet obstruction associated with benign prostatic hyperplasia

    Page :249

    D. Volanis, I. Karyotis, I. Boulalas, E. Serafetinidis, D. Delakas

    Plan Plan
  • ·POS-02.61: Vascular risk factors and post void residual: a new tool for an old problem?

    Page :249-250

    K. Stravodimos, G. Koritsiadis, B. Loymos, A. Lekas, C. Alamanis, D. Mitropoylos, C. Constantinides, I. Anastasioy

    Plan Plan
  • ·POS-02.62: Impact of different bladder volumes on uroflowmetry parameters in benign prostatic hyperplasia

    Page :250

    I. Sen, M. Onaran, C. Guneri, A. Camtosun, M. Celik, M. Tan, I. Bozkirli

    Plan Plan
  • ·POS-02.63: Correlation between subjective symptoms and bladder outlet obstruction parameters in men with lower urinary tract symptoms

    Page :250

    J.Y. Chung, H.M. Kim, L.H. Sung, W.J. Yang

    Plan Plan
  • ·POS-02.64: Suprapubic transvesical prostatectomy (Freyers) without suprapubic and urethral catheter only 4 days postoperatively

    Page :250-251

    B. El-Wkhi, N. Mandour

    Plan Plan
  • ·POS-02.65: Acute urinary retention due to primary retrovesical hydatid cyst

    Page :251

    G. Glück, N. Pietrareanu, N. Toma, I. Sinescu

    Plan Plan
  • ·POS-02.66: Secondary significant bleeding in the first month following TURP

    Page :251

    G. Normand, O. Celhay, R. Briffaux, C. Pirès, B. Doré, J. Irani

    Plan Plan
  • ·POS-02.67: The efficacy of transurethral resection of the prostate in patients with large prostate (over 80 g)

    Page :251

    Y.S. Lho, S.H. Paick, M. Baek, W.H. Park, H.G. Kim

    Plan Plan
  • ·POS-02.68: Our experience with 150 patients, treated by photoselective vaporization of the prostate (PVP) in the Czech Republic

    Page :252

    J. Klecka, M. Hora, P. Behounek, M. Hajzman

    Plan Plan
  • ·POS-02.69: Our experience with HoLEP-improvement in BPH treatment

    Page :252

    W. Lipczynski, S. Bak, B. Dobrowolska, J. Kusionowicz, Z. Dobrowolski, L. Michalski

    Plan Plan
  • ·POS-02.70: Bipolar electroresection - latest technological achievement in BPH TURP

    Page :252-253

    W. Lipczynski, S. Bak, B. Dobrowolska, J. Kusionowicz, Z. Dobrowolski, L. Michalski

    Plan Plan
  • ·POS-02.71: Comparative randomized study on the efficaciousness of treatment of BOO due to BPH in patients having till 100 gr prostate using endoscopic gyrus prostate resection versus opsu. Preliminary data

    Page :253

    R. Giulianelli, S. Brunori, G. Vincenti, F. Pisanti, L. Mavilla, L. Albanesi, B.C. Gentile, T. Shestani

    Plan Plan
  • ·POS-02.72: Clinical evaluation on sexual function of BPH patients after photoselective vaporization of the prostate

    Page :253

    Y.X. Shan, T. Wei, D.R. Yang

    Plan Plan
  • ·POS-02.73: Combination of alfuzosin and tamsulosin in BPH patients with acute urinary retention

    Page :254

    D. Pushkar, A. Zaitsev, P. Rasner, J.W. Kosko

    Plan Plan
  • ·POS-02.74: Detrusor overactivity after prostate resection: preventing postoperative incontinence with darifenacin

    Page :254

    S. Laschke, S. Carl

    Plan Plan
  • ·POS-02.75: A randomized clinical trial of an ethanol extract of Ganoderma lucidum (edible and medicinal mushroom) in men with lower urinary tract symptoms

    Page :254

    M. Noguchi, T. Kakuma, K. Tomiyasu, K. Itoh, F. Konishi, S. Kumamoto, K. Shimizu, R. Kondo, K. Matsuoka

    Plan Plan
  • ·POS-02.76: The effect of a₁-blocker in hypoxia in human obstructed detrusor

    Page :254-255

    K. Stravodimos, G. Koritsiadis, D. Mitropoylos, G. Koytalellis, I. Adamakis, A. Lazaris, A. Zervas

    Plan Plan
  • ·Abstract Withdrawn

    Page :255

    
  • ·POS-02.78: Intra operative tranrectal ultrasonography guide during TURP: Description of the technique

    Page :255

    N. Kamat

    Plan Plan
  • ·POS-02.79: Simple intratesticular cyst – is there a need for follow up?

    Page :255

    S.K. Misra, P. Thompson, C. Coker

    Plan Plan
  • ·POS-02.80: Diuresis renography for differentiation of upper urinary tract dilatation from obstruction: F+20 and F-15 methods

    Page :255-256

    R. Taghavi Razavizadeh, K. Ariana, R. Mahdavi Zafarghandi, M.R. Darabi Mahboub

    Plan Plan
  • ·POS-02.81: CT urography using the 64 multidetector CT scanner: correlation with cystoscopic and cytology findings

    Page :256

    T. Vriska, A. Nehra, B. King, T. Aadland, D. Nienow

    Plan Plan
  • ·POS-02.82: Laminin-5 immunochemistry identifies bellini ducts and bellini duct carcinoma

    Page :256

    X. Krah, B. Henkel, E. Hauschild, G. Eschholz, H. Kosmehl

    Plan Plan
  • ·Abstract Withdrawn

    Page :256

    
  • ·POS-02.84: Vasculogenic mimicry in renal cell carcinoma

    Page :256

    R. Barod, M.G.B. Tran, T.S. O’Brien, P.H. Maxwell

    Plan Plan
  • ·POS-02.85: Overexpression of metastin receptor in renal cell carcinoma: metastin and its receptor are probable targets for the suppression of renal cell carcinoma metastasis

    Page :257

    S. Shoji, T. Uchida, Y. Nagata, M. Shima, Y. Usui, T. Terachi, S. Umemura, X. Tang, N. Egashira, R.Y. Osamura

    Plan Plan
  • ·POS-02.86: Expression of voltage-gated potassium ion channels in human renal cell cancer

    Page :257

    P. Wadhwa, S. Wadhwa, S. Chaudhury, A.K. Dinda, T.C. Nag, N.P. Gupta

    Plan Plan
  • ·POS-02.87: Is the correct diagnosis being assigned to adult chromophobe renal cell carcinoma: An immunocytochemical verification?

    Page :257

    H.U. Ahmed, A. Tsiouris, M. Arya, A.V. Kaisary, R.J. Morgan, M.P.A. Young

    Plan Plan
  • ·POS-02.88: Gamma-delta T lymphocytes are of no prognostic value in clear cell renal cell carcinoma

    Page :257-258

    B.A. Inman, X. Frigola, K. Harris, S. Kuntz, C. Lohse, J. Cheville, B. Leibovich, E.D. Kwon

    Plan Plan
  • ·POS-02.89: Experimental study for percutaneous electro-vaporization of renal cell carcinoma using a new shape memory alloy probe

    Page :258

    A. Kawauchi, Y. Naitoh, J. Soh, K. Okihara, O. Ukimura, Y. Mizutani, T. Miki

    Plan Plan
  • ·POS-02.90: Preoperative prediction by imaging and prognostic significance of ostium renal vein invasion in renal cell carcinoma with inferior vena cava tumor thrombus

    Page :258

    L. Zini, L. Garnier-Destrieux, X. Leroy, J. Fantoni, L. Lemaitre, J. Biserte, A. Villers

    Plan Plan
  • ·POS-02.91: Role of upper tract imaging in patients with atypical urine cytology

    Page :258-259

    S.K. Misra, P.A. Berresford, C. Coker

    Plan Plan
  • ·POS-02.92: Can the ASA-American Society of Anesthesiology physical status classification predict the oncological outcomes in renal cell carcinoma?

    Page :259

    S.C. Zequi, G.C. Guimaraes, F.P. Fonseca, I. Werneck da Cunha, F.A. Soares, E.C. Ribeiro-Campos, W. Bachega, A. Lopes

    Plan Plan
  • ·POS-02.93: Partial nephrectomy for renal tumors

    Page :259

    M. Yazdani, D. Moshtaghi

    Plan Plan
  • ·POS-02.94: A new flexible video cystoscope with bullet-tip: is this more comfortable than the conventional type in females?

    Page :259-260

    S. Kitsukawa, T. Aoyagi, T. Samejima, T. Matsumoto, K. Noda

    Plan Plan
  • ·Abstract Withdrawn

    Page :260

    
  • ·POS-02.96: New convenient device for circumcision

    Page :260

    D. Ihm, S. Lee, J. Song

    Plan Plan
  • ·Abstract Withdrawn

    Page :260

    
  • ·POS-02.98: The effect of ophthalmic thermal cautery application to prevent neonatal circumcision bleeding complication with utilization of plastible ring

    Page :260

    M. Rezaeinasab, M. Jamali, S.T. Tabatabaei, A. Mosavat

    Plan Plan
  • ·POS-02.99: Early effect of non-surgical treatment using betamethasone valerate ointment for phimosis in Japanese childhood

    Page :260

    S. Kitsukawa, T. Aoyagi, K. Noda, S. Hosoda, N. Otsuru, Y. Yamamoto, T. Ito, T. Matsumoto

    Plan Plan
  • ·POS-02.100: A study of patients with cured nocturnal enuresis

    Page :260-261

    M. Tsugaya, T. Ito, S. Endo, T. Hamakawa, S. Okada, Y. Ito

    Plan Plan
  • ·POS-02.101: Is VCUG necessary for all patients that undergo pyeloplasty?

    Page :261

    S.A. Asgari, S. Falahatkar, G. Mokhtari, F. Pourreza

    Plan Plan
  • ·POS-02.102: Impalpable testis: Laparoscopy or inguinal canal exploration?

    Page :261

    F. Sharifiaghdas, F. MA Beigi

    Plan Plan
  • ·POS-02.103: Use of oxidized cellulose surgicel for corporal body grafting for sutureless correction of severe penile chordee: An experimental study in rabbits

    Page :261

    A. El-Assmy, W. Eassa, M. Abdl Hamid, E. Nour, A. Hafez

    Plan Plan
  • ·POS-02.104: Sleep stage and functional bladder capacity in children with refractory nocturnal enuresis

    Page :261-262

    T. Hirayama, S. Soh, M. Iwamura, T. Endo, T. Iwasaki, S. Baba

    Plan Plan
  • ·POS-02.105: Neonatal hypospadias

    Page :262

    G.Q. Liu, H.J. Tang, J.F. Wang, H. Li, D.J. Zhu, W. Zhen, Y.W. Zhao

    Plan Plan
  • ·POS-02.106: Yoke technique for severe proximal hypospadias

    Page :262

    T. Yamaguchi, Y. Koikawa, T. Konomoto, Y. Akita

    Plan Plan
  • ·POS-02.107: Open pyeloplasty with a minimally invasive incision in children: comparison of skin incision size

    Page :262

    A. Nakane, Y. Hayashi, K. Mizuno, K. Kojima, T. Maruyama, K. Kohri

    Plan Plan
  • ·POS-02.108: Dismembered pyeloplasty in infants: A review of 5 years single center experience

    Page :262-263

    F. Kazemi Rashed, S. Aslanabadi

    Plan Plan
  • ·Abstract Withdrawn

    Page :263

    
  • ·POS-02.110: Surgical management of late complications in a boy with prune-belly syndrome

    Page :263

    A. Lekas, A. Balangas, R. Homberg, S. Schattka, A. Kollias

    Plan Plan
  • ·POS-02.111: Indications for nephrectomy in children: A changing profile

    Page :263

    H. Jallouli, A. Sahnoun, I. Ben Abdallah, M. Gassara, A. Bahloul, M.N. Mhiri

    Plan Plan
  • ·POS-02.112: Paediatric bladder stones, a disappearing disease

    Page :263

    M. Mhiri, H. Ketata, M. Gassara, I. Benabdallah, M. HadjSlimen, A. Bahloul

    Plan Plan
  • ·Abstract Withdrawn

    Page :263

    
  • ·POS-02.114: Tubularized incised plate as first choice of therapy for hypospadias

    Page :264

    M. Mustafa, H. Abol-Enein

    Plan Plan
  • ·POS-02.115: Avagard^™ in pediatric urological surgery: safe, effective and time efficient

    Page :264

    J.S. Palmer

    Plan Plan
  • ·POS-02.116: A simple and reliable formula for determining the proper JJ stent length in the pediatric patient: Age + 10

    Page :264

    J.S. Palmer, L.S. Palmer

    Plan Plan
  • ·POS-02.117: Clinical evaluation of 47 boys with nonpalpable testis

    Page :264-265

    T. Kamimura, M. Nagano, H. Waketa, H. Tsukino, C. Onizuka, M. Yamauchi, S. Sugie, Y. Hasui, Y. Osada

    Plan Plan
  • ·Abstract Withdrawn

    Page :265

    
  • ·POS-02.119: Intravesical oxybutynin for children with poorly compliant neurogenic bladders: a Systematic Review

    Page :265

    L.A. Guerra, D. Moher, N. Barrowman, M. Sampson, J. Pike, M. Leonard

    Plan Plan
  • ·POS-02.120: Status quo of repeated botulinum-toxin injections in spina bifida children with detrusor hyperreflexia: long term follow up

    Page :265

    S. Laschke, S. Carl

    Plan Plan
  • ·POS-02.121: Results of continent vesicostomy as a newer alternative to appendicovesicostomy for Mitrofanoff procedure

    Page :265-266

    D. Irani

    Plan Plan
  • ·POS-02.122: Development of a multi-specialty robotic surgery program

    Page :266

    K.J. Palmer, V. Patel, K. Shah, R. Thaly

    Plan Plan
  • ·POS-02.123: Assessment of pain in patients undergoing office-based urological procedures as a function of staff surgeon versus resident

    Page :266

    J.S. Jones, C. Nguyen

    Plan Plan
  • ·POS-02.124: Successful microsurgical reimplantation of traumatic amputated testicle

    Page :266-267

    M. Salehi, S. Falahatkar, A. Noshad, S. Nikpour, M. Fouladimehr

    Plan Plan
  • ·POS-02.125: Office dilation of the female urethra: still a commonly performed procedure

    Page :267

    R. Santucci, Urologic Diseases in American Project

    Plan Plan
  • ·POS-02.126: Iatrogenic ureteric injury

    Page :267

    G. Glück, I. Sinescu

    Plan Plan
  • ·POS-02.127: Genitourinary trauma: The military hospital experience

    Page :267

    S.D. Mante

    Plan Plan
  • ·POS-02.128: Stenson’s duct stenosis - a rare complication of buccal mucosal harvest

    Page :267-268

    S.B. Kulkarni, S. Lambe, A. Bapat, D. Kamat, A. Dhumavat, J. Kulkarni

    Plan Plan
  • ·POS-02.129: Penile fracture co-existing or not with urethral injury

    Page :268

    A. Lekas, I. Fokitis, K. Filis, G. Doumanis, V. Politis, V. Charalampidis, S. Koritsiadis

    Plan Plan
  • ·POS-02.130: Renal injuries: from surgical intervention to conservative management

    Page :268-269

    A. Lekas, I. Fokitis, G. Lefakis, V. Politis, A. Balangas, D. Xenis, K. Filis, A. Kollias, S. Koritsiadis

    Plan Plan
  • ·POS-02.131: Efficacy of retrograde balloon dilation for the treatment of benign ureteral strictures

    Page :269

    H.S. Ahn, S.J. Kim, S.H. Lee, S. Kim, Y.S. Kim

    Plan Plan
  • ·POS-02.132: Dorsal onlay buccal mucosal urethroplasty for post TURP urethral strictures

    Page :269

    S.B. Kulkarni, S. Lambe, A. Bapat, D. Kamat, A. Dhumavat, J. Kulkarni

    Plan Plan
  • ·POS-02.133: Robotic-assisted laparoscopic ureteral reimplantation with psoas hitch: A multi-institutional multinational evaluation of 13 cases

    Page :269-270

    K.J. Palmer, V. Patel, K. Shah, M. Chammas, A. Mottrie, B. Sundaram

    Plan Plan
  • ·POS-02.134: Ureteral substitution by an isolated ileal segment via novel antireflux technique

    Page :270

    A. Hinev, S. Paunov, R. Raikov, P. Chankov, D. Anakievski, S. Dyakov, B. Balev

    Plan Plan
  • ·POS-02.135: Penile fractures: immediate surgical approach with a midline dorsal incision

    Page :270

    K. Livadas, E. Mazaris, D. Chalikopoulos, A. Skolarikos, A. Bisas, I. Kastriotis

    Plan Plan
  • ·POS-02.136: Dorsal onlay small intestinal submucosa urethroplasty : our experience

    Page :270

    S.B. Kulkarni, S. Lambe, A. Bapat, D. Kamat, A. Dhumavat, J. Kulkarni

    Plan Plan
  • ·POS-02.137: The role of cotton padding and elastic bandage in imobilizing the extremity after closure of bladder exstrophy

    Page :270-271

    S. Watya, S. Kaggwa, I. Kajja, S. Muwazi

    Plan Plan
  • ·POS-02.138: Surgical treatment of penoscrotal lymph edema

    Page :271

    A. Bolukbasi, F. Þengül, M. Ayhan, E. Aksungur, M. Görgü

    Plan Plan  
  • ·POS-02.139: Penile fracture. Differential diagnosis, Management and outcome

    Page :271

    J. Cabral Ribeiro, V. Hugo Nogueira, A. Carvalho, A. Ribeiro Santos

    Plan Plan
  • ·POS-02.140: Spontaneous rupture of the urinary bladder as a cause of death

    Page :271-272

    K. Albrecht, M. Tsokos, F. Schulz, S. Ückert, D. Breitmeier, U. Jonas

    Plan Plan
  • ·POS-02.141: The use of isolated cecal bowl segment in the complicated vaginal reconstruction

    Page :272

    D. Irani

    Plan Plan
  • ·POS-02.142: Results of buccal mucosal graft onlay patch urethroplasty in the repair of adult bulbar urethral stricture

    Page :272

    D. Irani, M.M. Hosseini

    Plan Plan
  • ·POS-02.143: Dorsal buccal mucosal onlay grafts in complex pendulous urethral reconstruction: extended indications and intermediate results

    Page :272-273

    D. Rosenstein

    Plan Plan
  • ·POS-02.144: Is ultrasound renal tract appropriate in screening for upper tract TCC?

    Page :273

    R. Gujadhur, P. Shah, R. Marsh, P. Menezes

    Plan Plan
  • ·POS-02.145: Adjuvant and neoadjuvant chemotherapy for urothelial cancer of the upper urinary tract with lymph node metastasis

    Page :273

    T. Isoyama, T. Watanabe, S. Morizane, K. Hikita, I. Miyagawa

    Plan Plan
  • ·POS-02.146: Transitional cell carcinoma of bladder in young adults

    Page :273

    M.H. Jalbani

    Plan Plan
  • ·POS-03.01: Retroperitoneal laparoscopic marsupialization of symptomatic renal cyst: comparison with transperitoneal approach

    Page :273-274

    J.H. Kim, J.O. Kwon, D.S. Ryu, T.H. Oh

    Plan Plan
  • ·POS-03.02: Transmesocolic pyeloplasty: experience of a single center

    Page :274

    O. Castillo, G. Vitagliano, M. Díaz, R. Sánchez-Salas, A. Foneron

    Plan Plan
  • ·POS-03.03: Risk factors for recurrence after radiofrequency ablation of renal tumors

    Page :274

    N. Ferakis, K. Bouropoulos, T. Granitsas, A. Pilitsis, S. Mylona, I. Poulias

    Plan Plan
  • ·Abstract Withdrawn

    Page :274

    
  • ·POS-03.04: Robotic pyeloplasty using a 4 arm technique

    Page :274-275

    R. Kooner, D. Golovsky, R. Thanigasalam, K. Rasiah

    Plan Plan
  • ·POS-03.05: Bleeding incidence following transrectal ultrasound-guided prostate biopsy in patients taking low dose aspirin

    Page :275

    D. Volanis, I. Karyotis, I. Boulalas, C. Konstadinidis, D. Delakas

    Plan Plan
  • ·POS-03.06: Retroperitoneal laparoscopic nephrouretectomy for urothelial carcinoma of the renal pelvis and ureter

    Page :275

    M. Nagano, T. Kamimura, H. Tsukino, H. Wakeda, K. Inoue, T. Kobayashi, Y. Yamashita, R. Hamasuna, Y. Hasui, Y. Osada

    Plan Plan
  • ·POS-03.07: Clinical experience of laparoscopic management for retroperitoneal masses

    Page :275-276

    T. Seki, S. Ishikawa, H. Higashiyama, M. Miura, M. Togashi, H. Harada, T. Hirano

    Plan Plan
  • ·POS-03.08: Transperitoneal laparoscopic nephrectomy for giant hydronephrosis

    Page :276

    S. Moudouni, Z. Dahami, A. El Haous, I. Sarf

    Plan Plan
  • ·POS-03.09: Assessment of incidence and interventional treatment in patients with post renal transplant lymphocele in Ghaem Hospital: from the first days of renal transplantation in Ghaem Hospital to 2006

    Page :276

    A. Yarmohamadi

    Plan Plan
  • ·POS-03.10: Evaluation of a new radiofrequency-based resection device (Habib^™ 4X) for ischemia-free partial nephrectomy in a porcine kidney model

    Page :276

    D.S. Engeler, T. Leippold, C. Hobi, A. Zerz, H. Marlovits, M. Hell, P.A. Diener, H.P. Schmid

    Plan Plan
  • ·Abstract Withdrawn

    Page :276

    
  • ·Abstract Withdrawn

    Page :276

    
  • ·POS-03.12: Simple ureteroscopy and ureteroscopic procedures in kidney transplanted and other patients underwent ureteral reimplantation

    Page :276-277

    F. Dadkhah, M. Aliaskary, S. Tara, N. Shakhsesalim

    Plan Plan
  • ·POS-03.13: Parathyroid hormone and valvular disorders in end stage renal disease patients

    Page :277

    F. Ataei, K. Pishehvar Esfahani, H. Shamsolkottabi, M. Shirazinejad, S. Yavari

    Plan Plan
  • ·POS-03.14: Effect of simple renal cysts on renal function with ^99mtc-dtpa scyntigraphy

    Page :277

    M. Kilinc, S. Guven, N. Cevat, M. Arslan, M.M. Piskin, M. Kaynar

    Plan Plan
  • ·POS-03.15: Preservation versus non-preservation of the gonadal vein while dissecting the ureter in donor nephrectomies

    Page :277-278

    M. Aliasgari, N. Shakhssalim, F. Dadkhah, A. Ghadian, S.M. Hosseini Moghadam

    Plan Plan
  • ·POS-03.16: Preservation versus non-preservation of the gonadal vein while dissecting the ureter in donor nephrectomies

    Page :278

    M. Aliasgari, N. Shakhssalim, F. Dadkhah, A. Ghadian, S.M.M. Hosseini Moghadam, Z. Razzaghi

    Plan Plan
  • ·Abstract Withdrawn

    Page :278

    
  • ·Abstract Withdrawn

    Page :278

    
  • ·POS-03.19: Age does matter in relation to survival in renal cell carcinoma

    Page :278

    D. Mehraban, M. Moosavi, A. Razi, G.H. Naderi

    Plan Plan
  • ·POS-03.20: Evaluation of the renal changes in patients with unilateral renal stone using ^99mtc-MAG₃

    Page :279

    M. Kilinc, S. Guven, N. Cevat, M. Arslan, M.M. Piskin, M. Kaynar

    Plan Plan
  • ·POS-03.21: Ca19-9 tumor marker in benign hydronephrosis and the correlation with lewis status blood group

    Page :279

    K. Stravodimos, G. Koritsiadis, A. Michalakis, V. Migdalis, N. Panagis, B. Loumos, A. Tsoukala, A. Karafoylidoy, A. Zervas

    Plan Plan
  • ·POS-03.22: The frequency of perirenal fat invasion according to size and protrusion shape of renal cell carcinomas

    Page :279-280

    H.N. Lee, H.S. Moon, Y.T. Kim, H.Y. Choi, H.Y. Park, Y.N. Woo, T.Y. Lee

    Plan Plan
  • ·POS-03.23: Buccal mucosal flap substitution urethroplasty for the long post-traumatic posterior urethral stricture

    Page :280

    D. Sharma, L. Goetz, M. Rampaul, G. Bajrangee, P. Ayoungchee, K. Ramsoobhag

    Plan Plan
  • ·POS-03.24: Results of the organ conserving therapy in the case of urothelial carcinoma of the upper urinary tract – a retrospective consideration of 4 cases

    Page :280

    X. Krah, E. Hauschild, G. Atanassov, C. Güttner, G. Eschholz, H.M. Weber

    Plan Plan
  • ·POS-03.25: Mini-incision muscle-sparing lumbotomy

    Page :280

    A. Hinev, S. Paunov, D. Anakievski, P. Chankov, R. Raikov, S. Dyakov

    Plan Plan
  • ·POS-03.26: Cautery wire balloon incision (Acucise) as treatment option for ureteral strictures lower than the UPJ

    Page :280-281

    V.F. de Kemp, A. Beganović, M.T.W.T. Lock

    Plan Plan
  • ·POS-03.27: Spontaneous rupture of renal tumors

    Page :281

    M. Grasso, S. Blanco, A. Vianchi, C. Di Bella, A. Grasso, A. Pappini

    Plan Plan
  • ·POS-03.28: Partial laparoscopic adrenalectomy in Conn’s syndrome

    Page :281

    O. Castillo, M. Díaz, R. Sánchez-Salas, G. Vitagliano, A. Foneron

    Plan Plan
  • ·POS-03.29: Treatment of the hydatid cyst of the kidney: a retrospective study about a series of 43 cases

    Page :281-282

    M. Bouacida, H. Ketata, I. Benabdallah, H. Jallouli, S. Kchaou, H. Fakhfakh, A. Bahloul, M.N. Mhiri

    Plan Plan
  • ·POS-03.30: Is pre-op stenting routinely required prior to retrograde intrarenal surgery (RIRS)?

    Page :282

    S. Bapat, A. Padhye, P. Yadav, A. Bhave, P. Mahajan, S. Purnapatre, K. Pai

    Plan Plan
  • ·POS-03.31: Needleoscopic percutaneous high ligation of inguinal hernia in children

    Page :282

    W.Y. Wong, Y.C. Tsai

    Plan Plan
  • ·POS-03.32: Laparoscopic partial cystectomy for adenocarcinoma of bladder

    Page :282-283

    J.H. Kim, J.O. Kwon, D.S. Ryu, T.H. Oh

    Plan Plan
  • ·POS-03.33: Transperitoneal versus retroperitoneal laparoscopic radical nephrectomy: patient selection and perioperative outcomes: a single-center experience

    Page :283

    R. Taue, H. Izaki, M. Gad El-Moul, T. Kishimoto, T. Fukumori, M. Takahashi, S. Kagawa, H. Kanayama

    Plan Plan
  • ·POS-03.34: Comfort and tolerability of SCD response compression system in patients undergoing radical retropubic prostatectomy

    Page :283

    L. Cindolo, E. de Fortuna, V. Tripodi, A. Quaranta, F. Attanasi, F. Del Vecchio, L. Schips, L. Salzano

    Plan Plan
  • ·POS-03.35: Transurethral resection of the ureteral orifice with antegrade stripping of the ureter (pluck-off technique) during hand-assisted laparoscopic nephroureterectomy: a safe procedure

    Page :283-284

    J. Tornero, P. López, P. Lopez-Cubillana, A. Prieto, A. Lopez, A. Maluff, F. Escudero, M. Pérez

    Plan Plan
  • ·Abstract Withdrawn

    Page :284

    
  • ·POS-03.37: Laparoscopic treatment for renal hydatid cyst using a retroperitoneal approach (an initial experience)

    Page :284

    R. Rabii, S. Elmhef, B. Querfani, F. Meziane

    Plan Plan
  • ·POS-03.38: Resection of renal hydatid cyst using a retroperitoneal approach

    Page :284

    R. Rabii, B. Querfani, S. Elmhef, F. Meziane

    Plan Plan
  • ·POS-03.39: Balloon dilation in stenotic pathology of the caliceal system

    Page :284

    P. Geavlete, V. Mirciulescu, R. Multescu, B. Geavlete

    Plan Plan
  • ·POS-03.40: Comparative study of the premeatal based flap and the tubularized incised plate urethroplasty in repairing distal penile hypospadias

    Page :284-285

    R. Mahdavi, K. Shafipoor, M. Mahdavi, M. Zolfaghari

    Plan Plan
  • ·POS-03.41: Penile fracture: a retrospective study of 102 cases

    Page :285

    A. Hidoussi, M. Jaidane, A. Slama, A. Youssef, N. Ben Sorba, A.F. Mosbah

    Plan Plan
  • ·POS-03.42: Assessment of outcomes of a new closed surgical technique for hydrocele operation and comparison with standard excisional techniques in patients referred to the educational hospitals of Mashhad University

    Page :285

    M.R. Darabi, A. Ahanian, M. Zolfaghari, L. Darabi

    Plan Plan
  • ·POS-03.43: Penile amputation and replantation: aetiology, diagnosis, management and outcome

    Page :285-286

    D.D. Odan, N.H. Ajuyah, A.O. Akingbala

    Plan Plan
  • ·POS-03.44: Urethroplasty with combined free tissue grafts

    Page :286

    C. Slavov, G. Venkov, E. Popov, M. Tzvetkov

    Plan Plan
  • ·POS-03.45: Primary mucinous tumor of the testis

    Page :286

    P. Kartsaklis, A. Gekas, C. Konstantinidis, I. Palaiodimos, S. Andreadakis, N. Kalogeropoulos, D. Baltogiannis, N. Sofikitis

    Plan Plan
  • ·POS-03.46: A familial case of Peyronie’s disease

    Page :286

    A. Gekas, P. Kartsaklis, C. Konstantinidis, S. Andreadakis, I. Palaiodimos, N. Kalogeropoulos, D. Baltogiannis, N. Sofikitis

    Plan Plan
  • ·POS-03.47: Foley balloon assisted scrotal pouch orchiopexy

    Page :286-287

    D. Dalela, R.J. Sinha, S. Sankhwar, V. Singh

    Plan Plan
  • ·Abstract Withdrawn

    Page :287

    
  • ·POS-03.49: Urethral injury associated with penile fracture: report of five cases

    Page :287

    H. Ketata, A. Bouhlel, M. Gassara, A. Sahnoun, A. Bahloul, M.N. Mhiri

    Plan Plan
  • ·POS-03.50: Urethral erosion after long-term urethral catheterization

    Page :287

    C. Konstantinidis, K. Kalokerinou, A. Siatelis, P. Kartsaklis, A. Nikolia, I. Karyotis, A. Gekas, D. Delakas

    Plan Plan
  • ·POS-03.51: The profile of testicular germ cell tumours in the south of Tunisia

    Page :287-288

    M. Bouacida, A. Bahloul, M.N. Mhiri, A. Sahnoun, W. Chaabene, M. Gassara

    Plan Plan
  • ·POS-03.52: Organ-sparing surgery for invasive penile cancer with using buccal mucosal graft for resurfacing after excision of tumors on the glans penis: early follow-up data

    Page :288

    G. Venkov

    Plan Plan
  • ·POS-03.53: Complications and survival in patients with retroperitoneal lymph node dissection (RPLND) after chemotherapy for testicular cancer in a medium volume referral centre

    Page :288

    A. Boeken Kruger, R. Richardson, T. Lock, G. Groenewegen, R. Bosch

    Plan Plan
  • ·POS-03.54: Penile fracture: no difference in treatment in two European centres

    Page :288-289

    S. Wozniak, R. Zdrojowy, P. Debinski, N. Kuppurajan, A. Kolodziej, P. Kowal, D. Ilo

    Plan Plan
  • ·POS-03.55: Adult para-testicular tumours: report of two cases

    Page :289

    M.A. Omar, A. Rao, H. Motiwala, O. Karim

    Plan Plan
  • ·POS-03.56: Quality of life in patients with prostate carcinoma treated with LH-RH agonists

    Page :289

    K. Jagodic, I. Bizjak, M. Erklavec, S. Poteko, H. Korosec-jagodic

    Plan Plan
  • ·POS-03.57: Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate caner

    Page :290

    Y. Fujii, J. Yonese, S. Kawakami, S. Yamamoto, Y. Okubo, D. Suyama, Y. Komai, T. Kijima, I. Fukui

    Plan Plan  
  • ·POS-03.58: Prevalence and distress due to hot flushes in patients receiving endocrine therapy for prostate cancer and therapeutic efficacy of Japanese herbal medicine

    Page :290

    M. Kajiwara, M. Oki, K. Mutaguchi, H. Moriyama

    Plan Plan
  • ·POS-03.59: Prospective randomized trial comparing transverse (pfannenstiel) and vertical incisions for patients undergoing radical retropubic prostatectomy

    Page :290-291

    M. Manoharan, T. Luongo, S. Vyas, R. Ayyathurai, M.S. Soloway

    Plan Plan
  • ·POS-03.60: A comparative head on efficacy study of 3 monthly goserelin 10.8 mg, 3 monthly leuprolide 11.25 mg with 3 montly leuprolide 22.5 mg preparations for treatment in patients with prostate cancer

    Page :291

    R. Sood, S. Kathuria

    Plan Plan
  • ·POS-03.61: Impact of hot flashes on quality of life during treatment with maximum androgen blockade for prostate cancer

    Page :291-292

    H. Sakai, T. Igawa, H. Kanetake, M. Hayashi, S. Iwasaki, Y. Kusaba, H. Hakariya, T. Hara

    Plan Plan
  • ·POS-03.62: Characterization of novel candidate biomarkers for prostate cancer using quantitative proteomic profiling

    Page :292

    S. Tyritzis, S. Garbis, K. Pavlakis, S. Vourekas, T. Roumeliotis, P. Zerefos, A. Vlahou, S. Kossida, J. Diaz, C. Constantinides

    Plan Plan
  • ·POS-03.63: Is neuroendocrine cell differentiation detected immunohistochemically using chromogranin A in diagnostic needle biopsy specimens from patients with bone metastatic prostate cancer a prognostic factor for outcome?

    Page :292

    Y. Yamada, K. Nakamura, S. Aoki, T. Taki, K. Naruse, M. Tobiume, K. Zennami, R. Katsuda, N. Honda

    Plan Plan
  • ·POS-03.64: Receptor activator of nuclear factor-κb ligand (RANKL) as a novel prognostic marker in prostate carcinoma

    Page :292-293

    F.C. Perez Martinez, V. Alonso, F.J. Calahorra, J.l. Sarasa, F. Manzarbeitia, P. Esbrit, R. Vela Navarrete

    Plan Plan
  • ·POS-03.65: Expression of HAI-1 in prostate cancer

    Page :293

    K. Yasuda, T. Akashi, Y. Fujiuchi, H... Fuse

    Plan Plan
  • ·POS-03.66: Adjuvant radiotherapy for pt3 prostate cancer after radical prostatectomy

    Page :293

    K. Kimura, O. Kamihira, S. Hagikura, Y. Funahashi, S. Kasugai, A. Fukatu, O. Matuura

    Plan Plan
  • ·POS-03.67: Pathomorphological changes of erythrocytes during prostate benign hyperplasia

    Page :293-294

    M. Alibegashvili, N. Kotrikadze, I. Bochorishvili, L. Managadze, T. Chigogidze, N. Gabunia

    Plan Plan
  • ·POS-03.68: Using of fluorescent method in the diagnosis of prostate tumors

    Page :294

    I. Bochorishvili, K. Arcivadze, L. Ramishvili, L. Managadze, T. Chigogidze

    Plan Plan
  • ·POS-03.69: Transrectal non invasive prostate cancer treatment by pulsed high intensity focused ultrasound (HIFU) devices: is current technology comparable?

    Page :294

    S. Thueroff, C. Chaussy

    Plan Plan
  • ·POS-03.70: Immunohistochemical localization of elongation factor 1a in human prostate adenocarcinomas

    Page :294

    V.V. Lyzogubov, I.A. Makedonsky, A.P. Pogribna, B.S. Negrutskii, A.V. El’skaya, A.M. Fridberg, S.I. Zabashny, V.S. Usenko

    Plan Plan
  • ·POS-03.71: Transcript signatures of tumor-related marker genes for the prediction of prostate cancer on paired prostate tissue samples and artificial biopsies

    Page :295

    S. Unversucht, A. Lohse, M. Zenker, S. Fuessel, A. Meye, M. Haase, M. Toma, R. Koch, G.B. Baretton, M.P. Wirth

    Plan Plan
  • ·Abstract Withdrawn

    Page :295

    
  • ·POS-03.73: Antibodies against the testis cancer antigen CTSP-1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical recurrence after surgery

    Page :295

    R.B. Parmigiani, F. Bettoni, A. Lopes, A.L. Carvalho, F. Fonseca, A.A. Camargo

    Plan Plan
  • ·POS-03.74: The role of inducible nitric oxide synthase (iNOS) at the biochemical failure after radical prostatectomy

    Page :295

    F.P. Fonseca, I.N. Nishimoto, S.C. Zequi, R.A. Coudry, F.A. Soares, A. Lopes

    Plan Plan
  • ·Abstract Withdrawn

    Page :296

    
  • ·POS-03.76: Bone mineral density in men undergoing prostate biopsy

    Page :296

    D.E. Leocádio, S. Mandalapu, B.S. Stein

    Plan Plan
  • ·POS-03.77: Correlation between the international prostate symptom score, prostate specific antigen, and quality of life findings in a screening population

    Page :296

    D.E. Leocádio, B.S. Stein, M. Schwartz

    Plan Plan
  • ·POS-03.78: Usefulness of magnetic resonance imaging (MRI) screening for the patients with gray-zone prostate-specific antigen levels

    Page :296

    O. Ishizuka, T. Ogawa, T. Tanabe, Y. Kinebuchi, M. Kawakami, Y. Igawa, O. Nishizawa

    Plan Plan
  • ·POS-03.79: Survey of relative frequency of incidental carcinoma of the prostate in patients undergone prostatectomy in Razi hospital in Rasht city, Iran

    Page :296-297

    I. Khosropanah, A. Roshani, M. Salehi, S. Askari, G. Mokhtari, S. Falahatkar, Z. Hydari Bateni, S. Khosropanah

    Plan Plan
  • ·POS-03.80: Large and sphere-shaped prostate affects the periprostatic nerve block anesthesia

    Page :297

    S. Voinea, M. Harza, C. Gingu, A. Iordache, C. Dudu, I. Manea, C. Pavel, B. Haineala, I. Sinescu

    Plan Plan
  • ·POS-03.81: Effect of transrectal color Doppler ultrasonography monitoring prostate nerve block on pain during prostate biopsy: a prospective randomized study

    Page :297

    Y. Nasu, N. Ono, T. Kurashige, E. Andou

    Plan Plan
  • ·POS-03.82: Malignant phyllodes tumor of the prostate (report of 2 cases and review of literature)

    Page :298

    R. Chen, Y. Xu, X. Zhang

    Plan Plan
  • ·POS-03.83: Using the Vienna nomogram to determine the number of prostate biopsy cores to be taken, does not seem to have statistical advantage: an ongoing, prospective, randomised study

    Page :298

    A.T. Lecuona, A. Naidoo, C.F. Heyns

    Plan Plan
  • ·POS-03.84: Robotic assisted transperineal saturation prostate biopsy in men with previous negative biopsy: comparison with transrectal approach

    Page :298-299

    H. Ho, P. Mohan, D.L. Li, J. Yuen, W.S. Ng, W. Lau, C. Cheng

    Plan Plan
  • ·POS-03.85: Serum PSA levels and prostate cancer in Iranian men

    Page :299

    D. Mehraban, G.H. Naderi, H. Arshadi, A. Tahvildar, A. Razi, S.M. Kazemeyni, M. Moosavi

    Plan Plan
  • ·POS-03.86: The meaning of anaesthesia by periprostatic injection in TR prostate biopsy

    Page :299

    G. Passavanti, V. Pizzuti, F.M. Costantini, A. Bragaglia, M. Carlucci, A.M. Aloisi, R. Paolini

    Plan Plan
  • ·POS-03.87: Significance of magnetic resonance image prior to prostate biopsies for the consideration of unnecessary biopsies

    Page :299-300

    A. Joraku, M. Yamaguchi, T. Oikawa, N. Sekido, S. Hinotsu, N. Miyanaga, K. Kawai, T. Shimazui, H. Akaza

    Plan Plan
  • ·POS-03.88: Prostate cancer detection using combined morphological MR imaging and MR 3D proton spectroscopy

    Page :300

    W. Lipczynski, Z. Dobrowolski, S.z. Bak, P. Trybek, A. Urbanik, R. Chrzan

    Plan Plan
  • ·POS-03.89: Blood supply in peripheral and transitional zone of the prostate gland in patients with adenoma and adenocarcinoma in 3D power Doppler imaging

    Page :300

    L. Wolinski, W. Lipczynski, K. Juszczak, Z. Dobrowolski, M. Dobrowolska-Bak

    Plan Plan
  • ·POS-03.90: Anti-tumor effect of telmisartan (angiotensin II receptor blocker) in prostate cancer

    Page :300

    K. Funao, M. Matsuyama, T. Naganuma, Y. Takemoto, T. Nakatani, R. Yoshimura

    Plan Plan
  • ·POS-03.91: Can the prostate cancer detection rate be improved with a saturation technique of prostate biopsy?

    Page :300-301

    S. Mallick, F. Comoz, S. Le Toquin, Y. Fouques, C. Jeanne-Pasquier, P. Rousselot, H. Bensadoun

    Plan Plan
  • ·POS-03.92: Early detection of prostata carcinoma: comparison of the diagnostical accuracy of complexed psa and ratio c/tpsa versus total psa and ratio F/TPSA

    Page :301

    W. Berg, U. Wolf, C.D. Haas, U.T. Becker, T. Deufel, J. Schubert

    Plan Plan
  • ·POS-03.93: Microbiological assessment of patients undergoing transrectal prostate needle biopsy with and without enema application before the procedure

    Page :301

    I. Sen, A. Camtosun, B. Sipahioglu, N. Sultan, S. Sozen, M. Onaran, I. Bozkirli

    Plan Plan
  • ·POS-03.94: An analysis of effective biopsy selection for men with serum PSA levels of less than 4.0 ng/ml

    Page :301-302

    H. Aoki, S. Kawamura, T. Tochigi, M. Kuwahara

    Plan Plan
  • ·POS-03.95: Long-term urinary sequellae following iodine 125 prostate brachytherapy

    Page :302

    J. Crook, N. Fleshner, C. Roberts, G. Pond

    Plan Plan
  • ·POS-03.96: The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry

    Page :302

    J. Crook, M. Neill, G. Studer, L. Le, M. McLean, I. Yeung, G. Pond

    Plan Plan
  • ·POS-03.97: Decision analyses for patients with biochemical failure after curative therapy on clinically localized prostate cancer in the prostate-specific antigen era

    Page :302-303

    F. Shimizu, A. Igarashi, T. Fukuda, Y. Kawachi, S. Minowada, Y. Ohashi, M. Fujime

    Plan Plan
  • ·POS-03.98: Operative complications of robotic assisted laparoscopic radical prostatectomy: the learning curve and beyond - a single surgeon series

    Page :303

    A. Patel, K. Shah, R. Thaly, K.J. Palmer, V. Patel

    Plan Plan
  • ·POS-03.99: Robotic radical prostatectomy: Technical refinements essential for success

    Page :303

    V. Patel, K.J. Palmer, K. Shah, R. Thaly

    Plan Plan
  • ·POS-03.100: Successful implementation of a robotic prostatectomy programme: a no-complication learning curve

    Page :303-304

    D. Golovsky, R. Kooner, R. Thanigasalam, K. Krishan Rasiah

    Plan Plan
  • ·POS-03.101: Nerve sparing radical prostatectomy: role in early prostate cancer patients

    Page :304

    T. Hussain, M. Al-Sudani

    Plan Plan
  • ·POS-03.102: Prostatectomy in the low PSA range (1-3.9 ng/ml) - is there a difference in histopatholgical reports depending on type of surgery?

    Page :304

    A. Nilsson, L. Hjertzell, L. Egevad, S. Brändstedt, M. Hellström

    Plan Plan
  • ·POS-03.103: Can preoperative clinicopathological parameters predict postoperative biochemical recurrence in the patients who received radical prostatectomy?

    Page :304-305

    N. Tanaka, Y. Matsumura, A. Tomioka, S. Anai, K. Fujimoto, Y. Hirao

    Plan Plan
  • ·POS-03.104: A prospective study of quality of life following high-intensity focused ultrasound therapy in the treatment of localized prostate cancer

    Page :305

    S. Shoji, T. Uchida, Y. Nagata, N. Mayumi, M. Nitta, M. Shima, Y. Usui, T. Terachi

    Plan Plan
  • ·POS-03.105: Are post operative CT scans necessary when performing true real time brachytherapy?

    Page :305

    S. Cornish, A. Van Rensburg, W. Van Niekerk

    Plan Plan
  • ·POS-03.106: Real time brachytherapy in patients having undergone prior TURP

    Page :305-306

    S. Cornish, A. Van Rensburg, W. Van Niekerk

    Plan Plan
  • ·POS-03.107: Iridium-192 high-dose-rate brachytherapy for T1c-T3bN0M0 prostate cancer

    Page :306

    Y. Jo, R. Hara, N. Kondo, T. Fujii, T. Yokoyama, Y. Miyaji, A. Nagai

    Plan Plan
  • ·POS-03.108: Impacts of intermittent androgen suppression on bone mineral density, fat metabolism and anemia in patients with locally advanced prostate cancer

    Page :306

    Y. Takezawa, M. Kobayashi, K. Ito, K. Suzuki, H. Yamanaka

    Plan Plan
  • ·POS-03.109: Simple and easy technique to prevent post-radical retropubic ptostatectomy inguinal hernia

    Page :306-307

    Y. Fujii, S. Yamamoto, J. Yonese, S. Kawakami, Y. Okubo, D. Suyama, Y. Komai, T. Kijima, I. Fukui

    Plan Plan
  • ·POS-03.110: Complete apical dissection at radical prostatectomy

    Page :307

    K. Kiyotaka, H. Ichikawa

    Plan Plan
  • ·POS-03.111: Continence rates and stricture formation following radical prostatectomy

    Page :307

    J. Bhatt, B. Little, H. Begg, S. McPhee, L. Cameron, A. Bell, E. Crombie, N. Al Saffar, G. Hollins

    Plan Plan
  • ·Abstract Withdrawn

    Page :307

    
  • ·POS-03.113: Initial Canadian experience of hypofractionated accelerated radiotherapy for low risk localized prostate cancer (pHART 3)

    Page :307

    L. Holden, A. Loblaw, P. Cheung, G. Morton, P. Basran, R. Tirona, M. Cardoso, G. Pang, S. Gardner

    Plan Plan
  • ·POS-03.114: Factors affecting the need for endoscopic intervention for debris or stricture after HIFU for prostate cancer

    Page :307-308

    T. Dudderidge, E. Zacharakis, J. Calleary, C. Allen, E. IIling, E. Emberton, H. Ahmed

    Plan Plan
  • ·POS-03.115: Tolerance of one session of high intensity focused ultrasound (Ablatherm^®) for localized prostate cancer: National prospective controlled study

    Page :308

    P. Conort, F. Desgrandchamps, V. Ravery, C. Ciofu, A. Bissery, A. Mallet

    Plan Plan
  • ·POS-03.116: Comparison between limited versus extended laparoscopic lymphadenectomy in localized prostate cancer: morbidity and efficiency

    Page :308-309

    B. Rousseau, N. Kerfant, A. Erauso, L. Doucet, M. Leloir, C. Deruelle, V. Joulin, A. Valeri, G. Fournier

    Plan Plan
  • ·POS-03.117: Robot assisted laparoscopic radical prostatectomy – our initial experience of 58 cases

    Page :309

    R. Nayyar, A.K. Hemal

    Plan Plan
  • ·POS-03.118: Influence of diabetes mellitus on the prognosis of prostate cancer patients

    Page :309

    D. Yamada, B. Suyama, T. Hirata, J. Nishiguchi

    Plan Plan
  • ·POS-03.119: Risk of developing a prostate neoplasia in a patient with HGPIN undergoing first re-biopsy, applying the saturation needle biopsy technique: a preliminary study

    Page :309

    R. Giulianelli, S. Brunori, B. Gentile, L. Mavilla, G. Vincenti, F. Pisanti, L. Albanesi, T. Shestani

    Plan Plan
  • ·POS-03.120: Pure neuroendocrine tumors of the prostate: an unusual entity

    Page :310

    M. Bouacida, A. Sahnoun, H. Jallouli, W. Gadhrib, H. Ketata, H. Fakhfakh, A. Bahloul, M.N. Mhiri

    Plan Plan
  • ·POS-03.121: Serum prostate specific antigen at presentation in white (European) compared to black (African) men with prostate cancer

    Page :310

    C.F. Heyns, M. Fisher

    Plan Plan
  • ·POS-03.122: High serum level PSA can be related to proctological disorders: results of a monoinstitutional survey

    Page :310-311

    M.A. Brausi, G. Verrini, M. Gavioli, G. Peracchia, G. DeLuca, G.L. Simonini, M. Viola, G.D.L. Giliberto

    Plan Plan
  • ·POS-03.123: Free to total ratio PSA predict the prognostic to biochemical recurrence in patients submitted to radical prostatectomy

    Page :311

    F.P. da Fonseca, S.C. Zequi, R.A. Coudry, F.A. Soares, A. Lopes

    Plan Plan
  • ·POS-03.124: Performance of percent free prostate specific antigen for detecting prostate cancer: a prospective evaluation

    Page :311

    M. Hadj Slimen, M. Gassara, W. Charfi, S. Kchaou, H. Ketata, Y. Ben Hadj Hmida, H. Masmoudi, H. Fakhfakh, A. Bahloul, M.N. Mhiri

    Plan Plan
  • ·Abstract Withdrawn

    Page :311

    
  • ·Abstract Withdrawn

    Page :311

    
  • ·Abstract Withdrawn

    Page :311

    
  • ·POS-03.125: Histopathologic outcomes of robotic-assisted laparoscopic radical prostatectomy: an analysis of positive margin status

    Page :311

    D. Arend, K. Shah, K.J. Palmer, R. Thaly, V. Patel

    Plan Plan
  • ·POS-03.126: SIOG (International Society of Geriatric Oncology) prostate cancer guidelines proposals in senior adult men

    Page :311-312

    J.P. Droz, L. Balducci, M. Bolla, M. Emberton, J. Fitzpatrick, S. Joniau, M. Kattan, S. Monfardini, J. Moul, A. Naeim, H. van Poppel, F. Saad, C. Sternberg

    Plan Plan
  • ·POS-03.127: Histologic tumor grade as an independant prognostic factor in paksitani males with prostate cancer

    Page :312

    F. Abbas, N. Faruqui, K. Sikander, I. Azam

    Plan Plan
  • ·POS-03.128: Fractal analysis in the study of prostate cancer neovascular network

    Page :312-313

    P. Kakouri, P. Pavlopoulos, N. Kavantzas, A. Apostolaki, E. Koniaris, S. Bouzoukas

    Plan Plan
  • ·POS-03.129: Tacrolimus rescue therapy in corticosteroid-resistant renal allograft rejection

    Page :313

    G.H. Naderi, D. Mehraban, S.M. Kazemeyni, S.R. Yahyazadeh

    Plan Plan
  • ·POS-03.130: The effect of successful renal transplantation on erectile dysfunction

    Page :313

    M. Taherimahmoudi, S. Moosavi, A. Mehrsai, M. Nikoobakht, A. Emamzadeh, G. Pourmand

    Plan Plan
  • ·POS-03.131: Our experience with endarterectomy and bypass vascular procedures in renal transplantation

    Page :313-314

    D. Basic, D. Milutinovic, J. Hadzi Djokic, M. Djokic, D. Radivojevic, R. Blagojevic, S. Micic

    Plan Plan
  • ·POS-03.132: The short time prognosis of kidney transplant recipients with severe heart failure

    Page :314

    D. Tacu, C. Bucsa, E. Kerezsy, L. Domnisor, D. Daia, M. Harza, M. Manu, B. Serbanescu, C. Tacu, I. Sinescu

    Plan Plan
  • ·POS-03.133: Risk factors of new onset diabetes mellitus after kidney transplantation

    Page :314

    C. Bucsa, D. Tacu, E. Kerezsy, L. Domnisor, D. Daia, M. Harza, M. Manu, B. Serbanescu, C. Tacu, L. Sinescu

    Plan Plan
  • ·POS-03.134: Viable testis after retroperitoneal mass cord ligation in internal ring of inguinal canal in fifteen kidney recipients: Five years of experience

    Page :314

    A. Zomorrodi, A. Buhuli

    Plan Plan
  • ·POS-03.135: Risk factors for malignancy in Japanese renal transplant recipients

    Page :315

    T. Abe, T. Imao, N. Ichimaru, S. Takahara, Y. Kokado, M. Okumi, R. Imamura, Y. Isaka, N. Nonomura, A. Okuyama

    Plan Plan
  • ·POS-03.136: Mouse model of chronic uraemia: Surgical aspects

    Page :315

    O. Ivanovski, I. Nikolov, Z. Popov

    Plan Plan
  • ·POS-03.137: Experience of ileal neobladder by padua procedure

    Page :315

    S. Okada, H. Watanabe, H. Naruyama, R. Ando, Y. Hashimoto, K. Tozawa, S. Sasaki, Y. Hayashi, K. Kohri

    Plan Plan
  • ·POS-03.138: Iatrogenic ureteral injury during endoscopic intervention (coloscopy) in a patient with continent urinary diversion with the Mainz Pouch II technique

    Page :315-316

    A. Lekas, A. Balangas, S. Schattka, W. Holtkamp, A. Kollias

    Plan Plan
  • ·POS-03.139: Mitrofanoff continent urinary diversions: the quality of life of 75 patients

    Page :316

    M. Hadj Slimen, I. Benabdallah, M. Gassara, W. Gadhrib, W. Chaaben, K. Chabchoub, M. Mhiri

    Plan Plan
  • ·POS-03.140: Dorsal onlay buccal mucosa full length urethroplasty – a single center experience

    Page :316

    S. Kulkarni, S. Lambe, A. Bapat, D. Kamat, A. Dhumavat, J. Kulkarni

    Plan Plan

• Author Index

  • ·Author Index

    Page :317-320